Section 73

EurekaMag PDF full texts Chapter 72,897


Mu, C.-T.; Lin, W.-T.; Chen, C.-H. 2020: Zoomable head-up display with the integration of holographic and geometrical imaging. Optics Express 28(24): 35716-35723
Jain, R.K.; Stroh, M. 2004: Zooming in and out with quantum dots. Nature Biotechnology 22(8): 959-960
Derkach, V. 2011: Zooming in on AMPA receptor regulation by CaMKII. Nature Neuroscience 14(6): 674-675
Eykelenboom, J.K.; Tanaka, T.U. 2020: Zooming in on chromosome dynamics. Cell Cycle 19(12): 1422-1432
Fitzpatrick, D. 2005: Zooming in on cortical maps. Nature Neuroscience 8(3): 264-266
Zhou, X.Jasmine.; Alber, F. 2012: Zooming in on genome organization. Nature Methods 9(10): 961-963
Smith, J.A.; Suraci, J.P.; Hunter, J.S.; Gaynor, K.M.; Keller, C.B.; Palmer, M.S.; Atkins, J.L.; Castañeda, I.; Cherry, M.J.; Garvey, P.M.; Huebner, S.E.; Morin, D.J.; Teckentrup, L.; Weterings, M.J.A.; Beaudrot, L. 2020: Zooming in on mechanistic predator-prey ecology: Integrating camera traps with experimental methods to reveal the drivers of ecological interactions. Journal of Animal Ecology 89(9): 1997-2012
Krasteva, P.V. 2014: Zooming in on nuclear logistics. Nature Methods 11(2): 126-127
Colantoni, A.; Rupert, J.; Vandelli, A.; Tartaglia, G.G.; Zacco, E. 2020: Zooming in on protein-RNA interactions: a multi-level workflow to identify interaction partners. Biochemical Society Transactions 48(4): 1529-1543
Narasimhan, K. 2012: Zooming in on seizures. Nature Neuroscience 15(2): 179
Cohn, N.; Foulsham, T. 2020: Zooming in on the cognitive neuroscience of visual narrative. Brain and Cognition 146: 105634
Ifenatuoha, C.; Okewale, B. 2021: Zooming in on the endometrial factor of recurrent implantation failure. Human Fertility 2021: 1-12
Seymour, J.R.; Amin, S.A.; Raina, J-Baptiste.; Stocker, R. 2017: Zooming in on the phycosphere: the ecological interface for phytoplankton-bacteria relationships. Nature Microbiology 2: 17065
Santhosh, L.; Rojas, J.C.; Lyons, P.G. 2021: Zooming into Focus Groups: Strategies for Qualitative Research in the Era of Social Distancing. Ats Scholar 2(2): 176-184
Rice, S.M.; Siegel, J.A.; Libby, T.; Graber, E.; Kourosh, A.S. 2021: Zooming into cosmetic procedures during the COVID-19 pandemic: the provider's perspective. International Journal of Women's Dermatology 7(2): 213-216
McKenna, J.; Fan, K.S. 2021: Zooming into the future of plastic surgery education. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 74(7): 1633-1701
Le Bras, A. 2021: Zooming into the heart. Lab Animal 50(1): 14
Bhaskar, A.; Ng, A.K.M.; Patil, N.G.; Fok, M. 2020: Zooming past the coronavirus lockdown: online spirometry practical demonstration with student involvement in analysis by remote control. Advances in Physiology Education 44(4): 516-519
Chandra, S.; Laoteppitaks, C.; Mingioni, N.; Papanagnou, D. 2020: Zooming-out COVID-19: Virtual clinical experiences in an emergency medicine clerkship. Medical Education 54(12): 1182-1183
Hugh, J.M.; Lesiak, K.; Greene, L.A.; Pierson, J.C. 2014: Zoon's balanitis. Journal of Drugs in Dermatology: Jdd 13(10): 1290-1291
Delaleu, J.ér.ém.; Cavelier-Balloy, B.én.éd.; Bagot, M.; Fouéré, S.éb.; Dauendorffer, J.-N.ël. 2020: Zoon's plasma cell balanitis associated with male genital lichen sclerosus. Jaad Case Reports 6(7): 670-672
Polack, B.; Boulouis, H.-J.; Guillot, J.; Chermette, R.é 2015: Zoonoses (synthetic tables): animal reservoirs of pathogens and way of transmission to man. Revue Francophone des Laboratoires: Rfl 477: 67-79
Barnett, T.; Fournié, G. 2021: Zoonoses and wet markets: beyond technical interventions. LANCET. Planetary Health 5(1): E2-E3
Schaapveld, K.; Treurniet, H.F. 1994: Zoonoses as a public health problem. Tijdschrift Voor Diergeneeskunde 119(9): 272-275
Shanholtz, M.I. 1960: Zoonoses of importance to Virginians. Virginia Medical Monthly 87: 493-494
Shanholtz, M.I. 1960: Zoonoses of importance to Virginians. Virginia Medical Monthly 87: 451
Steyn, J.; Fourie, I.; Steyl, J.; Williams, J.; Stivaktas, V.; Botha, E.; van Niekerk, S.; Reininghaus, B.; Venter, M. 2020: Zoonotic Alphaviruses in Fatal and Neurologic Infections in Wildlife and Nonequine Domestic Animals, South Africa. Emerging Infectious Diseases 26(6): 1182-1191
Mendoza-Roldan, J.A.; Gabrielli, S.; Cascio, A.; Manoj, R.R.S.; Bezerra-Santos, M.A.; Benelli, G.; Brianti, E.; Latrofa, M.S.; Otranto, D. 2021: Zoonotic Dirofilaria immitis and Dirofilaria repens infection in humans and an integrative approach to the diagnosis. Acta Tropica 223: 106083
Kumar, S.; Swain, S.; G S, P.; Singh, B.S.; Aggarwal, D. 2020: Zoonotic Diseases in India. Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive and Social Medicine 45(Suppl 1): S1-S2
Sithay, P.; Thongseesuksai, T.; Chanthavong, S.; Savongsy, O.; Khaminsou, N.; Boonmars, T.; Laummaunwai, P. 2020: Zoonotic Helminthiases in Rodents (Bandicota indica, Bandicota savilei, and Leopoldamys edwardsi) from Vientiane Capital, Lao PDR. American Journal of Tropical Medicine and Hygiene 103(6): 2323-2327
Ghosh, I.; Nadim, S.S.; Chattopadhyay, J. 2021: Zoonotic MERS-CoV transmission: modeling, backward bifurcation and optimal control analysis. Nonlinear Dynamics 103(3): 2973-2992
Mendoza-Roldan, J.A.; Modry, D.; Otranto, D. 2020: Zoonotic Parasites of Reptiles: a Crawling Threat. Trends in Parasitology 36(8): 677-687
Battisti, E.; Urach, K.; Hodžić, A.; Fusani, L.; Hufnagl, P.; Felsberger, G.; Ferroglio, E.; Duscher, G.G. 2020: Zoonotic Pathogens in Ticks from Migratory Birds, Italy. Emerging Infectious Diseases 26(12): 2986-2988
Belkahia, H.èn.; Selmi, R.; Zamiti, S.; Daaloul-Jedidi, M.; Messadi, L.; Ben Said, M. 2021: Zoonotic Rickettsia Species in Small Ruminant Ticks from Tunisia. Frontiers in Veterinary Science 8: 676896
Zendejas-Heredia, P.A.; Crawley, A.; Byrnes, H.; Traub, R.J.; Colella, V. 2021: Zoonotic Soil-Transmitted Helminths in Free-Roaming Dogs, Kiribati. Emerging Infectious Diseases 27(8): 2163-2165
Springer, A.; Glass, A.; Topp, A.-K.; Strube, C. 2020: Zoonotic Tick-Borne Pathogens in Temperate and Cold Regions of Europe-A Review on the Prevalence in Domestic Animals. Frontiers in Veterinary Science 7: 604910
Ruang-Areerate, T.; Piyaraj, P.; Suwannahitatorn, P.; Ruang-Areerate, P.; Thita, T.; Naaglor, T.; Witee, U.; Sakboonyarat, B.; Leelayoova, S.; Mungthin, M. 2021: Zoonotic Transmission of Blastocystis Subtype 1 among people in Eastern Communities of Thailand: Organic Fertilizer from Pig Feces as a Potential Source. Microbiology Spectrum 9(2): E0036221
Bahrami, F.; Haghighi, A.; Zamini, G.; Khademerfan, M. 2020: Zoonotic Transmission of Cryptosporidium and Microsporidia in Individuals of the Kurdistan Province, West of Iran. Journal of Parasitology 106(4): 464-470
Colella, V.; Nguyen, V.L.; Tan, D.Y.; Lu, N.; Fang, F.; Zhijuan, Y.; Wang, J.; Liu, X.; Chen, X.; Dong, J.; Nurcahyo, W.; Hadi, U.K.; Venturina, V.; Tong, K.B.Y.; Tsai, Y.-L.; Taweethavonsawat, P.; Tiwananthagorn, S.; Le, T.Q.; Bui, K.L.; Watanabe, M.; Rani, P.A.M.A.; Annoscia, G.; Beugnet, F.éd.ér.; Otranto, D.; Halos, L.én.ïg. 2020: Zoonotic Vectorborne Pathogens and Ectoparasites of Dogs and Cats in Eastern and Southeast Asia. Emerging Infectious Diseases 26(6): 1221-1233
Rabbani, I.Ar-Rifqi.; Mareta, F.Jihan.; Kusnoto; Hastutiek, P.; Lastuti, N.Dyah.Retno.; Mufasirin; Suharsono; Sardjana, I.Komang.Wiarsa.; Sukmanadi, M.; Suwanti, L.Tri. 2020: Zoonotic and Other Gastrointestinal Parasites in Cats in Lumajang, East Java, Indonesia. Infectious Disease Reports 12(11): 105-108
Goraichuk, I.V.; Arefiev, V.; Stegniy, B.T.; Gerilovych, A.P. 2021: Zoonotic and Reverse Zoonotic Transmissibility of SARS-CoV-2. Virus Research 302: 198473
Khan, W.; Noor-Un-Nisa; Rafiq, N.; Masood, Z.; Salim Ahmed, M.; Ur Rahman, H.; Kabir, M.; Ghaffar, R.; Naz, A.; Ali Shah, M.I. 2021: Zoonotic and non-zoonotic helminths in black rats of rain-fed and irrigated areas of Swat, Khyber Pakhtunkhwa, Pakistan. Saudi Journal of Biological Sciences 28(4): 2285-2290
Rabbani, I.A.-R.; Mareta, F.J.; Kusnoto; Hastutiek, P.; Lastuti, N.D.R.; Mufasirin; Suharsono; Sardjana, I.K.W.; Sukmanadi, M.; Suwanti, L.T. 2020: Zoonotic and other gastrointestinal parasites in cats in Lumajang, East Java, Indonesia. Infectious Disease Reports 12(Suppl 1): 8747
Anjorin, A.A.; Ashaka, O.S.; Tijani, S.O.; Openibo, J.O.; Odetokun, I.A. 2021: Zoonotic and reverse zoonotic transmission of severe acute respiratory syndrome coronavirus 2: a review and implications for Africa. Pan African Medical Journal 38: 39
Glud, H.A.; George, S.; Skovgaard, K.; Larsen, L.E. 2021: Zoonotic and reverse zoonotic transmission of viruses between humans and pigs. Apmis: Acta Pathologica Microbiologica et Immunologica Scandinavica 129(12): 675-693
Singh, G.; Angwafor, S.A.; Njamnshi, A.K.; Fraimow, H.; Sander, J.W. 2020: Zoonotic and vector-borne parasites and epilepsy in low-income and middle-income countries. Nature Reviews. Neurology 16(6): 333-345
Mravcová, K.; Štrkolcová, G.; Mucha, R.; Goldová, M. 2021: Zoonotic assemblages of Giardia duodenalis in captive non-human primates from the largest zoo in Slovakia. Journal of Parasitic Diseases: Official Organ of the Indian Society for Parasitology 45(2): 302-305
Fung, M.; Otani, I.; Pham, M.; Babik, J. 2021: Zoonotic coronavirus epidemics: Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 126(4): 321-337
Hotchkiss, E.J. 2021: Zoonotic cryptosporidiosis - challenges for control and source attribution. Veterinary Record 189(4): 150-152
Elton, L.; Haider, N.; Kock, R.; Thomason, M.J.; Tembo, J.; Arruda, L.ã B.ár.; Ntoumi, F.; Zumla, A.; McHugh, T.D. 2021: Zoonotic disease preparedness in sub-Saharan African countries. One Health Outlook 3(1): 5
Mtimet, N.; Wanyoike, F.; Rich, K.M.; Baltenweck, I. 2021: Zoonotic diseases and the COVID-19 pandemic: Economic impacts on Somaliland's livestock exports to Saudi Arabia. Global Food Security 28: 100512
Rajeev, R.; Prathiviraj, R.; Kiran, G.S.; Selvin, J. 2020: Zoonotic evolution and implications of microbiome in viral transmission and infection. Virus Research 290: 198175
Gibb, R.; Redding, D.W.; Chin, K.Qing.; Donnelly, C.A.; Blackburn, T.M.; Newbold, T.; Jones, K.E. 2020: Zoonotic host diversity increases in human-dominated ecosystems. Nature 584(7821): 398-402
Tajudeen, Y.A.; Oladunjoye, I.O.; Adebisi, Y.A. 2021: Zoonotic infectious diseases and maritime seaport: areas of concern. International Maritime Health 72(3): 237-238
Latif, A.A.; Mukaratirwa, S. 2020: Zoonotic origins and animal hosts of coronaviruses causing human disease pandemics: a review. Onderstepoort Journal of Veterinary Research 87(1): E1-E9
Guo, Y.; Li, N.; Feng, Y.; Xiao, L. 2021: Zoonotic parasites in farmed exotic animals in China: Implications to public health. International Journal for Parasitology. Parasites and Wildlife 14: 241-247
Hajipour, N.; Soltani, M.; Ketzis, J.; Hassanzadeh, P. 2021: Zoonotic parasitic organisms on vegetables: Impact of production system characteristics on presence, prevalence on vegetables in northwestern Iran and washing methods for removal. Food Microbiology 95: 103704
Dróżdż, M.; Małaszczuk, Mł.; Paluch, E.; Pawlak, A. 2021: Zoonotic potential and prevalence of Salmonella serovars isolated from pets. Infection Ecology and Epidemiology 11(1): 1975530
Hwang, S.; Shin, S.-U.; Kim, S.; Ryu, J.-H.; Choi, K.-S. 2020: Zoonotic potential of Enterocytozoon bieneusi in pre-weaned Korean native calves. Parasites and Vectors 13(1): 300
Bratcher, A.; Hoff, N.A.; Doshi, R.H.; Gadoth, A.; Halbrook, M.; Mukadi, P.; Musene, K.; Ilunga-Kebela, B.; Spencer, D.'A.; Bramble, M.S.; McIlwan, D.; Kelly, J.D.; Mukadi, D.; Kingebeni, P.M.; Ahuka, S.; Okitolonda-Wemakoy, E.; Muyembe-Tamfum, J.-J.; Rimoin, A.W. 2021: Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo. Plos Neglected Tropical Diseases 15(8): E0009566
Engel, G.A.; Small, C.T.; Soliven, K.; Feeroz, M.M.; Wang, X.; Kamrul Hasan, M.; Oh, G.; Rabiul Alam, S.M.; Craig, K.L.; Jackson, D.L.; Matsen Iv, F.A.; Linial, M.L.; Jones-Engel, L. 2013: Zoonotic simian foamy virus in Bangladesh reflects diverse patterns of transmission and co-infection. Emerging Microbes and Infections 2(9): E58
Fichman, V.; Marques de Macedo, P.; Francis Saraiva Freitas, D.; Carlos Francesconi do Valle, A.; Almeida-Silva, F.; Reis Bernardes-Engemann, A.éa.; Zancopé-Oliveira, R.M.; Almeida-Paes, R.; Clara Gutierrez-Galhardo, M. 2021: Zoonotic sporotrichosis in renal transplant recipients from Rio de Janeiro, Brazil. Transplant Infectious Disease: An Official Journal of the Transplantation Society 23(2): E13485
Kock, R.; Michel, A.L.; Yeboah-Manu, D.; Azhar, E.I.; Torrelles, J.B.; Cadmus, S.I.; Brunton, L.; Chakaya, J.M.; Marais, B.; Mboera, L.; Rahim, Z.; Haider, N.; Zumla, A. 2021: Zoonotic Tuberculosis - the Changing Landscape. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 113(Suppl 1): S68-S72
Islam, S.S.; Rumi, T.B.; Kabir, S.M.L.; Rahman, A.K.M.A.; Faisal, M.M.H.; Islam, R.; van der Zanden, A.G.M.; Ward, M.P.; Ross, A.G.; Rahim, Z. 2021: Zoonotic tuberculosis knowledge and practices among cattle handlers in selected districts of Bangladesh. Plos Neglected Tropical Diseases 15(4): E0009394
Páez-Martínez, A.és.; Laiton-Donato, K.; Usme-Ciro, J.é A. 2020: Zoonotic vaccinia in Colombia: Cumulative evidence of the emergence of poxviruses in the world. Revista de Salud Publica 20(6): 778-783
Lourenço, K.L.; Chinália, L.A.; Henriques, L.íc.R.; Rodrigues, R.A.új.L.; da Fonseca, F.áv.G.ãe. 2021: Zoonotic vaccinia virus strains belonging to different genetic clades exhibit immunomodulation abilities that are proportional to their virulence. Virology Journal 18(1): 124
Selmi, R.; Belkahia, H.èn.; Dhibi, M.; Abdelaali, H.; Lahmar, S.; Ben Said, M.; Messadi, L. 2021: Zoonotic vector-borne bacteria in wild rodents and associated ectoparasites from Tunisia. Infection Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 95: 105039
Zhang, L-Jun.; Fan, R-Ying.; Gong, Y-Ming. 2015: Zoophycos macroevolution since 541 Ma. Scientific Reports 5: 14954
Yang, J.; Zhang, X.; Xie, Y.; Song, C.; Zhang, Y.; Yu, H.; Burton, G.Allen. 2017: Zooplankton Community Profiling in a Eutrophic Freshwater Ecosystem-Lake Tai Basin by DNA Metabarcoding. Scientific Reports 7(1): 1773
La, H.Sul.; Park, K.; Wåhlin, A.; Arrigo, K.R.; Kim, D.Seon.; Yang, E.Jin.; Atkinson, A.; Fielding, S.; Im, J.; Kim, T-Wan.; Shin, H.Chul.; Lee, S.; Ha, H.Kyung. 2019: Zooplankton and micronekton respond to climate fluctuations in the Amundsen Sea polynya, Antarctica. Scientific Reports 9(1): 10087
Weydmann-Zwolicka, A.; Prątnicka, P.; Łącka, M.; Majaneva, S.; Cottier, F.; Berge, J.ør. 2021: Zooplankton and sediment fluxes in two contrasting fjords reveal Atlantification of the Arctic. Science of the Total Environment 773: 145599
Pitz, K.J.; Guo, J.; Johnson, S.B.; Campbell, T.L.; Zhang, H.; Vrijenhoek, R.C.; Chavez, F.P.; Geller, J. 2020: Zooplankton biogeographic boundaries in the California Current System as determined from metabarcoding. Plos one 15(6): E0235159
Fullgrabe, L.; Grosjean, P.; Gobert, S.; Lejeune, P.; Leduc, M.èl.; Engels, G.; Dauby, P.; Boissery, P.; Richir, J. 2020: Zooplankton dynamics in a changing environment: a 13-year survey in the northwestern Mediterranean Sea. Marine Environmental Research 159: 104962
Kvale, K.; Prowe, A.E.F.; Chien, C-T.; Landolfi, A.; Oschlies, A. 2021: Zooplankton grazing of microplastic can accelerate global loss of ocean oxygen. Nature Communications 12(1): 2358
Wittenborn, A.K.; Schmale, O.; Thiel, V. 2020: Zooplankton impact on lipid biomarkers in water column vs. surface sediments of the stratified Eastern Gotland Basin (Central Baltic Sea). Plos one 15(6): E0234110
Dexter, E.; Bollens, S.M. 2020: Zooplankton invasions in the early 21st century: a global survey of recent studies and recommendations for future research. Hydrobiologia 847(1): 309-319
Ismail, J.; Mustafa Kamal, A.H.; Idris, M.H.; Amin, S.M.N.; Hamli, H.; Sien, L.S.; Al-Asif, A.; Abualreesh, M.H. 2021: Zooplankton species composition and diversity in the seagrass habitat of Lawas, Sarawak, Malaysia. Biodiversity Data Journal 9: E67449
Perry, R.I.; Young, K.; Galbraith, M.; Chandler, P.; Velez-Espino, A.; Baillie, S. 2021: Zooplankton variability in the Strait of Georgia, Canada, and relationships with the marine survivals of Chinook and Coho salmon. Plos one 16(1): E0245941
Pous, N.ís.; Barcelona, A.; Sbardella, L.; Hidalgo, M.; Colomer, J.; Serra, T.; Salvadó, V.òr. 2021: Zooplankton-based reactors for tertiary wastewater treatment: a pilot-scale case study. Journal of Environmental Management 278(Part 1): 111538
Loeb, J. 2021: Zoos struggling to access Covid-19 support. Veterinary Record 188(7): 242-243
Hooper, J.N.A.; Wörheide, G.; Hajdu, E.; Erpenbeck, D.; DE Voogd, N.J.; Klautau, M. 2021: Zootaxa 20 years: Phylum Porifera. Zootaxa 4979(1): 3856
Ferreira, E.K.G.D.; Mazzarotto, G.A.C.A.; Silveira, G.F. 2021: Zootechnical data analysis in a breeding animal facility: tracing the patterns of mouse production. Laboratory Animal Research 37(1): 1
Polese, M.F.; Polese, M.F.; Radael, M.C.; Mendonça, P.P.; Motta, J.H.S.; Azevedo, R.V.; Souza, A.B.; Shimoda, E.; Lavander, H.D.; Aride, P.H.R.; Oliveira, A.T.; Vidal Júnior, M.V. 2021: Zootechnical indices and digestibility in juveniles of tambaqui Colossoma macropomum fed a diet containing particulate maize. Brazilian Journal of Biology 82: E232612
LaJeunesse, T.C. 2020: Zooxanthellae. Current Biology: Cb 30(19): R1110-R1113
Louzada, L.L.; Machado, F.áv.V.; Nóbrega, O.áv.T.; Camargos, E.F. 2021: Zopiclone to treat insomnia in older adults: a systematic review. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 50: 75-92
Verma, R.; Sarkar, S.; Shettigar, C. 2020: Zoster Brachial Plexopathy as a Presenting Manifestation of Human Immunodeficiency Virus Infection. Annals of Indian Academy of Neurology 23(6): 804-807
Dahl, S. 1952: Zoster Generalisatus Zoster Idiopaticus, Zoster Symptomaticus. Bibliotek for Laeger 144: 217-221
Tappeiner 1948: Zoster Rami Trigemini IIi and generalisatus with facial imitation. Klinische Medizin; Osterreichische Zeitschrift für Wissenschaftliche und Praktische Medizin 3(2): 73
Bruckel, K. 1948: Zoster affection and rheumatism; Observations based on Zoster-Meningo encephalitis in ankylosing spondylitis. Deutsche Medizinische Wochenschrift 73(17-20): 198-200
Al-Mendalawi, M.D. 2012: Zoster myelitis in sickle cell anemia. Neurosciences 17(1): 87
Kunz, H.E.; Makedonas, G.; Mehta, S.K.; Tyring, S.K.; Vangipuram, R.; Quiriarte, H.; Nelman-Gonzalez, M.; Pierson, D.L.; Crucian, B.E. 2020: Zoster patients on earth and astronauts in space share similar immunologic profiles. Life Sciences in Space Research 25: 119-128
Al-Ani, H.H.; Niederer, R.L. 2020: Zoster sine herpete: a disease that ophthalmologists should be aware of. Korean Journal of Pain 33(4): 403-404
Zhou, J.; Li, J.; Ma, L.; Cao, S. 2020: Zoster sine herpete: a review. Korean Journal of Pain 33(3): 208-215
Pellerat, J.; Vayre, J.; Rebattu, J.P. 1949: Zosterian herpes or bilateral shingles in a newborn. Lyon Medical 182(41): 234
Raghupathy, R.; Priyadarshini, A.; Mahalakshmi, V.; Sudha, R.; Krishnakanth, M.; Priya, M.B. 2020: Zosteriform Cutaneous Metastases with Primary Endometrial Carcinoma. Indian Journal of Dermatology 65(5): 420-422
Kim, J.C.; Kim, Y.C. 2021: Zosteriform Unilateral Linear Capillaritis. Annals of Dermatology 33(3): 298-300
Dagdelen, D.; Karadag, A.S.; Akdeniz, N.; Ozkanli, S.S.; Gurel, M.S. 2020: Zosteriform cutaneous metastasis: a case series. Dermatologic Therapy 33(6): E14137
Goldner, R.; Robinson, H.M. 1971: Zosteriform porokeratosis of Mibelli. Birth Defects Original Article Series 7(8): 251
Maki, Y.; Kimizuka, Y.; Murakami, K.; Sato, K.; Sasaki, H.; Yamamoto, T.; Watanabe, C.; Sano, T.; Miyata, J.; Fujikura, Y.; Kawana, A. 2021: Zosteriform skin metastasis caused by retrograde lymphatic migration of metastatic squamous cell lung carcinoma. Bmc Pulmonary Medicine 21(1): 41
Bhushan, R.; Supekar, B.B.; Mukhi, J.; Singh, R.P. 2021: Zosteriform-Fixed Drug Eruption Secondary to Ciprofloxacin. Indian Dermatology Online Journal 12(3): 456-458
Cheng, W.; Ma, J.; Xiang, L.; Sun, Y.; Huang, W.; Zhang, Z.; Kong, D.; Li, J. 2021: Zr4+-mediated hybrid chain reaction and its application for highly sensitive electrochemical detection of protein kinase a. Bioelectrochemistry 140: 107796
Kumar, G.A.; Rambabu, Y.; Guntu, R.K.; Sivaram, K.; Reddy, M.S.; Rao, C.S.; Venkatramu, V.; Kumar, V.R.; Sriman Narayana Iyengar, N.C. 2021: ZrxCa30-xP70 thermoluminescent bio glass, structure and elasticity. Journal of the Mechanical Behavior of Biomedical Materials 119: 104517
Wang, J.; Zhou, Y.; Zeng, M.; Zhao, Y.; Zuo, X.; Meng, F.; Lv, F.; Lu, Y. 2022: Zr(IV)-based metal-organic framework nanocomposites with enhanced peroxidase-like activity as a colorimetric sensing platform for sensitive detection of hydrogen peroxide and phenol. Environmental Research 203: 111818
Zhang, W.; Gong, M.; Yang, J.; Gu, J. 2021: Zr-MOFs Integrated with a Guest Capturer and a Photosensitizer for the Simultaneous Adsorption and Degradation of 4-Chlorophenol. Langmuir: the Acs Journal of Surfaces and Colloids 37(27): 8157-8166
Zhao, J.; Xu, L.; Su, Y.; Yu, H.; Liu, H.; Qian, S.; Zheng, W.; Zhao, Y. 2021: Zr-MOFs loaded on polyurethane foam by polydopamine for enhanced dye adsorption. Journal of Environmental Sciences 101: 177-188
Jiang, Y.; Liu, S.; Yuan, Q.; Liang, H. 2021: Zr-based acid-stable nucleotide coordination polymers: An excellent platform for acidophilic enzymes immobilization. Journal of Inorganic Biochemistry 216: 111338
Liu, W.; Jiang, K.; Hu, Y.; Li, Q.; Deng, Y.; Bao, J.; Lei, Y. 2021: Zr-doped CoFe-layered double hydroxides for highly efficient seawater electrolysis. Journal of Colloid and Interface Science 604: 767-775
Cheng, Y.; An, Y.; Liu, Y.; Wei, Q.; Han, W.; Zhang, X.; Zhou, P.; Wei, C.; Hu, N. 2020: ZrB2-Based "Brick-and-Mortar" Composites Achieving the Synergy of Superior Damage Tolerance and Ablation Resistance. Acs Applied Materials and Interfaces 12(29): 33246-33255
Li, Q.; Cheng, Y.; Li, X.; Guo, Y.; Chu, K. 2020: ZrB2 as an earth-abundant metal diboride catalyst for electroreduction of dinitrogen to ammonia. Chemical Communications 56(85): 13009-13012
Cubillos, G.I.; Romero, E.; Umaña-Perez, A. 2021: ZrN-ZrO x N y vs ZrO 2 -ZrO x N y coatings deposited via unbalanced DC magnetron sputtering. Scientific Reports 11(1): 18926
Wu, X.; Wei, J.; Wu, C.; Lv, G.; Wu, L. 2021: ZrO2/CeO2/polyacrylic acid nanocomposites with alkaline phosphatase-like activity for sensing. Spectrochimica Acta. Part a Molecular and Biomolecular Spectroscopy 263: 120165
Zhang, S.; Liu, H.; Zhou, J.; Liu, Y.; Han, G.; Hao, Y. 2021: ZrOx Negative Capacitance Field-Effect Transistor with Sub-60 Subthreshold Swing Behavior. Nanoscale Research Letters 16(1): 21
Guo, L.-G.; Shang, X.; Gao, J.; Zhang, H.; Gao, Y. 2020: ZrSe2 nanosheet as saturable absorber for soliton operations within an Er-doped passive mode-locked fiber laser. Applied Optics 59(25): 7484-7489
Zalzman, M.; Falco, G.; Sharova, L.V.; Nishiyama, A.; Thomas, M.; Lee, S-Lim.; Stagg, C.A.; Hoang, H.G.; Yang, H-Te.; Indig, F.E.; Wersto, R.P.; Ko, M.S.H. 2010: Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature 464(7290): 858-863
Amano, T.; Hirata, T.; Falco, G.; Monti, M.; Sharova, L.V.; Amano, M.; Sheer, S.; Hoang, H.G.; Piao, Y.; Stagg, C.A.; Yamamizu, K.; Akiyama, T.; Ko, M.S.H. 2013: Zscan4 restores the developmental potency of embryonic stem cells. Nature Communications 4: 1966
Hirata, T.; Amano, T.; Nakatake, Y.; Amano, M.; Piao, Y.; Hoang, H.G.; Ko, M.S.H. 2012: Zscan4 transiently reactivates early embryonic genes during the generation of induced pluripotent stem cells. Scientific Reports 2: 208
Hollenstein, N.; Rotsztejn, J.; Troendle, M.; Pedroni, A.; Zhang, C.; Langer, N. 2018: ZuCo, a simultaneous EEG and eye-tracking resource for natural sentence reading. Scientific Data 5: 180291
Ding, D.; Chen, C. 2020: Zucchini: the key ingredient to unveil piRNA precursor processing†. Biology of Reproduction 103(3): 452-454
LaBranche, T.P.; Kopec, A.K.; Mantena, S.R.; Hollingshead, B.D.; Harrington, A.W.; Stewart, Z.S.; Zhan, Y.; Hayes, K.D.; Whiteley, L.O.; Burdick, A.D.; Davis, J.W. 2020: Zucker Lean Rats with Hepatic Steatosis Recapitulate Asymptomatic Metabolic Syndrome and Exhibit Greater Sensitivity to Drug-Induced Liver Injury Compared with Standard Nonclinical Sprague-Dawley Rat Model. Toxicologic Pathology 48(8): 994-1007
Massanés, R.M.; Grasa, M.M.; López-Martí, J.; Díaz-Silva, M.; Fernández-López, J.A.; Remesar, X.; Alemany, M. 2003: Zucker obese rats store less acyl-estrone than lean controls. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 27(4): 428-432
Bertrand, I.; Quivy, D. 1947: Zucker's growth formula applied to a rat farm. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 141(11-12): 644-646
Fenton, M.; Coutinho, E.S.; Campbell, C. 2001: Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses. Cochrane Database of Systematic Reviews 3: Cd000525
Ramos, B.F.; Cal, R.; Brock, C.M.; Mangabeira Albernaz, P.L.; Zuma E Maia, F. 2021: Zuma Modified Maneuver as a Treatment to Geotropic Lateral Semicircular Canal Benign Paroxysmal Positional Vertigo. International Archives of Otorhinolaryngology 25(2): E255-E257
Hao, P.; Zhang, Y.; Li, Z.; Xi, J.; Tan, F. 2020: Zunyou Wu, China CDC's Chief Expert of Epidemiology. China Cdc Weekly 2(34): 669-670
De Magis, A.; Götz, S.; Hajikazemi, M.; Fekete-Szücs, Eő.; Caterino, M.; Juranek, S.; Paeschke, K. 2020: Zuo1 supports G4 structure formation and directs repair toward nucleotide excision repair. Nature Communications 11(1): 3907
Chen, L.; Ren, M.; Cao, J.; Sang, H.; Chen, H.; Xu, A.; Zhao, M. 2021: Zuogui Wan alleviated maternal kidney-yin deficiency-induced thymic epithelial cell dysfunction in newborn rats through Wnt/β-catenin signaling pathway. Journal of Ethnopharmacology 279:: 114337
Liu, H.; Zhong, L.; Dai, Q.; Yang, J.; Zhang, Y.; Zhang, B.; Jiang, Y. 2022: Zuoguiwan Ameliorates Cognitive Deficits and Neuro-Inflammation in Streptozotocin-Induced Alzheimer's Disease Rats. Neuroimmunomodulation 29(1): 63-69
Tong, Y.; Wang, R.; Liu, X.; Tian, M.; Wang, Y.; Cui, Y.; Zou, W.; Zhao, Y. 2021: Zuojin Pill ameliorates chronic atrophic gastritis induced by MNNG through TGF-β1/PI3K/Akt axis. Journal of Ethnopharmacology 271:: 113893
Wei, Y.; Wang, R.; Ren, S.; Liu, X.; Jing, M.; Li, R.; Tong, Y.; Wen, J.; Yang, T.; Wang, J.; Zhao, Y. 2021: Zuojin Pill ameliorates inflammation in indomethacin-induced gastric injury via inhibition of MAPK pathway. Journal of Ethnopharmacology 275:: 114103
Nie, Y.; Xu, S.-F.; Lu, Y.-L.; Zhao, X.-R.; Li, C.; Wei, L.-X.; Liu, J. 2021: Zuotai (β-HgS)-containing 70 Wei Zhen-Zhu-Wan differs from mercury chloride and methylmercury on hepatic cytochrome P450 in mice. F1000research 10: 203
Wienke, A. 2020: Zur Bedeutung der Aufklärung über Behandlungsalternativen. Laryngo- Rhino- Otologie 99(11): 815-816
Rimpau, W. 1949: Zur serologischen Diagnose der Leptospirose. Medizinische Monatsschrift 3(7): 481-483
Bullock, A.; Kaul, I.; Li, S.; Silber, C.; Doherty, J.; Kanes, S.J. 2021: Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: a phase 2, open-label study. Journal of the Neurological Sciences 421: 117277
Lanz, O.I.; Forzisi, I.; Vezzoni, A. 2021: Zurich Cementless Dual Mobility Cup for Canine Total Hip Prosthesis: Implant Characteristics and Surgical Outcome in 105 Cases. Veterinary and Comparative Orthopaedics and Traumatology: V.C.O.T 34(4): 294-302
Jank, B.; Haymerle, H.; Doblhoff-Dier, O. 1996: Zurich hazard analysis in biotechnology. Nature Biotechnology 14(7): 894-896
Pfister, H.O. 1947: Zurich in the Fight against Homelessness. Gesundheit 27(7): 245-250
Chen, J.; Lin, Z.; Ding, J. 2021: Zusanli (ST36) Acupoint Injection with Dexamethasone for Chemotherapy-Induced Myelosuppression: a Systematic Review and Meta-Analysis. Frontiers in Oncology 11: 684129
Serrano, L.F.; Rojas-Rojas, M.ía.M.; Machado, F.A. 2020: Zuska's breast disease: Breast imaging findings and histopathologic overview. Indian Journal of Radiology and Imaging 30(3): 327-333
Kohl, C.; Brinkmann, A.; Radonić, A.; Dabrowski, P.Wojtek.; Nitsche, A.; Mühldorfer, K.; Wibbelt, G.; Kurth, A. 2020: Zwiesel bat banyangvirus, a potentially zoonotic Huaiyangshan banyangvirus (Formerly known as SFTS)-like banyangvirus in Northern bats from Germany. Scientific Reports 10(1): 1370
Mou, K.; Zhang, J.; Mu, X.; Wang, L.; Liu, W.; Ge, R. 2021: Zwint facilitates melanoma progression by promoting c-Myc expression. Experimental and Therapeutic Medicine 22(2): 818
Woo Seo, D.; Yeop You, S.; Chung, W-Jae.; Cho, D-Hyung.; Kim, J-Sung.; Su Oh, J. 2015: Zwint-1 is required for spindle assembly checkpoint function and kinetochore-microtubule attachment during oocyte meiosis. Scientific Reports 5: 15431
Zúñiga, F.; Frei, I.A. 2021: Zwischen Anspruch und Wirklichkeit - Perspektive von fallverantwortlichen Pflegefachpersonen zur Rationierung in der spitalexternen Pflege. Pflege 34(1): 23-30
Rabes, C.; Bläuer, C.; Büche, V.; Gisler Ries, I.; Knüppel Lauener, S.; Kuehl, R.; Osthoff, M.; Pfeiffer, M.; Probst, S.; Todorov, V.; Panfil, E.-M. 2020: Zwischen Traum und Trauma - Aufbau und Betrieb einer Kohortenstation für Patient_innen mit COVID-19 in einem Akutspital - Eine Fallstudie. Pflege 33(4): 247-255
Nikam, S.P.; Chen, P.; Nettleton, K.; Hsu, Y.-H.; Becker, M.L. 2020: Zwitterion Surface-Functionalized Thermoplastic Polyurethane for Antifouling Catheter Applications. Biomacromolecules 21(7): 2714-2725
Jawad, A.H.; Abdulhameed, A.S.; Reghioua, A.; Yaseen, Z.M. 2020: Zwitterion composite chitosan-epichlorohydrin/zeolite for adsorption of methylene blue and reactive red 120 dyes. International Journal of Biological Macromolecules 163: 756-765
Ke, Z.; Lam, Y.-P.; Chan, K.-S.; Yeung, Y.-Y. 2020: Zwitterion-Catalyzed Deacylative Dihalogenation of β-Oxo Amides. Organic Letters 22(18): 7353-7357
Ng, W.-H.; Hu, R.-B.; Lam, Y.-P.; Yeung, Y.-Y. 2020: Zwitterion-Catalyzed Intermolecular Bromoesterifications. Organic Letters 22(14): 5572-5576
Cabanach, P.; Pena-Francesch, A.; Sheehan, D.; Bozuyuk, U.; Yasa, O.; Borros, S.; Sitti, M. 2020: Zwitterionic 3D-Printed Non-Immunogenic Stealth Microrobots. Advanced Materials 32(42): E2003013
Malik, A.; Seeberger, P.H.; Brezesinski, G.; Varón Silva, D. 2021: Zwitterionic Character and Lipid Composition Determine the Behaviour of Glycosylphosphatidylinositol Fragments in Monolayers. Chemphyschem: a European Journal of Chemical Physics and Physical Chemistry 22(8): 757-763
Zhang, Z.; Cao, Y.; Zhu, X.; Li, Y.; Cai, X. 2020: Zwitterionic Conjugated Polymer as the Single Component for Photoacoustic-Imaging-Guided Dual-Modal Near-Infrared Phototherapy. Acs Biomaterials Science and Engineering 6(7): 4005-4011
Tran, T.; Pan, S.; Chen, X.; Lin, X.-C.; Blevins, A.K.; Ding, Y.; Lin, H. 2020: Zwitterionic Hydrogel-Impregnated Membranes with Polyamide Skin Achieving Superior Water/Salt Separation Properties. Acs Applied Materials and Interfaces 12(43): 49192-49199
Groizard, T.; Kahlal, S.; Halet, J.-F.ço. 2020: Zwitterionic Mixed-Valence Species for the Design of Neutral Clocked Molecular Quantum-Dot Cellular Automata. Inorganic Chemistry 59(21): 15772-15779
Mele, E.; Heredia-Guerrero, Jé.A.; Bayer, I.S.; Ciofani, G.; Genchi, G.G.; Ceseracciu, L.; Davis, A.; Papadopoulou, E.L.; Barthel, M.J.; Marini, L.; Ruffilli, R.; Athanassiou, A. 2015: Zwitterionic Nanofibers of Super-Glue for Transparent and Biocompatible Multi-Purpose Coatings. Scientific Reports 5: 14019
Saha, P.; Ganguly, R.; Li, X.; Das, R.; Singha, N.K.; Pich, A. 2021: Zwitterionic Nanogels and Microgels: An Overview on their Synthesis and Applications. Macromolecular Rapid Communications 42(13): E2100112
Xu, R.; Cui, X.; Xin, Q.; Lu, M.; Li, Z.; Li, J.; Chen, X. 2021: Zwitterionic PMCP-functionalized titanium surface resists protein adsorption, promotes cell adhesion, and enhances osteogenic activity. Colloids and Surfaces. B Biointerfaces 206: 111928
Yuan, Z.; Li, B.; Niu, L.; Tang, C.; McMullen, P.; Jain, P.; He, Y.; Jiang, S. 2020: Zwitterionic Peptide Cloak Mimics Protein Surfaces for Protein Protection. Angewandte Chemie 59(50): 22378-22381
Bennion, D.M.; Horne, R.; Peel, A.; Reineke, P.; Henslee, A.; Kaufmann, C.; Guymon, C.A.; Hansen, M.R. 2021: Zwitterionic Photografted Coatings of Cochlear Implant Biomaterials Reduce Friction and Insertion Forces. Otology and Neurotology: Official Publication of the American Otological Society American Neurotology Society and European Academy of Otology and Neurotology 42(10): 1476-1483
Tsao, C.; Zhang, P.; Yuan, Z.; Dong, D.; Wu, K.; Niu, L.; McMullen, P.; Luozhong, S.; Hung, H.-C.; Cheng, Y.-H.; Jiang, S. 2020: Zwitterionic Polymer Conjugated Glucagon-like Peptide-1 for Prolonged Glycemic Control. Bioconjugate Chemistry 31(7): 1812-1819
Zhang, J.; He, L.; Wei, G.; Jiang, X.; Fu, L.; Zhao, Y.; Zhang, L.; Yang, L.; Li, Y.; Wang, Y.; Mo, H.; Shen, J. 2019: Zwitterionic Polymer-Grafted Polylactic Acid Vascular Patches Based on a Decellularized Scaffold for Tissue Engineering. Acs Biomaterials Science and Engineering 5(9): 4366-4375
Cheng, Y.; Wang, J.; Li, M.; Fu, F.; Zhao, Y.; Yu, J. 2020: Zwitterionic Polymer-Grafted Superhydrophilic and Superoleophobic Silk Fabrics for Anti-Oil Applications. Macromolecular Rapid Communications 41(21): E2000162
Xue, W.; Trital, A.; Shen, J.; Wang, L.; Chen, S. 2020: Zwitterionic Polypeptide-Based Nanodrug Augments pH-Triggered Tumor Targeting via Prolonging Circulation time and Accelerating Cellular Internalization. Acs Applied Materials and Interfaces 12(41): 46639-46652
Xu, J.; Xu, J.; Moon, H.; Sintim, H.O.; Lee, H. 2020: Zwitterionic Porous Conjugated Polymers as a Versatile Platform for Antibiofouling Implantable Bioelectronics. Acs Applied Polymer Materials 2(2): 528-536
Malali, S.; Chyba, J.; Knor, M.; Horní, M.; Nečas, M.; Novotný, J.; Marek, R. 2020: Zwitterionic Ru(III) Complexes: Stability of Metal-Ligand Bond and Host-Guest Binding with Cucurbit[7]uril. Inorganic Chemistry 59(14): 10185-10196
Holmlin, R.E.; Chen, X.; Chapman, R.G.; Takayama, S.; Whitesides, G.M. 2001: Zwitterionic SAMs that Resist Nonspecific Adsorption of Protein from Aqueous Buffer. Langmuir: the Acs Journal of Surfaces and Colloids 17(9): 2841-2850
Genest, A.; Portinha, D.; Pouget, E.; Lamnawar, K.; Ganachaud, F.; Fleury, E. 2021: Zwitterionic Silicone Materials Derived from Aza-Michael Reaction of Amino-Functional PDMS with Acrylic Acid. Macromolecular Rapid Communications 42(5): E2000372
Cho, E.Jung.; Doh, K-Oh.; Park, J.; Hyun, H.; Wilson, E.M.; Snyder, P.W.; Tsifansky, M.D.; Yeo, Y. 2016: Zwitterionic chitosan for the systemic treatment of sepsis. Scientific Reports 6: 29739
Luo, Y.; Huang, S.; Ma, L. 2021: Zwitterionic hydrogel-coated heart valves with improved endothelialization and anti-calcification properties. Materials Science and Engineering. C Materials for Biological Applications 128: 112329
Zhang, L.; Cao, Z.; Bai, T.; Carr, L.; Ella-Menye, J-Rene.; Irvin, C.; Ratner, B.D.; Jiang, S. 2013: Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nature Biotechnology 31(6): 553-556
Han, X.; Lu, Y.; Xie, J.; Zhang, E.; Zhu, H.; Du, H.; Wang, K.; Song, B.; Yang, C.; Shi, Y.; Cao, Z. 2020: Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions. Nature Nanotechnology 15(7): 605-614
Xu, X.; Wang, K.; Guo, H.; Sun, G.; Chen, R.; Yu, J.; Liu, J.; Lin, C.; Wang, J. 2021: Zwitterionic modified electrostatic flocking surfaces for diatoms and mussels resistance. Journal of Colloid and Interface Science 588: 9-18
Lei, M.; Zhang, W.; Yi, C.; Yan, L.; Tian, Y. 2021: Zwitterionic nanogels with temperature sensitivity and redox-degradability for controlled drug release. Colloids and Surfaces. B Biointerfaces 206: 111959
Shin, C.M.; Cho, S.; Kim, D.H.; Ha, Y.; Shin, H.J.; Shin, N.; Kim, D.W.; Choi, C.H.; Cho, W.K.; Oh, S.-H. 2021: Zwitterionic polydopamine coatings suppress silicone implant-induced capsule formation. Biomaterials Science 9(9): 3425-3432
Qian, L.; Liu, W.; Yang, M.; Nica, V.; Yang, J.; Liu, H.; Ning, L.; Zhang, S.; Zhang, Q. 2020: Zwitterionic polymer chain-assisted lysozyme imprinted core-shell carbon microspheres with enhanced recognition and selectivity. Talanta 217: 121085
Ren, K.; Ke, X.; Chen, Z.; Zhao, Y.; He, L.; Yu, P.; Xing, J.; Luo, J.; Xie, J.; Li, J. 2021: Zwitterionic polymer modified xanthan gum with collagen II-binding capability for lubrication improvement and ROS scavenging. Carbohydrate Polymers 274: 118672
Li, X.; Nayak, K.; Stamm, M.; Tripathi, B.P. 2021: Zwitterionic silica nanogel-modified polysulfone nanoporous membranes formed by in-situ method for water treatment. Chemosphere 280: 130615
Yang, G.; Zhou, L. 2014: Zwitterionic versus canonical amino acids over the various defects in zeolites: a two-layer ONIOM calculation. Scientific Reports 4: 6594
Wang, S.; Zhang, F.; Yu, G.; Wang, Z.; Jacobson, O.; Ma, Y.; Tian, R.; Deng, H.; Yang, W.; Chen, Z.-Y.; Chen, X. 2020: Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Theranostics 10(15): 6629-6637
Liu, Q.; Chiu, A.; Wang, L-Hai.; An, D.; Zhong, M.; Smink, A.M.; de Haan, B.J.; de Vos, P.; Keane, K.; Vegge, A.; Chen, E.Y.; Song, W.; Liu, W.F.; Flanders, J.; Rescan, C.; Grunnet, L.Groth.; Wang, X.; Ma, M. 2019: Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulation. Nature Communications 10(1): 5262
Anand, S.; Swami, P.; Goel, G.; Gupta, S. 2021: Zwitterions for impedance spectroscopy: the new buffers in town. Analytica Chimica Acta 1166: 338547
Zawadzka, D.; Stalmach, M.; Oblacińska, A.; Tabak, I. 2021: Związek poczucia sensu życia z zadowoleniem z życia, występowaniem dolegliwości subiektywnych oraz statusem ekonomicznym rodziny w populacji uczniów gimnazjum. Piśmiennictwo 21(1): 60-68
Gao, T.-G.; Ma, C.-M.; Yuan, H.-J.; Liu, H.-S.; Ma, Q.; Flowers, T.J.; Wang, S.-M. 2021: ZxNHX1 indirectly participates in controlling K+ homeostasis in the xerophyte Zygophyllum xanthoxylum. Functional Plant Biology: Fpb 48(4): 402-410
Puckett, D.L.; Alquraishi, M.; Alani, D.; Chahed, S.; Donohoe, D.; Voy, B.; Whelan, J.; Bettaieb, A. 2020: Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway. Cell Communication and Signaling: Ccs 18(1): 126
Puckett, D.; Alquraishi, M.; Alani, D.S.; Chahed, S.; Frankel, V.D.; Donohoe, D.; Voy, B.; Whelan, J.; Bettaieb, A. 2020: Zyflamend, a unique herbal blend, induces cell death and inhibits adipogenesis through the coordinated regulation of PKA and JNK. Adipocyte 9(1): 454-471
Seckbach, M. 1948: Zygogenic and anzygogenic substances for Glaucoma scintillans ciliate. Annales de l'Institut Pasteur 75(2): 156-162
Elzanie, A.S.; Park, K.E.; Irgebay, Z.; Choi, J.; Zellner, E.G. 2021: Zygoma Fractures Are Associated with Increased Morbidity and Mortality in the Pediatric Population. Journal of Craniofacial Surgery 32(2): 559-563
Bedrossian, E. 2021: Zygomatic Implants Operative Consideration to Minimize Technical Errors, Complications, and their Management. Atlas of the Oral and Maxillofacial Surgery Clinics of North America 29(2): 277-289
Weyh, A.; Quimby, A.; Salman, S. 2021: Zygomatic Implants in Avulsive and Ablative Defects. Atlas of the Oral and Maxillofacial Surgery Clinics of North America 29(2): 271-276
Vega, L.G.; Border, M. 2021: Zygomatic Implants in Combination with Dental Implants. Atlas of the Oral and Maxillofacial Surgery Clinics of North America 29(2): 233-241
Andre, A.; Dym, H. 2021: Zygomatic Implants: a Review of a Treatment Alternative for the Severely Atrophic Maxilla. Atlas of the Oral and Maxillofacial Surgery Clinics of North America 29(2): 163-172
Alterman, M.; Fleissig, Y.; Casap, N. 2021: Zygomatic Implants: Placement Considerations in Implant-Supported Maxillary Prosthesis. Atlas of the Oral and Maxillofacial Surgery Clinics of North America 29(2): 173-183
Carter, L.C.; Haller, A.D.; Calamel, A.D.; Pfaffenbach, A.C. 1999: Zygomatic air cell defect (ZACD). Prevalence and characteristics in a dental clinic outpatient population. Dento Maxillo Facial Radiology 28(2): 116-122
Engebretsen, S.; Patrick, T.; Helwig, C.; O'Niel, M. 2020: Zygomatic air cells in connection with Luc's abscess. International Journal of Pediatric Otorhinolaryngology 138: 110251
Goker, F.; Grecchi, E.; Mancini, E.G.; Del Fabbro, M.; Grecchi, F. 2020: Zygomatic implant survival in 9 ectodermal dysplasia patients with 3.5- to 7-year follow-up. Oral Diseases 26(8): 1803-1809
Ramezanzade, S.; Yates, J.; Tuminelli, F.J.; Keyhan, S.O.; Yousefi, P.; Lopez-Lopez, J. 2021: Zygomatic implants placed in atrophic maxilla: an overview of current systematic reviews and meta-analysis. Maxillofacial Plastic and Reconstructive Surgery 43(1): 1
Rehnblom, E.; Gordon-Evans, W.J.; Kramek, B.; Seelig, D.; Veytsman, S. 2021: Zygomatic sialocele secondary to infarction treated with sialoadenectomy in a dog. Canadian Veterinary Journal 62(10): 1083-1088
Costa, J.V.d.; Ramos, A.L.; Iwaki Filho, L. 2021: Zygomatic-maxillary cortical bone thickness in hyper, normo and hypodivergent patients. Dental Press Journal of Orthodontics 26(1): E211965
Alam, M.; Hasan, S.A.; Chandra, K. 2021: Zygomatico-Coronoid Pseudoarthrosis Due to Osteochandroma of Coronoid Process: a Rare Entity. Iranian Journal of Otorhinolaryngology 33(116): 183-186
Park, J.K.-H.; Kim, S.W. 2020: Zygomaticomaxillary complex fracture after two-jaw surgery. Archives of Craniofacial Surgery 21(5): 301-304
Van Hout, W.M.M.T.; de Kort, W.W.B.; Ten Harkel, T.C.; Van Cann, E.M.; Rosenberg, A.J.W.P. 2022: Zygomaticomaxillary complex fracture repair with intraoperative CBCT imaging. a prospective cohort study. Journal of Cranio-Maxillo-Facial Surgery: Official Publication of the European Association for Cranio-Maxillo-Facial Surgery 50(1): 54-60
Sarilita, E.; Rynn, C.; Mossey, P.A.; Black, S. 2021: Zygomaticus major muscle bony attachment site: a Thiel-embalmed cadaver study. Morphologie: Bulletin de l'Association des Anatomistes 105(348): 24-28
Yoder, J.B.; Gomez, G.; Carlson, C.J. 2020: Zygomorphic flowers have fewer potential pollinator species. Biology Letters 16(9): 20200307
Takakura, S. 2008: Zygomycosis. Nihon Rinsho. Japanese Journal of Clinical Medicine 66(12): 2356-2361
Doan, L.; Al-Khafaji, A. 2017: Zygomycosis-Induced Rash After Liver Transplant. American Journal of Gastroenterology 112(4): 533
Jain, D.; Kumar, Y.; Vasishta, R.K.; Rajesh, L.; Pattari, S.K.; Chakrabarti, A. 2006: Zygomycotic necrotizing fasciitis in immunocompetent patients: a series of 18 cases. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 19(9): 1221-1226
Dai, J.; Li, K.; Song, N.; Yao, W.; Xia, H.; Yang, Q.; Zhang, X.; Li, X.; Wang, Z.; Yao, L.; Yang, S.; Chen, X. 2020: Zygosaccharomyces rouxii, an Aromatic Yeast Isolated from Chili Sauce, Is Able to Biosynthesize 2-Phenylethanol via the Shikimate or Ehrlich Pathways. Frontiers in Microbiology 11: 597454
Wu, X.; Viveiros, M.M.; Eppig, J.J.; Bai, Y.; Fitzpatrick, S.L.; Matzuk, M.M. 2003: Zygote arrest 1 (Zar1) is a novel maternal-effect gene critical for the oocyte-to-embryo transition. Nature Genetics 33(2): 187-191
Patil, H.; Hughes, K.R.; Lemgruber, L.; Philip, N.; Dickens, N.; Starnes, G.L.; Waters, A.P. 2020: Zygote morphogenesis but not the establishment of cell polarity in Plasmodium berghei is controlled by the small GTPase, RAB11A. Plos Pathogens 16(5): E1008091
Chen, H.; Miao, Y.; Wang, K.; Bayer, M. 2021: Zygotic Embryogenesis in Flowering Plants. Methods in Molecular Biology 2288: 73-88
Korzh, V. 2021: Zygotic Genome Activation: Critical Prelude to the Most Important time of your Life. Methods in Molecular Biology 2218: 319-329
Okuno, T.; Li, W.Y.; Hatano, Y.; Takasu, A.; Sakamoto, Y.; Yamamoto, M.; Ikeda, Z.; Shindo, T.; Plessner, M.; Morita, K.; Matsumoto, K.; Yamagata, K.; Grosse, R.; Miyamoto, K. 2020: Zygotic Nuclear F-Actin Safeguards Embryonic Development. Cell Reports 31(13): 107824
Thompson, W.A.; Vijayan, M.M. 2021: Zygotic exposure to venlafaxine disrupts cortisol stress axis activity in multiple generations of zebrafish. Environmental Pollution 274: 116535
Kling, J. 2007: ZymoGenetics' moves recall young Genentech. Nature Biotechnology 25(9): 955
Alcover, N.àl.; Carceller, A.; Álvaro, G.; Guillén, M. 2019: Zymobacter palmae pyruvate decarboxylase production process development: Cloning in Escherichia coli, fed-batch culture and purification. Engineering in Life Sciences 19(7): 502-512
Stojanovski, B.M.; Pelc, L.A.; Zuo, X.; Di Cera, E. 2020: Zymogen and activated protein C have similar structural architecture. Journal of Biological Chemistry 295(45): 15236-15244
Essigke, D.; Ilyaskin, A.V.; Wörn, M.; Bohnert, B.N.; Xiao, M.; Daniel, C.; Amann, K.; Birkenfeld, A.L.; Szabo, R.; Bugge, T.H.; Korbmacher, C.; Artunc, F. 2021: Zymogen-locked mutant prostasin (Prss8) leads to incomplete proteolytic activation of the epithelial sodium channel (ENaC) and severely compromises triamterene tolerance in mice. Acta Physiologica 232(1): E13640
Oort, J.; Willighagen, R.G. 1961: Zymograms in human pathology. Nature 190: 642-644
La Rocca, G.; Pucci-Minafra, I.; Marrazzo, A.; Taormina, P.; Minafra, S. 2004: Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. British Journal of Cancer 90(7): 1414-1421
Vandooren, J.; Geurts, N.; Martens, E.; Van den Steen, P.E.; Opdenakker, G. 2013: Zymography methods for visualizing hydrolytic enzymes. Nature Methods 10(3): 211-220
Felczak, M.M.; Bowers, R.M.; Woyke, T.; TerAvest, M.A. 2021: Zymomonas diversity and potential for biofuel production. Biotechnology for Biofuels 14(1): 112
Caminschi, I.; Lahoud, M.H.; Pizzolla, A.; Wakim, L.M. 2019: Zymosan by-passes the requirement for pulmonary antigen encounter in lung tissue-resident memory CD8 + T cell development. Mucosal Immunology 12(2): 403-412
Chen, X.; Luo, Q.; Ding, J.; Yang, M.; Zhang, R.; Chen, F. 2020: Zymosan promotes proliferation, Candida albicans adhesion and IL-1β production of oral squamous cell carcinoma in vitro. Infectious Agents and Cancer 15: 51
Thomas, G.P.L.; Hemmrich, K.; Abberton, K.M.; McCombe, D.; Penington, A.J.; Thompson, E.W.; Morrison, W.A. 2008: Zymosan-induced inflammation stimulates neo-adipogenesis. International Journal of Obesity 32(2): 239-248
Fatehi, F.; Moradi, K.; Okhovat, A.A.; Shojatalab, G.; Sedighi, B.; Boostani, R.; Sarraf, P.; Haghi Ashtiani, B.; Ghasemi, M.; Moussavi, S.; Anjidani, N.; Nafissi, S. 2021: Zytux in Refractory Myasthenia Gravis: a Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar. Frontiers in Neurology 12: 682622
Wen, X-Mei.; Luo, T.; Jiang, Y.; Wang, L-Hong.; Luo, Y.; Chen, Q.; Yang, K.; Yuan, Y.; Luo, C.; Zhang, X.; Yan, Z-Xuan.; Fu, W-Juan.; Tan, Y-Huan.; Niu, Q.; Xiao, J-Fang.; Chen, L.; Wang, J.; Huang, J-Feng.; Cui, Y-Hong.; Zhang, X.; Wang, Y.; Bian, X-Wu. 2020: Zyxin (ZYX) promotes invasion and acts as a biomarker for aggressive phenotypes of human glioblastoma multiforme. Laboratory Investigation; a Journal of Technical Methods and Pathology 100(6): 812-823
Han, X.; Li, P.; Yang, Z.; Huang, X.; Wei, G.; Sun, Y.; Kang, X.; Hu, X.; Deng, Q.; Chen, L.; He, A.; Huo, Y.; Li, D.; Betzig, E.; Luo, J. 2017: Zyxin regulates endothelial von Willebrand factor secretion by reorganizing actin filaments around exocytic granules. Nature Communications 8: 14639
Ma, B.; Cheng, H.; Gao, R.; Mu, C.; Chen, L.; Wu, S.; Chen, Q.; Zhu, Y. 2016: Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways. Nature Communications 7: 11123
Gallais Sérézal, I.; Ferkal, S.; Lerman, L.; Mulé, S.; Funalot, B.; Wolkenstein, P. 2021: 18F]FDG Positron emission tomography with whole body magnetic resonance imaging ([18F]FDG-PET/MRI) as a diagnosis tool in Schwannomatosis. Orphanet Journal of Rare Diseases 16(1): 49
Pardthaisong, T. 1990: [Psychosocial aspects of aging. Warasan Prachakon Lae Sangkhom 2(2): 185-203; 247-248
Granados, J.C.; Richelle, A.; Gutierrez, J.M.; Zhang, P.; Zhang, X.; Bhatnagar, V.; Lewis, N.E.; Nigam, S.K. 2021: Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3. Journal of Biological Chemistry 296: 100575
Steel, A. 1987: `Dry tap' in glue ears. Journal of the Royal Society of Medicine 80(8): 537
Neame, J.H. 1988: `Dry tap' in glue ears. Journal of the Royal Society of Medicine 81(1): 59
Patil, S.; Patil, N.; Joglekar, C.; Yadav, A.; Nilawar, A.; Banavali, U.; Bhat, R.; Dombale, V.; Warpe, B.; Mohite, R.; Joshi, K. 2020: ADolescent and pr Econception health peRspectiVe of Adult Non-communicable diseases (DERVAN): protocol for rural prospective adolescent girls cohort study in Ratnagiri district of Konkan region of India (DERVAN-1). Bmj Open 10(9): E035926
Khuri, F.R.; Nemunaitis, J.; Ganly, I.; Arseneau, J.; Tannock, I.F.; Romel, L.; Gore, M.; Ironside, J.; MacDougall, R.H.; Heise, C.; Randlev, B.; Gillenwater, A.M.; Bruso, P.; Kaye, S.B.; Hong, W.K.; Kirn, D.H. 2000: A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nature Medicine 6(8): 879-885
Yang, J-Bo.; Tian, J-Ying.; Dai, Z.; Ye, F.; Ma, S-Cheng.; Wang, A-Guo. 2017: A-Glucosidase inhibitors extracted from the roots of Polygonum multiflorum Thunb. Fitoterapia 117(1): 65-70
Jiang, X.; Ma, Z.; Xu, J.; Chen, K.; Xu, L.; Li, W.; Huang, X.; Feng, D. 2015: A-SiNx:H-based ultra-low power resistive random access memory with tunable Si dangling bond conduction paths. Scientific Reports 5: 15762
Ahankari, A.; Hayter, M.; Whitfield, C.; Ali, P.; Giridhari, S.; Tambe, S.; Kabra, P.; Rayamane, K.; Ovseiko, P. 2019: ADolescents gEnder surVey, rEsponsible coup les evaluatiOn, and capacity building Project in India (DEVELOP): a study protocol. F1000research 8: 958
Barata, L.; Cabañas, A.; Lafuente, H.; Vargas, C.; Ceprián, Mía.; Campa, L.; Jiménez-Sánchez, L.; Pazos, M.Ruth.; Alvarez, F-José.; Martínez-Orgado, Jé. 2019: AEEG and neurologic exam findings correlate with hypoxic-ischemic brain damage severity in a piglet survival model. Pediatric Research 85(4): 539-545
Sun, J.; Huang, X.; Niu, C.; Wang, X.; Li, W.; Liu, M.; Wang, Y.; Huang, S.; Chen, X.; Li, X.; Wang, Y.; Jin, L.; Xiao, J.; Cong, W. 2021: AFGF alleviates diabetic endothelial dysfunction by decreasing oxidative stress via Wnt/β-catenin-mediated upregulation of HXK2. Redox Biology 39: 101811
Van der Laan, H.P.; Van den Bosch, L.; Schuit, E.; Steenbakkers, R.J.H.M.; van der Schaaf, A.; Langendijk, J.A. 2021: Impact of radiation-induced toxicities on quality of life of patients treated for head and neck cancer. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 160: 47-53
Niedworok, C.J.; Brown, A.P.Y.; Jorge Cardoso, M.; Osten, P.; Ourselin, S.; Modat, M.; Margrie, T.W. 2016: AMAP is a validated pipeline for registration and segmentation of high-resolution mouse brain data. Nature Communications 7: 11879
Fan, R.; Papatheodoridis, G.; Sun, J.; Innes, H.; Toyoda, H.; Xie, Q.; Mo, S.; Sypsa, V.; Guha, I.N.; Kumada, T.; Niu, J.; Dalekos, G.; Yasuda, S.; Barnes, E.; Lian, J.; Suri, V.; Idilman, R.; Barclay, S.T.; Dou, X.; Berg, T.; Hayes, P.C.; Flaherty, J.F.; Zhou, Y.; Zhang, Z.; Buti, M.; Hutchinson, S.J.; Guo, Y.; Calleja, J.L.; Lin, L.; Zhao, L.; Chen, Y.; Janssen, H.L.A.; Zhu, C.; Shi, L.; Tang, X.; Gaggar, A.; Wei, L.; Jia, J.; Irving, W.L.; Johnson, P.J.; Lampertico, P.; Hou, J. 2020: AMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis. Journal of Hepatology 73(6): 1368-1378
Yamashita, Y.; Joshita, S.; Sugiura, A.; Yamazaki, T.; Kobayashi, H.; Wakabayashi, S.-I.; Yamada, Y.; Shibata, S.; Kunimoto, H.; Iwadare, T.; Matsumura, M.; Miyabayashi, C.; Okumura, T.; Ozawa, S.; Nozawa, Y.; Kobayashi, N.; Komatsu, M.; Fujimori, N.; Saito, H.; Umemura, T. 2021: AMAP score prediction of hepatocellular carcinoma occurrence and incidence-free rate after a sustained virologic response in chronic hepatitis C. Hepatology Research: the Official Journal of the Japan Society of Hepatology 51(9): 933-942
Blackburn, J.S.; Langenau, D.M. 2010: AMAZe-ing tools for mosaic analysis in zebrafish. Nature Methods 7(3): 188-190
Minty, G.; Hoppen, A.; Boehm, I.; Alhindi, A.; Gibb, L.; Potter, E.; Wagner, B.C.; Miller, J.; Skipworth, R.J.E.; Gillingwater, T.H.; Jones, R.A. 2020: ANMJ-morph: a simple macro for rapid analysis of neuromuscular junction morphology. Royal Society Open Science 7(4): 200128
Duan, K.; Calhoun, V.D.; Liu, J.; Silva, R.F. 2020: ANy-way Independent Component Analysis. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2020: 1770-1774
Riddell, M.; Nakayama, A.; Hikita, T.; Mirzapourshafiyi, F.; Kawamura, T.; Pasha, A.; Li, M.; Masuzawa, M.; Looso, M.; Steinbacher, T.; Ebnet, K.; Potente, M.; Hirose, T.; Ohno, S.; Fleming, I.; Gattenlöhner, S.; Aung, P.P.; Phung, T.; Yamasaki, O.; Yanagi, T.; Umemura, H.; Nakayama, M. 2018: APKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability. Nature Communications 9(1): 5357
Raman, R.; Damle, I.; Rote, R.; Banerjee, S.; Dingare, C.; Sonawane, M. 2016: APKC regulates apical localization of Lgl to restrict elongation of microridges in developing zebrafish epidermis. Nature Communications 7: 11643
Smith, C.A.; Lau, K.M.; Rahmani, Z.; Dho, S.E.; Brothers, G.; She, Y.Min.; Berry, D.M.; Bonneil, E.; Thibault, P.; Schweisguth, Fçois.; Le Borgne, R.; McGlade, C.Jane. 2007: APKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb. EMBO Journal 26(2): 468-480
Grifoni, D.; Garoia, F.; Bellosta, P.; Parisi, F.; De Biase, D.; Collina, G.; Strand, D.; Cavicchi, S.; Pession, A. 2007: APKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia. Oncogene 26(40): 5960-5965
Chibly, A.M.; Wong, W.Yu.; Pier, M.; Cheng, H.; Mu, Y.; Chen, J.; Ghosh, S.; Limesand, K.H. 2018: APKCζ-dependent Repression of Yap is Necessary for Functional Restoration of Irradiated Salivary Glands with IGF-1. Scientific Reports 8(1): 6347
Nickols, N.; Anand, A.; Johnsson, K.; Brynolfsson, J.; Borreli, P.; Parikh, N.; Juarez, J.; Jafari, L.; Eiber, M.; Rettig, M. 2022: APROMISE: a Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL Images of Veterans with Prostate Cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 63(2): 233-239
Gianì, S.; Silletti, S.; Gavazzi, F.; Morello, L.; Spinsanti, G.; Parati, K.; Breviario, D. 2020: ATBP: a versatile tool for fish genotyping. Plos one 15(8): E0237111
Enriquez, A.; Garcia, F. 2020: AVL/aVR discordance: Value for localization of ventricular arrhythmias. Journal of Electrocardiology 60: A1-A2
Sedighi, S.; Fattahi, M.; Dehghani, P.; Aslani, A.; Mehdipour Namdar, Z.; Hassanzadeh, M. 2021: AVR ST-segment changes and prognosis of ST-segment elevation myocardial infarction. Health Science Reports 4(4): E387
Freeman, L.; Brimacombe, C.S.; Elhaik, E. 2020: AYChr-DB: a database of ancient human y haplogroups. Nar Genomics and Bioinformatics 2(4): Lqaa 081
Gajaria, T.K.; Dabhi, S.D.; Jha, P.K. 2019: Ab initio Energetics and Thermoelectric Profiles of Gallium Pnictide Polytypes. Scientific Reports 9(1): 5884
Madsen, J.; Pennycook, T.J.; Susi, T. 2021: Ab initio description of bonding for transmission electron microscopy. Ultramicroscopy 231: 113253
Wu, X-Xi.; Zheng, K.I.; Boursier, Jérôme.; Chan, W-Kheong.; Yilmaz, Y.; Romero-Gómez, M.; El Kassas, M.; Targher, G.; Byrne, C.D.; Huang, Z-Ming.; Zheng, M-Hua. 2021: AcNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study. Eclinicalmedicine 41: 101145
Bonelli, L. 1948: Aerosol; theoretical bases and new technical principles. Minerva Medica 39(21): 522-525
Hayashi, S.; Hirayama, T. 2016: Ahg12 is a dominant proteasome mutant that affects multiple regulatory systems for germination of Arabidopsis. Scientific Reports 6: 25351
Yousefzadeh, M.; Esfahanian, P.; Movahed, S.M.S.; Gorgin, S.; Rahmati, D.; Abedini, A.; Nadji, S.A.; Haseli, S.; Bakhshayesh Karam, M.; Kiani, A.; Hoseinyazdi, M.; Roshandel, J.; Lashgari, R. 2021: Ai-corona: Radiologist-assistant deep learning framework for COVID-19 diagnosis in chest CT scans. Plos one 16(5): E0250952
Mehl, T.; Gruenstaeudl, M. 2021: Airpg: automatically accessing the inverted repeats of archived plastid genomes. Bmc Bioinformatics 22(1): 413
Koshy, R.; Ranawat, A.; Scaria, V. 2017: Al mena: a comprehensive resource of human genetic variants integrating genomes and exomes from Arab, Middle Eastern and North African populations. Journal of Human Genetics 62(10): 889-894
Müller, A. 2016: Al-Ghorab Shunt for Priapism. Journal of Sexual Medicine 13(8): 1279-1284
Bossanyi, M.-A.é; Carpentier, V.; Glouzon, J.-P.S.; Ouangraoua, A.ïd.; Anselmetti, Y. 2020: AliFreeFoldMulti: alignment-free method to predict secondary structures of multiple RNA homologs. Nar Genomics and Bioinformatics 2(4): Lqaa 086
Parkinson, L.; Stawicki, T.M. 2021: Alms1 mutant zebrafish do not show hair cell phenotypes seen in other cilia mutants. Plos one 16(4): E0246844
Catz, E.G.; Speir, W.A. 1984: Alpha 1-Antitrypsin deficiency. Southern Medical Journal 77(4): 479-483
Sadalge, A.; Coughlin, L.; Fu, H.; Wang, B.; Valladares, O.; Valentino, R.; Blendy, J.A. 2003: Alpha 1d Adrenoceptor signaling is required for stimulus induced locomotor activity. Molecular Psychiatry 8(7): 664-672
Hanabusa, T.; Nanjo, K. 1998: Alpha 2-Macroglobulin. Nihon Rinsho. Japanese Journal of Clinical Medicine 56(Suppl 3): 106-108
Kirby, R.; Andersson, K.E.; Lepor, H.; Steers, W.D. 2000: Alpha(1)-Adrenoceptor selectivity and the treatment of benign prostatic hyperplasia and lower urinary tract symptoms. Prostate Cancer and Prostatic Diseases 3(2): 76-83
Yamamoto, Y.; Koike, K. 2001: Alpha(1)-Adrenoceptor subtypes in the mouse mesenteric artery and abdominal aorta. British Journal of Pharmacology 134(5): 1045-1054
Scopinho, A.A.; Resstel, L.B.M.; Corrêa, F.M.A. 2008: Alpha(1)-Adrenoceptors in the lateral septal area modulate food intake behaviour in rats. British Journal of Pharmacology 155(5): 752-756
O'Leary, M.P. 1999: Alpha(1)-Blockade in the nineties: focus on the patient. Prostate Cancer and Prostatic Diseases 2(S4): S16-S20
Höfner, K. 1999: Alpha(1)-Blocker therapy in the nineties: focus on the disease. Prostate Cancer and Prostatic Diseases 2(S4): S9
Al-Damluji, S.; Shen, W.B.; White, S.; Barnard, E.A. 2001: Alpha(1B) adrenergic receptors in gonadotrophin-releasing hormone neurones: relation to Transport-P. British Journal of Pharmacology 132(1): 336-344
Roberts, R.E.; Kendall, D.A.; Wilson, V.G. 1999: Alpha(2)-adrenoceptor and NPY receptor-mediated contractions of porcine isolated blood vessels: evidence for involvement of the vascular endothelium. British Journal of Pharmacology 128(8): 1705-1712
Orito, K.; Kishi, M.; Imaizumi, T.; Nakazawa, T.; Hashimoto, A.; Mori, T.; Kambe, T. 2001: Alpha(2)-adrenoceptor antagonist properties of OPC-28326, a novel selective peripheral vasodilator. British Journal of Pharmacology 134(4): 763-770
Teixeira, M.M.; Robinson, M.K.; Shock, A.; Hellewell, P.G. 2001: Alpha(4) integrin-dependent eosinophil recruitment in allergic but not non-allergic inflammation. British Journal of Pharmacology 132(2): 596-604
Cruet-Hennequart, Séverine.; Maubant, S.; Luis, Jé.; Gauduchon, P.; Staedel, C.; Dedhar, S. 2003: Alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 22(11): 1688-1702
Carro-Juárez, M.; Rodríguez-Manzo, G. 2006: Alpha-Adrenergic agents modulate the activity of the spinal pattern generator for ejaculation. International Journal of Impotence Research 18(1): 32-38
Toya, Y.; Ebina, T.; Umemura, S. 2006: Alpha-Adrenergic receptor gene. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 5): 379-384
Yuan, K.; Chung, L.W.K.; Siegal, G.P.; Zayzafoon, M. 2007: Alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression. Laboratory Investigation; a Journal of Technical Methods and Pathology 87(9): 938-950
Yonemura, S.; Wada, Y.; Watanabe, T.; Nagafuchi, A.; Shibata, M. 2010: Alpha-Catenin as a tension transducer that induces adherens junction development. Nature Cell Biology 12(6): 533-542
Van Kaer, L. 2005: Alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nature Reviews. Immunology 5(1): 31-42
Mahapatra, D.; Donahue, D.A.; Nyska, A.; Hayashi, S.-M.; Koyanagi, M.; Maronpot, R.R. 2021: Alpha-Glycosyl Isoquercitrin (AGIQ) and its lack of carcinogenicity in rasH2 mice. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 151: 112103
Bhushan, S.; Gartmann, M.; Halic, M.; Armache, J-Paul.; Jarasch, A.; Mielke, T.; Berninghausen, O.; Wilson, D.N.; Beckmann, R. 2010: Alpha-Helical nascent polypeptide chains visualized within distinct regions of the ribosomal exit tunnel. Nature Structural and Molecular Biology 17(3): 313-317
Marckmann, P.; Jespersen, J. 1994: Alpha-Linolenic acid and reduction of cardiac deaths. Lancet 344(8922): 622
Wilkinson, S. 1958: Alpha-Picoline from Rumex obtusifolius L. Nature 181(4609): 636-637
Fujiwara, H.; Hasegawa, M.; Dohmae, N.; Kawashima, A.; Masliah, E.; Goldberg, M.S.; Shen, J.; Takio, K.; Iwatsubo, T. 2002: Alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nature Cell Biology 4(2): 160-164
Liu, S.; Ninan, I.; Antonova, I.; Battaglia, F.; Trinchese, F.; Narasanna, A.; Kolodilov, N.; Dauer, W.; Hawkins, R.D.; Arancio, O. 2004: Alpha-Synuclein produces a long-lasting increase in neurotransmitter release. EMBO Journal 23(22): 4506-4516
Heintz, N.; Zoghbi, H. 1997: Alpha-Synuclein--a link between Parkinson and Alzheimer diseases?. Nature Genetics 16(4): 325-327
Tomasetti, M.; Strafella, E.; Staffolani, S.; Santarelli, L.; Neuzil, J.; Guerrieri, R. 2010: Alpha-Tocopheryl succinate promotes selective cell death induced by vitamin K3 in combination with ascorbate. British Journal of Cancer 102(8): 1224-1234
Lecuit, T. 2010: Alpha-catenin mechanosensing for adherens junctions. Nature Cell Biology 12(6): 522-524
Buser, W. 1947: Alpha-cholestenone and epi-alpha-cholestenone. Helvetica Chimica Acta 30(5): 1379-1391
Holzinger, L. 1949: Alpha-substituted glycerol ethers, their pharmacology and clinical utility. WienerMedizinischeWochenschrift 99(17-18): 201
Sulzer, D. 2001: Alpha-synuclein and cytosolic dopamine: stabilizing a bad situation. Nature Medicine 7(12): 1280-1282
Gellis, S.S. 1976: Alpha1-Antitrypsin deficiency. American Journal of Diseases of Children 130(6): 592
Zheleznova, N.; Sedelnikova, A.; Weiss, D.S. 2008: Alpha1beta2delta, a silent GABAA receptor: recruitment by tracazolate and neurosteroids. British Journal of Pharmacology 153(5): 1062-1071
Qian, J.; Zhu, C-Hua.; Tang, S.; Shen, A-Jun.; Ai, J.; Li, J.; Geng, M-Yu.; Ding, J. 2009: Alpha2,6-hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells. Acta Pharmacologica Sinica 30(7): 1039-1045
Fagerholm, V.; Scheinin, M.; Haaparanta, M. 2008: Alpha2A-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice. British Journal of Pharmacology 154(6): 1287-1296
Briggs, C.A.; Schrimpf, M.R.; Anderson, D.J.; Gubbins, E.J.; Grønlien, J.H.; Håkerud, M.; Ween, H.; Thorin-Hagene, K.; Malysz, J.; Li, J.; Bunnelle, W.H.; Gopalakrishnan, M.; Meyer, M.D. 2008: Alpha7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analogues. British Journal of Pharmacology 153(5): 1054-1061
Hotokezaka, Y.; van Leyen, K.; Lo, E.H.; Beatrix, B.; Katayama, I.; Jin, G.; Nakamura, T. 2009: AlphaNAC depletion as an initiator of ER stress-induced apoptosis in hypoxia. Cell Death and Differentiation 16(11): 1505-1514
Yoshii, S.; Tanaka, M.; Otsuki, Y.; Wang, D.Y.; Guo, R.J.; Zhu, Y.; Takeda, R.; Hanai, H.; Kaneko, E.; Sugimura, H. 1999: AlphaPIX nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase. Oncogene 18(41): 5680-5690
Albert, M.L.; Kim, J.I.; Birge, R.B. 2000: Alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells. Nature Cell Biology 2(12): 899-905
Merten, R. 1947: And d peptidases; a differentiation and characterization of dipeptide-cleaving enzymes in organ extracts. Biochemische Zeitschrift 318(2-3): 167-184
Auswahl 1948: And training of hospital administrators. Veska 12(9): 221
Thambu, K.; Balagurunathan, K. 2022: AnexVis: a Transcriptome Tool to Visualize Organ/Tissue-Specific Glycosaminoglycan Biosynthetic and Catabolic Pathways in Human Health and Diseases. Methods in Molecular Biology 2303: 389-401
Zhao, Y.; Federico, A.; Faits, T.; Manimaran, S.; Segrè, D.; Monti, S.; Johnson, W.E. 2021: Animalcules: interactive microbiome analytics and visualization in R. Microbiome 9(1): 76
Liu, S.; Qin, T.; Liu, Z.; Wang, J.; Jia, Y.; Feng, Y.; Gao, Y.; Li, K. 2020: Anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells. Cell Death and Disease 11(5): 309
Gaonkar, K.S.; Marini, F.; Rathi, K.S.; Jain, P.; Zhu, Y.; Chimicles, N.A.; Brown, M.A.; Naqvi, A.S.; Zhang, B.; Storm, P.B.; Maris, J.M.; Raman, P.; Resnick, A.C.; Strauch, K.; Taroni, J.N.; Rokita, J.L. 2020: AnnoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions. Bmc Bioinformatics 21(1): 577
Corpas, J.; Mauleón, P.; Gómez Arrayás, R.ón.; Carretero, J.C. 2020: Anti-Hydroarylation of Activated Internal Alkynes: Merging Pd and Energy Transfer Catalysis. Organic Letters 22(16): 6473-6478
Marceddu, G.; Dallavilla, T.; Xhuvani, A.; Daja, M.; De Antoni, L.; Casadei, A.; Bertelli, M. 2020: AppMAGI: A complete laboratory information management system for clinical diagnostics. Acta Bio-Medica: Atenei Parmensis 91(13-S): E2020015
Aranha, Márcia.M.; Herrmann, D.; Cachitas, H.; Neto-Silva, R.M.; Dias, S.; Vasconcelos, M.Luísa. 2017: Apterous Brain Neurons Control Receptivity to Male Courtship in Drosophila Melanogaster Females. Scientific Reports 7: 46242
Municoy, M.í; Roda, S.; Soler, D.; Soutullo, A.; Guallar, V. 2020: AquaPELE: a Monte Carlo-Based Algorithm to Sample the Effects of Buried Water Molecules in Proteins. Journal of Chemical Theory and Computation 16(12): 7655-7670
Van Cauwenbergh, C.; Van Schil, K.; Cannoodt, R.; Bauwens, M.; Van Laethem, T.; De Jaegere, S.; Steyaert, W.; Sante, T.; Menten, Börn.; Leroy, B.P.; Coppieters, F.; De Baere, E. 2017: ArrEYE: a customized platform for high-resolution copy number analysis of coding and noncoding regions of known and candidate retinal dystrophy genes and retinal noncoding RNAs. Genetics in Medicine: Official Journal of the American College of Medical Genetics 19(4): 457-466
Dhangar, S.; Ghatanatti, J.; Vundinti, B.R. 2020: Array-CGH revealed gain of Yp11.2 in 49,XXXXY and gain of Xp22.33 in 48,XXYY karyotypes of two rare klinefelter variants. Intractable and Rare Diseases Research 9(3): 145-150
Wehrli, M.; Dougan, S.T.; Caldwell, K.; O'Keefe, L.; Schwartz, S.; Vaizel-Ohayon, D.; Schejter, E.; Tomlinson, A.; DiNardo, S. 2000: Arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407(6803): 527-530
Thieleking, R.; Medawar, E.; Disch, L.; Witte, A.V. 2020: Art.pics Database: An Open Access Database for Art Stimuli for Experimental Research. Frontiers in Psychology 11: 576580
Tanaka, Y.; Fukui, N.; Shinokubo, H. 2020: As-Indaceno[3,2,1,8,7,6-ghijklm]terrylene as a near-infrared absorbing C 70 -fragment. Nature Communications 11(1): 3873
Sharma, R.D.; Joshi, S.; Amlathe, S. 2011: Assisted disposable sensors for quantitative determination of. Analytical Methods: Advancing Methods and Applications 3(2): 452-456
Lohmeier, J.; Kaneko, T.; Hamm, B.; Makowski, M.R.; Okano, H. 2019: AtlasBREX: Automated template-derived brain extraction in animal MRI. Scientific Reports 9(1): 12219
Westphal, C.H.; Rowan, S.; Schmaltz, C.; Elson, A.; Fisher, D.E.; Leder, P. 1997: Atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nature Genetics 16(4): 397-401
Algammal, A.M.; Hashem, H.R.; Alfifi, K.J.; Hetta, H.F.; Sheraba, N.S.; Ramadan, H.; El-Tarabili, R.M. 2021: AtpD gene sequencing, multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes of emerging XDR and MDR-Proteus mirabilis. Scientific Reports 11(1): 9476
Hill, N.J.; Mooney, S.W.J.; Prusky, G.T. 2021: Audiomath: a neuroscientist's sound toolkit. Heliyon 7(2): E06236
Jing, R.; Li, Y.; Xue, L.; Liu, F.; Li, M.; Luo, J. 2020: AutoBioSeqpy: a Deep Learning Tool for the Classification of Biological Sequences. Journal of Chemical Information and Modeling 60(8): 3755-3764
Xie, Y.; Luo, X.; Li, H.; Xu, Q.; He, Z.; Zhao, Q.; Zuo, Z.; Ren, J. 2020: AutoRPA: a web server for constructing cancer staging models by recursive partitioning analysis. Computational and Structural Biotechnology Journal 18: 3361-3367
Courtney, M.G.R.; Chang, K.C.T.; Mei, B.; Meissel, K.; Rowe, L.I.; Issayeva, L.B. 2021: Autopsych: An R Shiny tool for the reproducible Rasch analysis, differential item functioning, equating, and examination of group effects. Plos one 16(10): E0257682
Yanai, A.; Arama, E.; Kilfin, G.; Motro, B. 1997: Ayk1, a novel mammalian gene related to Drosophila aurora centrosome separation kinase, is specifically expressed during meiosis. Oncogene 14(24): 2943-2950
Fu, J.; Wang, K.; Liu, D.; Zhang, Z.; Sui, M.; Yan, P. 2020: B-Axis Phase Boundary Movement Induced (020) Plane Cracking in LiFePO4. Acs Applied Materials and Interfaces 12(35): 39245-39251
Delbaere, S.; De Clercq, A.; Mizumoto, S.; Noborn, F.; Bek, J.W.; Alluyn, L.; Gistelinck, C.; Syx, D.; Salmon, P.L.; Coucke, P.J.; Larson, G.ör.; Yamada, S.; Willaert, A.; Malfait, F. 2020: B3galt6 Knock-Out Zebrafish Recapitulate β3GalT6-Deficiency Disorders in Human and Reveal a Trisaccharide Proteoglycan Linkage Region. Frontiers in Cell and Developmental Biology 8: 597857
Chen, G.; An, N.; Ye, W.; Huang, S.; Chen, Y.; Hu, Z.; Shen, E.; Zhu, J.; Gong, W.; Tong, G.; Zhu, Y.; Fang, L.; Cai, C.; Li, X.; Kim, K.; Jin, L.; Xiao, J.; Cong, W. 2021: BFGF alleviates diabetes-associated endothelial impairment by downregulating inflammation via S-nitrosylation pathway. Redox Biology 41: 101904
Jiang, Y.; Zhang, C.; Wang, T. 2021: BFGF ameliorates intestinal mucosal permeability and barrier function through tight junction proteins in burn injury rats. Burns: Journal of the International Society for Burn Injuries 47(5): 1129-1136
Goel, M.; Dhingra, N.K. 2021: BFGF and insulin lead to migration of Müller glia to photoreceptor layer in rd1 mouse retina. Neuroscience Letters 755: 135936
Chakrabarti, S.; Mazumder, B.; Rajkonwar, J.; Pathak, M.Pratim.; Patowary, P.; Chattopadhyay, P. 2021: BFGF and collagen matrix hydrogel attenuates burn wound inflammation through activation of ERK and TRK pathway. Scientific Reports 11(1): 3357
Ray, P.E.; Bruggeman, L.A.; Weeks, B.S.; Kopp, J.B.; Bryant, J.L.; Owens, J.W.; Notkins, A.L.; Klotman, P.E. 1994: BFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. Kidney International 46(3): 759-772
Parma, L.; Peters, H.A.B.; Sluiter, T.J.; Simons, K.H.; Lazzari, P.; de Vries, M.R.; Quax, P.H.A. 2020: BFGF blockade reduces intraplaque angiogenesis and macrophage infiltration in atherosclerotic vein graft lesions in ApoE3*Leiden mice. Scientific Reports 10(1): 15968
Gan, Y.; Sun, Y.; Jin, J.; Wang, Y.; Chen, J.; Chung, Y.; Li, X.; Ye, H. 2021: BFGF could be a biomarker of malignancy in RS3PE syndrome: an ambispective single-center cohort analysis of 51 patients. Arthritis Research and Therapy 23(1): 261
Miho, Y.; Kouroku, Y.; Fujita, E.; Mukasa, T.; Urase, K.; Kasahara, T.; Isoai, A.; Momoi, M.Y.; Momoi, T. 1999: BFGF inhibits the activation of caspase-3 and apoptosis of P19 embryonal carcinoma cells during neuronal differentiation. Cell Death and Differentiation 6(5): 463-470
Sun, D.; Wang, W.; Wang, X.; Wang, Y.; Xu, X.; Ping, F.; Du, Y.; Jiang, W.; Cui, D. 2018: BFGF plays a neuroprotective role by suppressing excessive autophagy and apoptosis after transient global cerebral ischemia in rats. Cell Death and Disease 9(2): 172
Wang, Z-Guang.; Wang, Y.; Huang, Y.; Lu, Q.; Zheng, L.; Hu, D.; Feng, W-Ke.; Liu, Y-Long.; Ji, K-Ting.; Zhang, H-Yu.; Fu, X-Bing.; Li, X-Kun.; Chu, M-Ping.; Xiao, J. 2015: BFGF regulates autophagy and ubiquitinated protein accumulation induced by myocardial ischemia/reperfusion via the activation of the PI3K/Akt/mTOR pathway. Scientific Reports 5: 9287
Bartůnek, P.; Pajer, P.; Karafiát, Vít.; Blendinger, G.; Dvorák, M.; Zenke, M. 2002: BFGF signaling and v-Myb cooperate in sustained growth of primitive erythroid progenitors. Oncogene 21(3): 400-410
Chen, G.; An, N.; Zhu, Y.; Zhou, R.; Noh, M.-G.; Kim, H.; Lee, H.J.; Shen, Y.; Cho, Y.-C.; Jin, L.; Cong, W.; Lee, J.-H.; Kim, K. 2021: BFGF-mediated phosphorylation of δ-catenin increases its protein stability and the ability to induce the nuclear redistribution of β-catenin. American Journal of Cancer Research 11(8): 3877-3892
Bersten, D.C.; Sullivan, A.E.; Peet, D.J.; Whitelaw, M.L. 2013: BHLH-PAS proteins in cancer. Nature Reviews. Cancer 13(12): 827-841
Ranjan, R.; Khurana, R.; Malik, N.; Badoni, S.; Parida, S.K.; Kapoor, S.; Tyagi, A.K. 2017: BHLH142 regulates various metabolic pathway-related genes to affect pollen development and anther dehiscence in rice. Scientific Reports 7: 43397
Killock, D. 2019: BTMB is a promising predictive biomarker. Nature Reviews. Clinical Oncology 16(7): 403
Ray, S.; Tillo, D.; Ufot, A.; Assad, N.; Durell, S.; Vinson, C. 2020: BZIP Dimers CREB1, ATF2, Zta, ATF3|cJun, and cFos|cJun Prefer to Bind to Some Double-Stranded DNA Sequences Containing 5-Formylcytosine and 5-Carboxylcytosine. Biochemistry 59(38): 3529-3540
Kaminaka, H.; Näke, C.; Epple, P.; Dittgen, J.; Schütze, K.; Chaban, C.; Holt, B.F.; Merkle, T.; Schäfer, E.; Harter, K.; Dangl, J.L. 2006: BZIP10-LSD1 antagonism modulates basal defense and cell death in Arabidopsis following infection. EMBO Journal 25(18): 4400-4411
Miller, C.A.; Qiao, Y.; DiSera, T.; D'Astous, B.; Marth, G.T. 2014: Bam.iobio: a web-based, real-time, sequence alignment file inspector. Nature Methods 11(12): 1189
Bernhards, C.B.; Lux, M.W.; Katoski, S.E.; Goralski, T.D.P.; Liem, A.T.; Gibbons, H.S. 2021: BarCoder: a tool to generate unique, orthogonal genetic tags for qPCR detection. Bmc Bioinformatics 22(1): 98
Demšar, J.; Repovš, G.; Štrumbelj, E. 2020: Bayes4psy-An Open Source R Package for Bayesian Statistics in Psychology. Frontiers in Psychology 11: 947
Jézéquel, P.; Gouraud, W.; Ben Azzouz, F.; Guérin-Charbonnel, C.; Juin, P.P.; Lasla, H.; Campone, M. 2021: Bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Database: the Journal of Biological Databases and Curation 2021
Jansen, B.; Schlagbauer-Wadl, H.; Brown, B.D.; Bryan, R.N.; van Elsas, A.; Müller, M.; Wolff, K.; Eichler, H.G.; Pehamberger, H. 1998: Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nature Medicine 4(2): 232-234
Kondo, S.; Yin, D.; Takeuchi, J.; Morimura, T.; Oda, Y.; Kikuchi, H. 1994: Bcl-2 gene enables rescue from in vitro myelosuppression (bone marrow cell death) induced by chemotherapy. British Journal of Cancer 70(3): 421-426
Apakama, I.; Robinson, M.C.; Walter, N.M.; Charlton, R.G.; Royds, J.A.; Fuller, C.E.; Neal, D.E.; Hamdy, F.C. 1996: Bcl-2 overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer. British Journal of Cancer 74(8): 1258-1262
Pollina, L.; Pacini, F.; Fontanini, G.; Vignati, S.; Bevilacqua, G.; Basolo, F. 1996: Bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas. British Journal of Cancer 73(2): 139-143
Tsimbouri, P.; Drotar, M.E.; Coy, J.L.; Wilson, J.B. 2002: Bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes. Oncogene 21(33): 5182-5187
Takeda, M.R.; Gurbuxani, S. 2021: Bcr3 PML-RARA: short fusion, small blasts!. Blood 137(19): 2708
Itoh, Y. 1995: Beta 2-Microglobulin. Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 1: 230-232
Galeazzi, R.L.; Gugger, M.; Weidmann, P. 1979: Beta blockade with pindolol: differential cardiac and renal effects despite similar plasma kinetics in normal and uremic man. Kidney International 15(6): 661-668
Brito-Martins, M.; Harding, S.E.; Ali, N.N. 2008: Beta(1)- and beta(2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. British Journal of Pharmacology 153(4): 751-759
Hutchinson, D.S.; Evans, B.A.; Summers, R.J. 2001: Beta(1)-Adrenoceptors compensate for beta(3)-adrenoceptors in ileum from beta(3)-adrenoceptor knock-out mice. British Journal of Pharmacology 132(2): 433-442
Vignes, J-R.; Eimer, S.; Dupuy, R.; Donois, E.; Liguoro, D. 2007: Beta(2)-Microglobulin amyloidosis caused spinal cord compression in a long-term haemodialysis patient. Spinal Cord 45(4): 322-326
Hallsworth, M.P.; Twort, C.H.; Lee, T.H.; Hirst, S.J. 2001: Beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells. British Journal of Pharmacology 132(3): 729-741
Wu, C.H.; Rastegar, M.; Gordon, J.; Safa, A.R. 2001: Beta(2)-microglobulin induces apoptosis in HL-60 human leukemia cell line and its multidrug resistant variants overexpressing MRP1 but lacking Bax or overexpressing P-glycoprotein. Oncogene 20(48): 7006-7020
Shrout, J.; Yousefzadeh, M.; Dodd, A.; Kirven, K.; Blum, C.; Graham, A.; Benjamin, K.; Hoda, R.; Krishna, M.; Romano, M.; Wallace, M.; Garrett-Mayer, E.; Mitas, M. 2008: Beta(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients. British Journal of Cancer 98(12): 1999-2005
Hao, K.; Peng, S.; Xing, H.; Yu, Y.; Huang, A.; Hong, X.; Wang, Y.; Chen, C.; Wang, B.; Zhang, X.; Liu, J.; Zhu, G.; Huo, Y.; Chen, D.; Zhao, X.; Ronnenberg, A.; Wu, D.; Niu, T.; Xu, X. 2004: Beta(3) Adrenergic receptor polymorphism and obesity-related phenotypes in hypertensive patients. Obesity Research 12(1): 125-130
Hutchinson, D.S.; Evans, B.A.; Summers, R.J. 2000: Beta(3)-adrenoceptor regulation and relaxation responses in mouse ileum. British Journal of Pharmacology 129(6): 1251-1259
Price, E.A.; Coombe, D.R.; Murray, J.C. 1996: Beta-1 Integrins mediate tumour cell adhesion to quiescent endothelial cells in vitro. British Journal of Cancer 74(11): 1762-1766
Jeffries, A.R.; Mungall, A.J.; Dawson, E.; Halls, K.; Langford, C.F.; Murray, R.M.; Dunham, I.; Powell, J.F. 2003: Beta-1,3-Glucuronyltransferase-1 gene implicated as a candidate for a schizophrenia-like psychosis through molecular analysis of a balanced translocation. Molecular Psychiatry 8(7): 654-663
Hiatt, W.R.; Wolfel, E.E.; Stoll, S.; Nies, A.S.; Zerbe, G.O.; Brammell, H.L.; Horwitz, L.D. 1985: Beta-2 Adrenergic blockade evaluated with epinephrine after placebo, atenolol, and nadolol. Clinical Pharmacology and Therapeutics 37(1): 2-6
Mainieri, D.; Montani, J.P.; Seydoux, J.; Giacobino, J.P.; Boss, O.; Dulloo, A.G. 2007: Beta-Adrenergic control of stearoyl-CoA desaturase 1 repression in relation to sympathoadrenal regulation of thermogenesis. International Journal of Obesity 31(2): 378-381
Ebina, T.; Kimura, K.; Toya, Y.; Umemura, S. 2006: Beta-Adrenergic receptor gene. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 5): 385-390
Carroll, J.F.; Kyser, C.K.; Martin, M.M. 2002: Beta-Adrenoceptor density and adenylyl cyclase activity in obese rabbit hearts. International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 26(5): 627-632
Kalaria, R.N.; Hedera, P. 1996: Beta-Amyloid vasoactivity in Alzheimer's disease. Lancet 347(9013): 1492-1493
Thomas, T.; Thomas, G.; McLendon, C.; Sutton, T.; Mullan, M. 1996: Beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380(6570): 168-171
Iaccarino, G.; Trimarco, V.; Lanni, F.; Cipolletta, E.; Izzo, R.; Arcucci, O.; De Luca, N.; Di Renzo, G. 2005: Beta-Blockade and increased dyslipidemia in patients bearing Glu27 variant of beta2 adrenergic receptor gene. Pharmacogenomics Journal 5(5): 292-297
Bai, S-Kyung.; Lee, S-Jin.; Na, H-Jun.; Ha, K-Soo.; Han, J-A.; Lee, H.; Kwon, Y-Guen.; Chung, C-Kwon.; Kim, Y-Myeong. 2005: Beta-Carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-kappaB activation. Experimental and Molecular Medicine 37(4): 323-334
Kim, T.Hoon.; Xiong, H.; Zhang, Z.; Ren, B. 2005: Beta-Catenin activates the growth factor endothelin-1 in colon cancer cells. Oncogene 24(4): 597-604
Duan, Y.; Liao, A.P.; Kuppireddi, S.; Ye, Z.; Ciancio, M.J.; Sun, J. 2007: Beta-Catenin activity negatively regulates bacteria-induced inflammation. Laboratory Investigation; a Journal of Technical Methods and Pathology 87(6): 613-624
Eger, A.; Stockinger, A.; Park, J.; Langkopf, E.; Mikula, M.; Gotzmann, J.; Mikulits, W.; Beug, H.; Foisner, R. 2004: Beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene 23(15): 2672-2680
Hu, Y.; Chen, Y.; Douglas, L.; Li, S. 2009: Beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia 23(1): 109-116
Beiter, K.; Hiendlmeyer, E.; Brabletz, T.; Hlubek, F.; Haynl, A.; Knoll, C.; Kirchner, T.; Jung, A. 2005: Beta-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 24(55): 8200-8204
Resnik, E. 1997: Beta-Catenin--one player, two games. Nature Genetics 16(1): 9-11
Mathis, D.; Vence, L.; Benoist, C. 2001: Beta-Cell death during progression to diabetes. Nature 414(6865): 792-798
Sunehag, A.L.; Man, C.Dalla.; Toffolo, G.; Haymond, M.W.; Bier, D.M.; Cobelli, C. 2009: Beta-Cell function and insulin sensitivity in adolescents from an OGTT. Obesity 17(2): 233-239
Dor, Y. 2006: Beta-Cell proliferation is the major source of new pancreatic beta cells. Nature Clinical Practice. Endocrinology and Metabolism 2(5): 242-243
Huang, Q.S.; Valyi-Nagy, T.; Kesari, S.; Fraser, N.W. 1997: Beta-Gal enzyme activity driven by the HSV LAT promoter does not correspond to beta-gal RNA levels in mouse trigeminal ganglia. Gene Therapy 4(8): 797-807
Wright, M.J.; Rosenthal, E.; Stewart, L.; Wightman, L.M.; Miller, A.D.; Latchman, D.S.; Marber, M.S. 1998: Beta-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: a cautionary tale. Gene Therapy 5(3): 301-308
van Moorsel, C.H.M.; van Wijngaarden, E.E.; Fokkema, I.F.A.C.; den Dunnen, J.T.; Roos, D.; van Zwieten, R.; Giordano, P.C.; Harteveld, C.L. 2004: Beta-Globin mutation detection by tagged single-base extension and hybridization to universal glass and flow-through microarrays. European Journal of Human Genetics: Ejhg 12(7): 567-573
Xiao, Y.; Xue, X.; Wu, Y-feng.; Xin, G-zheng.; Qian, Y.; Xie, T-pei.; Gong, L-kun.; Ren, J. 2009: Beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism. Acta Pharmacologica Sinica 30(11): 1559-1565
Li, X.; Kusmierczyk, A.R.; Wong, P.; Emili, A.; Hochstrasser, M. 2007: Beta-Subunit appendages promote 20S proteasome assembly by overcoming an Ump1-dependent checkpoint. EMBO Journal 26(9): 2339-2349
Lackner, K.J.; Schmitz, G. 1998: Beta-VLDL of patients with type IIi hyperlipoproteinemia interferes with homogeneous determination of HDL-cholesterol based on polyethylene glycol-modified enzymes. Clinical Chemistry 44(12): 2546-2548
Pacanowski, M.A.; Gong, Y.; Cooper-Dehoff, R.M.; Schork, N.J.; Shriver, M.D.; Langaee, T.Y.; Pepine, C.J.; Johnson, J.A. 2008: Beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension. Clinical Pharmacology and Therapeutics 84(6): 715-721
Shapiro, L. 2001: Beta-catenin and its multiple partners: promiscuity explained. Nature Structural Biology 8(6): 484-487
Michaelson, J.S.; Leder, P. 2001: Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 20(37): 5093-5099
Jeong, J-W.; Lee, H.S.; Franco, H.L.; Broaddus, R.R.; Taketo, M.M.; Tsai, S.Y.; Lydon, J.P.; DeMayo, F.J. 2009: Beta-catenin mediates glandular formation and dysregulation of beta-catenin induces hyperplasia formation in the murine uterus. Oncogene 28(1): 31-40
Taniguchi, H.; Yamato, E.; Tashiro, F.; Ikegami, H.; Ogihara, T.; Miyazaki, J. 2003: Beta-cell neogenesis induced by adenovirus-mediated gene delivery of transcription factor pdx-1 into mouse pancreas. Gene Therapy 10(1): 15-23
Kulkarni, R.N.; Holzenberger, M.; Shih, D.Q.; Ozcan, U.; Stoffel, M.; Magnuson, M.A.; Kahn, C.R. 2002: Beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nature Genetics 31(1): 111-115
Liu, Y.; Pan, J.; Wang, S.; Li, X.; Huang, Y. 2002: Beta-fibrinogen gene -455A/G polymorphism and plasma fibrinogen level in Chinese stroke patients. Chinese Medical Journal 115(2): 214-216
Marshall 1999: Beta-secretase identified. Nature Biotechnology 17(12): 1149
Lemaitre, R.N.; Heckbert, S.R.; Sotoodehnia, N.; Bis, J.C.; Smith, N.L.; Marciante, K.D.; Hindorff, L.A.; Lange, L.A.; Lumley, T.S.; Rice, K.M.; Wiggins, K.L.; Psaty, B.M. 2008: Beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke. American Journal of Hypertension 21(3): 290-296
Linné, Y.; Dahlman, I.; Hoffstedt, J. 2005: Beta1-Adrenoceptor gene polymorphism predicts long-term changes in body weight. International Journal of Obesity 29(5): 458-462
Velling, T.; Nilsson, S.; Stefansson, A.; Johansson, S. 2004: Beta1-Integrins induce phosphorylation of Akt on serine 473 independently of focal adhesion kinase and Src family kinases. Embo Reports 5(9): 901-905
Berken, A.; Abel, J.; Unfried, K. 2003: Beta1-integrin mediates asbestos-induced phosphorylation of AKT and ERK1/2 in a rat pleural mesothelial cell line. Oncogene 22(52): 8524-8528
Cheslack-Postava, K.; Fallin, M.D.; Avramopoulos, D.; Connors, S.L.; Zimmerman, A.W.; Eberhart, C.G.; Newschaffer, C.J. 2007: Beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort. Molecular Psychiatry 12(3): 283-291
van Woerden, G.M.; Hoebeek, F.E.; Gao, Z.; Nagaraja, R.Y.; Hoogenraad, C.C.; Kushner, S.A.; Hansel, C.; De Zeeuw, C.I.; Elgersma, Y. 2009: BetaCaMKII controls the direction of plasticity at parallel fiber-Purkinje cell synapses. Nature Neuroscience 12(7): 823-825
Lee, B.Heon.; Bae, J.Sup.; Park, R.Woon.; Kim, J.Eun.; Park, J.Yong.; Kim, I.San. 2006: Betaig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through alphavbeta5 integrin. Experimental and Molecular Medicine 38(2): 153-161
Yaguchi, S.; Yaguchi, J.; Inaba, K. 2014: Bicaudal-C is required for the formation of anterior neurogenic ectoderm in the sea urchin embryo. Scientific Reports 4: 6852
Irion, U.; St Johnston, D. 2007: Bicoid RNA localization requires specific binding of an endosomal sorting complex. Nature 445(7127): 554-558
Rutter, L.; Cook, D. 2020: BigPint: a Bioconductor visualization package that makes big data pint-sized. Plos Computational Biology 16(6): E1007912
Rachid Zaim, S.; Kenost, C.; Berghout, J.; Chiu, W.; Wilson, L.; Zhang, H.H.; Lussier, Y.A. 2020: BinomialRF: interpretable combinatoric efficiency of random forests to identify biomarker interactions. Bmc Bioinformatics 21(1): 374
Kamoun, C.; Roméjon, J.; de Soyres, H.; Gallois, A.; Girard, E.; Hupé, P. 2020: Biogitflow: development workflow protocols for bioinformatics pipelines with git and GitLab. F1000research 9: 632
Shanmugakani, R.K.; Sugawara, Y.; Akeda, Y.; Hagiya, H.; Sakamoto, N.; Aye, M.M.; Myint, T.; Hamada, S.; Tomono, K. 2020: BlaOXA -731 , a new chromosome-encoded blaOXA -48 -like variant in Shewanella sp. from the aquatic environment in Myanmar. Environmental Microbiology Reports 12(5): 548-554
Haider, M.H.; Ain, N.U.; Abrar, S.; Riaz, S. 2020: BlaOXA, blaSHV-, and blaTEM- extended-spectrum β-lactamases in Gram-negative strains from burn patients in Lahore, Pakistan. Journal of Infection in Developing Countries 14(12): 1410-1417
Brodin, P.; Poumailloux, M. 1949: Bman-Sachs disease cured by high doses of penicillin. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 65(15-16): 644-648
Jensen, S.M.; Kluxen, F.M.; Streibig, J.C.; Cedergreen, N.; Ritz, C. 2020: Bmd: an R package for benchmark dose estimation. Peerj 8: E10557
Bebko, A.O.; Troje, N.F. 2020: BmlTUX: Design and Control of Experiments in Virtual Reality and Beyond. I-Perception 11(4): 2041669520938400
Flemming, A. 2020: BnAbs for HIV: shepherding towards improbable mutations. Nature Reviews. Immunology 20(2): 71
Flemming, A. 2020: BnAbs for HIV: shepherding towards improbable mutations. Nature Reviews. Drug Discovery 19(2): 90
Clark, R.S.B.; Nathaniel, P.D.; Zhang, X.; Dixon, C.Edward.; Alber, S.M.; Watkins, S.C.; Melick, J.A.; Kochanek, P.M.; Graham, S.H. 2007: Boc-Aspartyl(OMe)-fluoromethylketone attenuates mitochondrial release of cytochrome c and delays brain tissue loss after traumatic brain injury in rats. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 27(2): 316-326
Azam, M.W.; Zuberi, A.; Khan, A.U. 2020: BolA gene involved in curli amyloids and fimbriae production in E. coli: exploring pathways to inhibit biofilm and amyloid formation. Journal of Biological Research 27: 10
Unbehend, M.; Kozak, G.M.; Koutroumpa, F.; Coates, B.S.; Dekker, T.; Groot, A.T.; Heckel, D.G.; Dopman, E.B. 2021: Bric à brac controls sex pheromone choice by male European corn borer moths. Nature Communications 12(1): 2818
Minami, M.; Kinoshita, N.; Kamoshida, Y.; Tanimoto, H.; Tabata, T. 1999: Brinker is a target of Dpp in Drosophila that negatively regulates Dpp-dependent genes. Nature 398(6724): 242-246
Pérez-Lluch, S.íl.; Klein, C.C.; Breschi, A.; Ruiz-Romero, M.; Abad, A.; Palumbo, E.; Bekish, L.; Arnan, C.; Guigó, R. 2020: BsAS, an antisense long non-coding RNA, essential for correct wing development through regulation of blistered/DSRF isoform usage. Plos Genetics 16(12): E1009245
Guan, L.; Hu, X.; Liu, L.; Xing, Y.; Zhou, Z.; Liang, X.; Yang, Q.; Jin, S.; Bao, J.; Gao, H.; Du, M.; Li, J.; Zhang, L. 2017: Bta-miR-23a involves in adipogenesis of progenitor cells derived from fetal bovine skeletal muscle. Scientific Reports 7: 43716
Pawelec, W.; Lenkowski, P. 1954: Butazolidine; 3,5-dioxo-1,2-diphenyl-4-n-butyl-pyrazolidine. Polski Tygodnik Lekarski 9(2): 55-59
Franssen, C.F.; Tervaert, J.W.; Stegeman, C.A.; Kallenberg, C.G. 1996: C-ANCA as a marker of Wegener's disease. Lancet 347(8994): 116; Author Reply 118
Niles, J.L.; McCluskey, R.T. 1996: C-ANCA as a marker of Wegener's disease. Lancet 347(8994): 116-7; Author Reply 118
Bosch, X.; Urbano-Márquez, A. 1996: C-ANCA as a marker of Wegener's disease. Lancet 347(8994): 117; Author Reply 118
Clark, H.E. 1996: C-ANCA as a marker of Wegener's disease. Lancet 347(8994): 117; Author Reply 118
Malnick, S.D.; Bass, D.D.; Sthoeger, Z.M. 1996: C-ANCA as a marker of Wegener's disease. Lancet 347(8994): 117-118
Contreras, P.S.; Tapia, P.J.; González-Hódar, L.; Peluso, I.; Soldati, C.; Napolitano, G.; Matarese, M.; Heras, M.L.; Valls, C.; Martinez, A.; Balboa, E.; Castro, J.; Leal, N.; Platt, F.M.; Sobota, A.; Winter, D.; Klein, A.és.D.; Medina, D.L.; Ballabio, A.; Alvarez, A.R.; Zanlungo, S. 2020: C-Abl Inhibition Activates TFEB and Promotes Cellular Clearance in a Lysosomal Disorder. Iscience 23(11): 101691
Montecino, F.án.; González, N.; Blanco, N.; Ramírez, M.J.; González-Martín, A.án.; Alvarez, A.R.; Olguín, H. 2021: C-Abl Kinase Is Required for Satellite Cell Function Through Pax7 Regulation. Frontiers in Cell and Developmental Biology 9: 606403
di Bari, M.Giovanna.; Ciuffini, L.; Mingardi, M.; Testi, R.; Soddu, S.; Barilà, D. 2006: C-Abl acetylation by histone acetyltransferases regulates its nuclear-cytoplasmic localization. Embo Reports 7(7): 727-733
Yañez, M.J.; Campos, F.; Marín, T.; Klein, A.D.; Futerman, A.H.; Alvarez, A.R.; Zanlungo, S. 2021: C-Abl activates RIPK3 signaling in Gaucher disease. Biochimica et Biophysica Acta. Molecular Basis of Disease 1867(5): 166089
Ganguly, S.S.; Fiore, L.S.; Sims, J.T.; Friend, J.W.; Srinivasan, D.; Thacker, M.A.; Cibull, M.L.; Wang, C.; Novak, M.; Kaetzel, D.M.; Plattner, R. 2012: C-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression. Oncogene 31(14): 1804-1816
Fiore, L.S.; Ganguly, S.S.; Sledziona, J.; Cibull, M.L.; Wang, C.; Richards, D.L.; Neltner, J.M.; Beach, C.; McCorkle, J.R.; Kaetzel, D.M.; Plattner, R. 2014: C-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer. Oncogene 33(36): 4508-4520
Li, X.; Ma, Q.; Wang, J.; Liu, X.; Yang, Y.; Zhao, H.; Wang, Y.; Jin, Y.; Zeng, J.; Li, J.; Song, L.; Li, X.; Li, P.; Qian, X.; Cao, C. 2010: C-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3. Cell Death and Differentiation 17(8): 1277-1287
Keshet, R.; Adler, J.; Ricardo Lax, I.; Shanzer, M.; Porat, Z.; Reuven, N.; Shaul, Y. 2015: C-Abl antagonizes the YAP oncogenic function. Cell Death and Differentiation 22(6): 935-945
Meltser, V.; Ben-Yehoyada, M.; Reuven, N.; Shaul, Y. 2010: C-Abl downregulates the slow phase of double-strand break repair. Cell Death and Disease 1: E20
Dias, S.S.; Milne, D.M.; Meek, D.W. 2006: C-Abl phosphorylates Hdm2 at tyrosine 276 in response to DNA damage and regulates interaction with ARF. Oncogene 25(50): 6666-6671
Yuan, M.; Luong, P.; Hudson, C.; Gudmundsdottir, K.; Basu, S. 2010: C-Abl phosphorylation of ΔNp63α is critical for cell viability. Cell Death and Disease 1: E16
Kua, H-Yi.; Liu, H.; Leong, W.Fook.; Li, L.; Jia, D.; Ma, G.; Hu, Y.; Wang, X.; Chau, J.F.L.; Chen, Y-Guang.; Mishina, Y.; Boast, S.; Yeh, J.; Xia, L.; Chen, G-Qiang.; He, L.; Goff, S.P.; Li, B. 2012: C-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression. Nature Cell Biology 14(7): 727-737
Stuart, J.R.; Kawai, H.; Tsai, K.K.C.; Chuang, E.Y.; Yuan, Z-Min. 2005: C-Abl regulates early growth response protein (EGR1) in response to oxidative stress. Oncogene 24(55): 8085-8092
He, X.; Zheng, Z.; Song, T.; Wei, C.; Ma, H.; Ma, Q.; Zhang, Y.; Xu, Y.; Shi, W.; Ye, Q.; Zhong, H. 2010: C-Abl regulates estrogen receptor alpha transcription activity through its stabilization by phosphorylation. Oncogene 29(15): 2238-2251
Xiang, J.; Zhang, Y.; Bao, D.; Cao, N.; Zhang, X.; Li, P.; Qiu, S.; Guo, J.; He, D.; Li, B.; Yao, L.; Liu, H. 2017: C-Abl regulates gastrointestinal muscularis propria homeostasis via ERKs. Scientific Reports 7(1): 3563
Theis, S.; Roemer, K. 1998: C-Abl tyrosine kinase can mediate tumor cell apoptosis independently of the Rb and p53 tumor suppressors. Oncogene 17(5): 557-564
Meltser, V.; Ben-Yehoyada, M.; Shaul, Y. 2011: C-Abl tyrosine kinase in the DNA damage response: cell death and more. Cell Death and Differentiation 18(1): 2-4
Zhou, L.; Zhang, Q.; Zhang, P.; Sun, L.; Peng, C.; Yuan, Z.; Cheng, J. 2017: C-Abl-mediated Drp1 phosphorylation promotes oxidative stress-induced mitochondrial fragmentation and neuronal cell death. Cell Death and Disease 8(10): E3117
Fu, J.; Mu, G.; Qiu, L.; Zhao, J.; Ou, C. 2020: C-Abl-p38α signaling pathway mediates dopamine neuron loss in trigeminal neuralgia. Molecular Pain 16: 1744806920930855
Wu, R.; Chen, H.; Ma, J.; He, Q.; Huang, Q.; Liu, Q.; Li, M.; Yuan, Z. 2016: C-Abl-p38α signaling plays an important role in MPTP-induced neuronal death. Cell Death and Differentiation 23(3): 542-552
Shaul, Y. 2000: C-Abl: activation and nuclear targets. Cell Death and Differentiation 7(1): 10-16
Wu, J.; Salva, K.A.; Wood, G.S. 2015: C-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death. Journal of Investigative Dermatology 135(3): 861-868
Dinulescu, D.M.; Wood, L.J.; Shen, L.; Loriaux, M.; Corless, C.L.; Gross, A.W.; Ren, R.; Deininger, M.W.N.; Druker, B.J. 2003: C-CBL is not required for leukemia induction by Bcr-Abl in mice. Oncogene 22(55): 8852-8860
Shen, C.; Lu, Y.; Zhang, J.; Li, Y.; Zhang, Y.; Fan, D. 2021: C-Casitas b-Lineage Lymphoma Downregulation Improves the Ability of Long-term Cultured Mesenchymal Stem Cells for Promoting Angiogenesis and Diabetic Wound Healing. Cell Transplantation 30: 963689721989605
Naramura, M.; Jang, I-Kyung.; Kole, H.; Huang, F.; Haines, D.; Gu, H. 2002: C-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nature Immunology 3(12): 1192-1199
Teckchandani, A.M.; Feshchenko, E.A.; Tsygankov, A.Y. 2001: C-Cbl facilitates fibronectin matrix production by v-Abl-transformed NIH3T3 cells via activation of small GTPases. Oncogene 20(14): 1739-1755
Meyer, R.D.; Husain, D.; Rahimi, N. 2011: C-Cbl inhibits angiogenesis and tumor growth by suppressing activation of PLCγ1. Oncogene 30(19): 2198-2206
Penengo, L.; Rubin, C.; Yarden, Y.; Gaudino, G. 2003: C-Cbl is a critical modulator of the Ron tyrosine kinase receptor. Oncogene 22(24): 3669-3679
Tanaka, S.; Amling, M.; Neff, L.; Peyman, A.; Uhlmann, E.; Levy, J.B.; Baron, R. 1996: C-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. Nature 383(6600): 528-531
Kim, S.Y.; Kim, J-H.; Song, J.J. 2013: C-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5. Cancer Gene Therapy 20(2): 82-87
Lyle, C.; Richards, S.; Yasuda, K.; Napoleon, M.Arthur.; Walker, J.; Arinze, N.; Belghasem, M.; Vellard, I.; Yin, W.; Ravid, J.D.; Zavaro, E.; Amraei, R.; Francis, J.; Phatak, U.; Rifkin, I.R.; Rahimi, N.; Chitalia, V.C. 2019: C-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth. Scientific Reports 9(1): 20257
Cecconi, F. 2011: C-Cbl targets active Src for autophagy. Nature Cell Biology 14(1): 48-49
Song, K.S.; Yoon, J-H.; Kim, K.S.; Ahn, D.W. 2012: C-Ets1 inhibits the interaction of NF-κB and CREB, and downregulates IL-1β-induced MUC5AC overproduction during airway inflammation. Mucosal Immunology 5(2): 207-215
Tai, T-S.; Fang, L-W.; Lai, M-Z. 2004: C-FLICE inhibitory protein expression inhibits T-cell activation. Cell Death and Differentiation 11(1): 69-79
Luebke, T.; Schwarz, L.; Beer, Y.Yan.; Schumann, S.; Misterek, M.; Sander, F.Ewald.; Plaza-Sirvent, C.; Schmitz, I. 2019: C-FLIP and CD95 signaling are essential for survival of renal cell carcinoma. Cell Death and Disease 10(6): 384
Guiet, C.; Silvestri, E.; De Smaele, E.; Franzoso, G.; Vito, P. 2002: C-FLIP efficiently rescues TRAF-2-/- cells from TNF-induced apoptosis. Cell Death and Differentiation 9(2): 138-144
Longley, D.B.; Wilson, T.R.; McEwan, M.; Allen, W.L.; McDermott, U.; Galligan, L.; Johnston, P.G. 2006: C-FLIP inhibits chemotherapy-induced colorectal cancer cell death. Oncogene 25(6): 838-848
Hsu, T-Sheng.; Mo, S-Ting.; Hsu, P-Ning.; Lai, M-Zong. 2018: C-FLIP is a target of the E3 ligase deltex1 in gastric cancer. Cell Death and Disease 9(2): 135
Bank, U.; Deiser, K.; Plaza-Sirvent, C.; Osbelt, L.; Witte, A.; Knop, L.; Labrenz, R.; Jänsch, R.; Richter, F.; Biswas, A.; Zenclussen, A.C.; Vivier, E.; Romagnani, C.; Kühl, A.A.; Dunay, I.R.; Strowig, T.; Schmitz, I.; Schüler, T. 2020: C-FLIP is crucial for IL-7/IL-15-dependent NKp46 + ILC development and protection from intestinal inflammation in mice. Nature Communications 11(1): 1056
Tomaipitinca, L.; Petrungaro, S.; D'Acunzo, P.; Facchiano, A.; Dubey, A.; Rizza, S.; Giulitti, F.; Gaudio, E.; Filippini, A.; Ziparo, E.; Cecconi, F.; Giampietri, C. 2021: C-FLIP regulates autophagy by interacting with Beclin-1 and influencing its stability. Cell Death and Disease 12(7): 686
Quintavalle, C.; Incoronato, M.; Puca, L.; Acunzo, M.; Zanca, C.; Romano, G.; Garofalo, M.; Iaboni, M.; Croce, C.M.; Condorelli, G. 2010: C-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity. Cell Death and Differentiation 17(12): 1908-1916
Quintavalle, C.; Incoronato, M.; Puca, L.; Acunzo, M.; Zanca, C.; Romano, G.; Garofalo, M.; Iaboni, M.; Croce, C.M.; Condorelli, G. 2017: C-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity. Cell Death and Differentiation 24(6): 1134
Follows, G.Alexander.; Tagoh, H.; Richards, S.John.; Melnik, S.; Dickinson, H.; de Wynter, E.; Lefevre, P.; Morgan, G.John.; Bonifer, C. 2005: C-FMS chromatin structure and expression in normal and leukaemic myelopoiesis. Oncogene 24(22): 3643-3651
Kuonen, F.ço.; Li, N.Y.; Haensel, D.; Patel, T.; Gaddam, S.; Yerly, L.; Rieger, K.; Aasi, S.; Oro, A.E. 2021: C-FOS drives reversible basal to squamous cell carcinoma transition. Cell Reports 37(1): 109774
Oliveira-Ferrer, L.; Rößler, K.; Haustein, V.; Schröder, C.; Wicklein, D.; Maltseva, D.; Khaustova, N.; Samatov, T.; Tonevitsky, A.; Mahner, S.; Jänicke, F.; Schumacher, U.; Milde-Langosch, K. 2014: C-FOS suppresses ovarian cancer progression by changing adhesion. British Journal of Cancer 110(3): 753-763
Giampietri, C.; Petrungaro, S.; Coluccia, P.; Antonangeli, F.; Giannakakis, K.; Faraggiana, T.; Filippini, A.; Cossu, G.; Ziparo, E. 2010: C-Flip overexpression affects satellite cell proliferation and promotes skeletal muscle aging. Cell Death and Disease 1: E38
Kiss, A.; Osacka, J. 2020: C-Fos and FosB/ΔFosB colocalizations in selected forebrain structures after olanzapine, amisulpride, aripiprazole, and quetiapine single administration in rats preconditioned by two different mild stressors sequences. Endocrine Regulations 54(1): 43-52
Luyck, K.; Scheyltjens, I.; Nuttin, B.; Arckens, L.; Luyten, L. 2020: C-Fos expression following context conditioning and deep brain stimulation in the bed nucleus of the stria terminalis in rats. Scientific Reports 10(1): 20529
Ribeiro, M.G.; de Oliveira, I.R.; Santana, R.C.; Costa, D.T.; Quarantini, L.C.; de Castro E Silva, E.; Fregoneze, J.B. 2007: C-Fos expression identifies brain areas activated in response to nortriptyline. Molecular Psychiatry 12(7): 613-615
Miampamba; Sharkey 1999: C-Fos expression in the myenteric plexus, spinal cord and brainstem following injection of formalin in the rat colonic wall. Journal of the Autonomic Nervous System 77(2-3): 140-151
Abarrategi, A.; Gambera, S.; Alfranca, A.; Rodriguez-Milla, M.A.; Perez-Tavarez, R.; Rouault-Pierre, K.; Waclawiczek, A.; Chakravarty, P.; Mulero, F.; Trigueros, César.; Navarro, S.; Bonnet, D.; García-Castro, J. 2018: C-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells. Scientific Reports 8(1): 15615
Xiang, H.; Wang, S.; Kong, X.; Yu, Y.; Shen, L.; Long, C.; Liu, X.; Wei, G-Hui. 2021: C-Fos is upregulated in the genital tubercle of DEHP-induced hypospadiac rats and the prepuce of patients with hypospadias. Systems Biology in Reproductive Medicine 2021: 1-8
Chai, Y.; Chipitsyna, G.; Cui, J.; Liao, B.; Liu, S.; Aysola, K.; Yezdani, M.; Reddy, E.S.; Rao, V.N. 2001: C-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. Oncogene 20(11): 1357-1367
Deng, T.; Karin, M. 1994: C-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 371(6493): 171-175
Manios, K.; Tsiambas, E.; Stavrakis, I.; Stamatelopoulos, A.; Kavantzas, N.; Agrogiannis, G.; C Lazaris, A. 2020: C-Fos/ c-Jun transcription factors in non-small cell lung carcinoma. Journal of Buon: Official Journal of the Balkan Union of Oncology 25(5): 2141-2143
Dynek, J.N.; Goncharov, T.; Dueber, E.C.; Fedorova, A.V.; Izrael-Tomasevic, A.; Phu, L.; Helgason, E.; Fairbrother, W.J.; Deshayes, K.; Kirkpatrick, D.S.; Vucic, D. 2010: C-IAP1 and UbcH5 promote K11-linked polyubiquitination of RIP1 in TNF signalling. EMBO Journal 29(24): 4198-4209
Yang, F.; Ozols, E.; Ma, F.Y.; Leong, K.G.; Tesch, G.H.; Jiang, X.; Nikolic-Paterson, D.J. 2021: C-Jun Amino Terminal Kinase Signaling Promotes Aristolochic Acid-Induced Acute Kidney Injury. Frontiers in Physiology 12: 599114
Busquets, O.; Parcerisas, A.; Verdaguer, E.; Ettcheto, M.; Camins, A.; Beas-Zarate, C.; Castro-Torres, R.én.D.ío.; Auladell, C. 2021: C-Jun N-Terminal Kinases in Alzheimer's Disease: a Possible Target for the Modulation of the Earliest Alterations. Journal of Alzheimer's Disease: Jad 82(S1): S127-S139
Tian, H.; Yuning, W.; Yang, W.; Liu, F.; Yu, Y.; Ren, S.; Wang, A.; Zhang, D. 2022: C-Jun N-terminal kinase (JNK) in Procambarus clarkii: Molecular characterization and involvement in oxidative stress-induced apoptosis during molting cycle. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 257: 110676
Escudero, C.A.; Cabeza, C.; Moya-Alvarado, G.; Maloney, M.T.; Flores, C.M.; Wu, C.; Court, F.A.; Mobley, W.C.; Bronfman, F.C. 2019: C-Jun N-terminal kinase (JNK)-dependent internalization and Rab5-dependent endocytic sorting mediate long-distance retrograde neuronal death induced by axonal BDNF-p75 signaling. Scientific Reports 9(1): 6070
Lorenzati, M.; Boda, E.; Parolisi, R.; Bonato, M.; Borsello, T.; Herdegen, T.; Buffo, A.; Vercelli, A. 2021: C-Jun N-terminal kinase 1 (JNK1) modulates oligodendrocyte progenitor cell architecture, proliferation and myelination. Scientific Reports 11(1): 7264
Tripathi, D.; Cheekatla, S.S.; Paidipally, P.; Radhakrishnan, R.Kumar.; Welch, E.; Thandi, R.Sivangala.; Tvinnereim, A.R.; Vankayalapati, R. 2018: C-Jun N-terminal kinase 1 defective CD4+CD25+FoxP3+ cells prolong islet allograft survival in diabetic mice. Scientific Reports 8(1): 3310
Mandić, A.D.; Bennek, E.; Verdier, J.; Zhang, K.; Roubrocks, S.; Davis, R.J.; Denecke, B.; Gassler, N.; Streetz, K.; Kel, A.; Hornef, M.; Cubero, F.J.; Trautwein, C.; Sellge, G. 2017: C-Jun N-terminal kinase 2 promotes enterocyte survival and goblet cell differentiation in the inflamed intestine. Mucosal Immunology 10(5): 1211-1223
Lagadinou, E.D.; Ziros, P.G.; Tsopra, O.A.; Dimas, K.; Kokkinou, D.; Thanopoulou, E.; Karakantza, M.; Pantazis, P.; Spyridonidis, A.; Zoumbos, N.C. 2008: C-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia. Leukemia 22(10): 1899-1908
Jiménez, B.; Volpert, O.V.; Reiher, F.; Chang, L.; Muñoz, A.; Karin, M.; Bouck, N. 2001: C-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1. Oncogene 20(26): 3443-3448
Sclip, A.; Tozzi, A.; Abaza, A.; Cardinetti, D.; Colombo, I.; Calabresi, P.; Salmona, M.; Welker, E.; Borsello, T. 2014: C-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo. Cell Death and Disease 5: E1019
Yoon, C-H.; Kim, M-J.; Kim, R-K.; Lim, E-J.; Choi, K-S.; An, S.; Hwang, S-G.; Kang, S-G.; Suh, Y.; Park, M-J.; Lee, S-J. 2012: C-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells. Oncogene 31(44): 4655-4666
Khatlani, T.S.; Wislez, M.; Sun, M.; Srinivas, H.; Iwanaga, K.; Ma, L.; Hanna, A.E.; Liu, D.; Girard, L.; Kim, Y.H.; Pollack, J.R.; Minna, J.D.; Wistuba, I.I.; Kurie, J.M. 2007: C-Jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells. Oncogene 26(18): 2658-2666
Shin, E.Y.; Kim, S.Y.; Kim, E.G. 2001: C-Jun N-terminal kinase is involved in motility of endothelial cell. Experimental and Molecular Medicine 33(4): 276-283
Zhang, S.; Lin, Y.; Kim, Y-S.; Hande, M.P.; Liu, Z-G.; Shen, H-M. 2007: C-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly(ADP-ribose) polymerase-1 activation. Cell Death and Differentiation 14(5): 1001-1010
Xie, X.; Kaoud, T.S.; Edupuganti, R.; Zhang, T.; Kogawa, T.; Zhao, Y.; Chauhan, G.B.; Giannoukos, D.N.; Qi, Y.; Tripathy, D.; Wang, J.; Gray, N.S.; Dalby, K.N.; Bartholomeusz, C.; Ueno, N.T. 2017: C-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun. Oncogene 36(18): 2599-2608
Cao, M.; Chen, F.; Xie, N.; Cao, M-Yao.; Chen, P.; Lou, Q.; Zhao, Y.; He, C.; Zhang, S.; Song, X.; Sun, Y.; Zhu, W.; Mou, L.; Luan, S.; Gao, H. 2018: C-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities. Cell Death and Disease 9(12): 1140
Aguilera, C.; Nakagawa, K.; Sancho, R.; Chakraborty, A.; Hendrich, B.; Behrens, A. 2011: C-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex. Nature 469(7329): 231-235
Huang, Y.-C.; Pan, W.; Li, H.; Yan, T. 2020: C-Jun NH2-terminal kinase suppression significantly inhibits the growth of transplanted breast tumors in mice. Journal of International Medical Research 48(6): 300060520929858
Madeo, A.; Vinciguerra, M.; Lappano, R.; Galgani, M.; Gasperi-Campani, A.; Maggiolini, M.; Musti, A.M. 2010: C-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells. Oncogene 29(7): 978-991
Zhu, X.; Jia, X.; Cheng, F.; Tian, H.; Zhou, Y. 2020: C-Jun acts downstream of PI3K/AKT signaling to mediate the effect of leptin on methionine adenosyltransferase 2B in hepatic stellate cells in vitro and in vivo. Journal of Pathology 252(4): 423-432
Wu, Y.; Zhang, X.; Zehner, Z.E. 2003: C-Jun and the dominant-negative mutant, TAM67, induce vimentin gene expression by interacting with the activator Sp1. Oncogene 22(55): 8891-8901
Chen, S-Y.; Cai, C.; Fisher, C.J.; Zheng, Z.; Omwancha, J.; Hsieh, C-L.; Shemshedini, L. 2006: C-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Oncogene 25(54): 7212-7223
Qian, M.; Kralova, J.; Yu, W.; Bose, H.R.; Dvorak, M.; Sanders, B.G.; Kline, K. 1997: C-Jun involvement in vitamin E succinate induced apoptosis of reticuloendotheliosis virus transformed avian lymphoid cells. Oncogene 15(2): 223-230
Lynn, R.C.; Weber, E.W.; Sotillo, E.; Gennert, D.; Xu, P.; Good, Z.; Anbunathan, H.; Lattin, J.; Jones, R.; Tieu, V.; Nagaraja, S.; Granja, J.; de Bourcy, C.F.A.; Majzner, R.; Satpathy, A.T.; Quake, S.R.; Monje, M.; Chang, H.Y.; Mackall, C.L. 2019: C-Jun overexpression in CAR T cells induces exhaustion resistance. Nature 576(7786): 293-300
Sevilla, A.; Santos, C.R.; Barcia, R.; Vega, F.M.; Lazo, P.A. 2004: C-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK). Oncogene 23(55): 8950-8958
Hettinger, K.; Vikhanskaya, F.; Poh, M.K.; Lee, M.K.; de Belle, I.; Zhang, J-T.; Reddy, S.A.G.; Sabapathy, K. 2007: C-Jun promotes cellular survival by suppression of PTEN. Cell Death and Differentiation 14(2): 218-229
Jin, J.Y.; Ke, H.; Hall, R.P.; Zhang, J.Y. 2011: C-Jun promotes whereas JunB inhibits epidermal neoplasia. Journal of Investigative Dermatology 131(5): 1149-1158
Jiang, C.; Xie, P.; Sun, R.; Sun, X.; Liu, G.; Ding, S.; Zhu, M.; Yan, B.; Liu, Q.; Chen, X.; Zhao, C. 2018: C-Jun-mediated microRNA-302d-3p induces RPE dedifferentiation by targeting p21 Waf1/Cip1. Cell Death and Disease 9(5): 451
Tsiambas, E.; Mastronikolis, N.; P Fotiades, P.; Kyrodimos, E.; Chrysovergis, A.; Papanikolaou, V.; Mastronikolis, S.; Peschos, D.; Roukas, D.; Ragos, V. 2020: C-Jun/c-Fos complex in laryngeal squamous cell carcinoma. Journal of Buon: Official Journal of the Balkan Union of Oncology 25(2): 618-620
Nadella, K.; Faucz, F.R.; Stratakis, C.A. 2020: C-KIT oncogene expression in PRKAR1A-mutant adrenal cortex. Endocrine-Related Cancer 27(10): 591-599
Tomizawa, F.; Jang, M.-K.; Mashima, T.; Seimiya, H. 2020: C-KIT regulates stability of cancer stemness in CD44-positive colorectal cancer cells. Biochemical and Biophysical Research Communications 527(4): 1014-1020
Heighway, J.; Hasleton, P.S. 1986: C-Ki-ras amplification in human lung cancer. British Journal of Cancer 53(2): 285-287
Bell, S.M.; Kelly, S.A.; Hoyle, J.A.; Lewis, F.A.; Taylor, G.R.; Thompson, H.; Dixon, M.F.; Quirke, P. 1991: C-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. British Journal of Cancer 64(1): 174-178
Tang, W.Y.; Elnatan, J.; Lee, Y.S.; Goh, H.S.; Smith, D.R. 1999: C-Ki-ras mutations in colorectal adenocarcinomas from a country with a rapidly changing colorectal cancer incidence. British Journal of Cancer 81(2): 237-241
Kwak, M.; Ninche, N.; Klein, S.; Saur, D.; Ghazizadeh, S. 2018: C-Kit + Cells in Adult Salivary Glands do not Function as Tissue Stem Cells. Scientific Reports 8(1): 14193
Wu, Y.; Li, J.; Saleem, S.; Yee, S-Pok.; Hardikar, A.A.; Wang, R. 2010: C-Kit and stem cell factor regulate PANC-1 cell differentiation into insulin- and glucagon-producing cells. Laboratory Investigation; a Journal of Technical Methods and Pathology 90(9): 1373-1384
Steeb, T.; Wessely, A.; Petzold, A.; Kohl, C.; Erdmann, M.; Berking, C.; Heppt, M.V. 2021: C-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis. European Journal of Cancer 157: 348-357
Regan, J.L.; Kendrick, H.; Magnay, F-A.; Vafaizadeh, V.; Groner, B.; Smalley, M.J. 2012: C-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer. Oncogene 31(7): 869-883
Chau, W.K.; Ip, C.K.; Mak, A.S.C.; Lai, H-C.; Wong, A.S.T. 2013: C-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling. Oncogene 32(22): 2767-2781
Monsel, G.; Ortonne, N.; Bagot, M.; Bensussan, A.; Dumaz, N. 2010: C-Kit mutants require hypoxia-inducible factor 1alpha to transform melanocytes. Oncogene 29(2): 227-236
Moura Silva, H.; Kitoko, J.Z.; Queiroz, C.P.; Kroehling, L.; Matheis, F.; Yang, K.L.; Reis, B.S.; Ren-Fielding, C.; Littman, D.R.; Bozza, M.T.; Mucida, D.; Lafaille, J.J. 2021: C-MAF-dependent perivascular macrophages regulate diet-induced metabolic syndrome. Science Immunology 6(64): Eabg 7506
Xu, M.; Pokrovskii, M.; Ding, Y.; Yi, R.; Au, C.; Harrison, O.J.; Galan, C.; Belkaid, Y.; Bonneau, R.; Littman, D.R. 2018: C-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont. Nature 554(7692): 373-377
Kim, H-Jeong.; Yoon, A.; Ryu, J-Yoon.; Cho, Y-Jae.; Choi, J-Joo.; Song, S.Yong.; Bang, H.; Lee, J.Soo.; Cho, W.Chi.; Choi, C.Hun.; Lee, J-Won.; Kim, B-Gie.; Bae, D-Soo. 2016: C-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma. Scientific Reports 6: 38502
Ren, H.Z.; Cheung, S.; Churg, A. 2020: C-MET immunohistochemistry for differentiating malignant mesothelioma from benign mesothelial proliferations. Human Pathology 105: 31-36
Vries, H.M.d.; Bekers, E.; van Oosterom, M.N.; Karakullukcu, M.B.; van, H.G.; Poel, d.; van Leeuwen, F.W.B.; Buckle, T.; Brouwer, O.R. 2022: C-MET Receptor-Targeted Fluorescence on the Road to Image-Guided Surgery in Penile Squamous Cell Carcinoma Patients. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 63(1): 51-56
Wu, K-Juey.; Mattioli, M.; Morse, H.C.; Dalla-Favera, R. 2002: C-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cbeta) gene. Oncogene 21(51): 7872-7882
Schleger, C.; Verbeke, C.; Hildenbrand, R.; Zentgraf, H.; Bleyl, U. 2002: C-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 15(4): 462-469
Reyes-González, J.M.; Vivas-Mejía, P.E. 2021: C-MYC and Epithelial Ovarian Cancer. Frontiers in Oncology 11: 601512
Wu, G.; Liu, T.; Li, H.; Li, Y.; Li, D.; Li, W. 2018: C-MYC and reactive oxygen species play roles in tetrandrine-induced leukemia differentiation. Cell Death and Disease 9(5): 473
D'Cruz, C.M.; Gunther, E.J.; Boxer, R.B.; Hartman, J.L.; Sintasath, L.; Moody, S.E.; Cox, J.D.; Ha, S.I.; Belka, G.K.; Golant, A.; Cardiff, R.D.; Chodosh, L.A. 2001: C-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nature Medicine 7(2): 235-239
Cheng, S.W.; Davies, K.P.; Yung, E.; Beltran, R.J.; Yu, J.; Kalpana, G.V. 1999: C-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function. Nature Genetics 22(1): 102-105
Wade, M.A.; Sunter, N.J.; Fordham, S.E.; Long, A.; Masic, D.; Russell, L.J.; Harrison, C.J.; Rand, V.; Elstob, C.; Bown, N.; Rowe, D.; Lowe, C.; Cuthbert, G.; Bennett, S.; Crosier, S.; Bacon, C.M.; Onel, K.; Scott, K.; Scott, D.; Travis, L.B.; May, F.E.B.; Allan, J.M. 2015: C-MYC is a radiosensitive locus in human breast cells. Oncogene 34(38): 4985-4994
Fest, T.; Mougey, V.; Dalstein, Véronique.; Hagerty, M.; Milette, D.; Silva, S.; Mai, S. 2002: C-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis. Oncogene 21(19): 2981-2990
Shimizu, T.; Ishikawa, T.; Sugihara, E.; Kuninaka, S.; Miyamoto, T.; Mabuchi, Y.; Matsuzaki, Y.; Tsunoda, T.; Miya, F.; Morioka, H.; Nakayama, R.; Kobayashi, E.; Toyama, Y.; Kawai, A.; Ichikawa, H.; Hasegawa, T.; Okada, S.; Ito, T.; Ikeda, Y.; Suda, T.; Saya, H. 2010: C-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis. Oncogene 29(42): 5687-5699
Wu, S.; Yin, X.; Fang, X.; Zheng, J.; Li, L.; Liu, X.; Chu, L. 2015: C-MYC responds to glucose deprivation in a cell-type-dependent manner. Cell Death Discovery 1: 15057
Tang, Y.-C.; Hsiao, J.-R.; Jiang, S.-S.; Chang, J.-Y.; Chu, P.-Y.; Liu, K.-J.; Fang, H.-L.; Lin, L.-M.; Chen, H.-H.; Huang, Y.-W.; Chen, Y.-T.; Tsai, F.-Y.; Lin, S.-F.; Chuang, Y.-J.; Kuo, C.-C. 2021: C-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation. Theranostics 11(11): 5232-5247
Liu, D.; Liu, Y.; Zheng, X.; Liu, N. 2021: C-MYC-induced long noncoding RNA MEG3 aggravates kidney ischemia-reperfusion injury through activating mitophagy by upregulation of RTKN to trigger the Wnt/β-catenin pathway. Cell Death and Disease 12(2): 191
Pelengaris, S.; Khan, M.; Evan, G. 2002: C-MYC: more than just a matter of life and death. Nature Reviews. Cancer 2(10): 764-776
Gabryšová, L.; Alvarez-Martinez, M.; Luisier, Rëlle.; Cox, L.S.; Sodenkamp, J.; Hosking, C.; Pérez-Mazliah, Dán.; Whicher, C.; Kannan, Y.; Potempa, K.; Wu, X.; Bhaw, L.; Wende, H.; Sieweke, M.H.; Elgar, G.; Wilson, M.; Briscoe, J.; Metzis, V.; Langhorne, J.; Luscombe, N.M.; O'Garra, A. 2018: C-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4 + T cells. Nature Immunology 19(5): 497-507
Haining, W.Nicholas.; Weiss, S.A. 2018: C-Maf in CD4 + T cells: it's all about context. Nature Immunology 19(5): 429-431
Dhakshinamoorthy, S.; Jaiswal, A.K. 2002: C-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction. Oncogene 21(34): 5301-5312
Chang, H.; Qi, Q.; Xu, W.; Patterson, B. 2007: C-Maf nuclear oncoprotein is frequently expressed in multiple myeloma. Leukemia 21(7): 1572-1574
Neumann, C.; Blume, J.; Roy, U.; Teh, P.P.; Vasanthakumar, A.; Beller, A.; Liao, Y.; Heinrich, F.; Arenzana, T.L.; Hackney, J.A.; Eidenschenk, C.; Gálvez, E.J.C.; Stehle, C.; Heinz, G.A.; Maschmeyer, P.; Sidwell, T.; Hu, Y.; Amsen, D.; Romagnani, C.; Chang, H-Dong.; Kruglov, A.; Mashreghi, M-Farzin.; Shi, W.; Strowig, T.; Rutz, S.; Kallies, A.; Scheffold, A. 2019: C-Maf-dependent T reg cell control of intestinal T H 17 cells and IgA establishes host-microbiota homeostasis. Nature Immunology 20(4): 471-481
Sim, W.Jing.; Iyengar, P.Vasudevan.; Lama, D.; Lui, S.Kit.Leng.; Ng, H.Chun.; Haviv-Shapira, L.; Domany, E.; Kappei, D.; Tan, T.Zea.; Saei, A.; Jaynes, P.William.; Verma, C.Shekhar.; Kumar, A.Prem.; Rouanne, M.; Ha, H.Koo.; Radulescu, C.; Ten Dijke, P.; Eichhorn, P.Johan.Adam.; Thiery, J.Paul. 2019: C-Met activation leads to the establishment of a TGFβ-receptor regulatory network in bladder cancer progression. Nature Communications 10(1): 4349
Xu, X.; Zhu, Y.; Liang, Z.; Li, S.; Xu, X.; Wang, X.; Wu, J.; Hu, Z.; Meng, S.; Liu, B.; Qin, J.; Xie, L.; Zheng, X. 2016: C-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling. Cell Death and Disease 7: E2088
Silva Paiva, R.; Gomes, I.ês.; Casimiro, S.; Fernandes, I.; Costa, L.ís. 2020: C-Met expression in renal cell carcinoma with bone metastases. Journal of Bone Oncology 25: 100315
Gibney, G.T.; Aziz, S.A.; Camp, R.L.; Conrad, P.; Schwartz, B.E.; Chen, C.R.; Kelly, W.K.; Kluger, H.M. 2013: C-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 24(2): 343-349
Garcia, S.; Dalès, J-P.; Jacquemier, J.; Charafe-Jauffret, E.; Birnbaum, D.; Andrac-Meyer, L.; Lavaut, M-N.; Allasia, C.; Carpentier-Meunier, S.; Bonnier, P.; Charpin-Taranger, C. 2007: C-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. British Journal of Cancer 96(2): 329-335
Szabo, R.; Rasmussen, A.L.; Moyer, A.B.; Kosa, P.; Schafer, J.M.; Molinolo, A.A.; Gutkind, J.S.; Bugge, T.H. 2011: C-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase. Oncogene 30(17): 2003-2016
Jia, G.; Li, F.; Tong, R.; Liu, Y.; Zuo, M.; Ma, L.; Ji, X. 2020: C-Met/MAPK pathway promotes the malignant progression of residual hepatocellular carcinoma cells after insufficient radiofrequency ablation. Medical Oncology 37(12): 117
Ferguson, J.; Hawkins, S.W.; Doxey, D. 1950: C-Mitotic action of some simple gases. Nature 165(4208): 1021-1022
Tomita, A.; Towatari, M.; Tsuzuki, S.; Hayakawa, F.; Kosugi, H.; Tamai, K.; Miyazaki, T.; Kinoshita, T.; Saito, H. 2000: C-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300. Oncogene 19(3): 444-451
Waldron, T.; De Dominici, M.; Soliera, A.R.; Audia, A.; Iacobucci, I.; Lonetti, A.; Martinelli, G.; Zhang, Y.; Martinez, R.; Hyslop, T.; Bender, T.P.; Calabretta, B. 2012: C-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells. Leukemia 26(4): 644-653
Zhang, L.; Wang, X.; Li, Y.; Han, J.; Gao, X.; Li, S.; Wang, F. 2021: C-Myb facilitates immune escape of esophageal adenocarcinoma cells through the miR-145-5p/SPOP/PD-L1 axis. Clinical and translational medicine 11(9): e464
Dúcka, M.; Kučeríková, M.; Trčka, F.; Červinka, J.; Biglieri, E.; Šmarda, J.; Borsig, L.; Beneš, P.; Knopfová, L. 2021: C-Myb interferes with inflammatory IL1α-NF-κB pathway in breast cancer cells. Neoplasia 23(3): 326-336
Zorbas, M.; Sicurella, C.; Bertoncello, I.; Venter, D.; Ellis, S.; Mucenski, M.L.; Ramsay, R.G. 1999: C-Myb is critical for murine colon development. Oncogene 18(42): 5821-5830
Yu, X.; Liu, W.; Fan, Z.; Qian, F.; Zhang, D.; Han, Y.; Xu, L.; Sun, G.; Qi, J.; Zhang, S.; Tang, M.; Li, J.; Chai, R.; Wang, H. 2017: C-Myb knockdown increases the neomycin-induced damage to hair-cell-like HEI-OC1 cells in vitro. Scientific Reports 7: 41094
Maurice, D.; Hooper, J.; Lang, G.; Weston, K. 2007: C-Myb regulates lineage choice in developing thymocytes via its target gene Gata3. EMBO Journal 26(15): 3629-3640
Kaspar, P.; Prochazka, J.; Efenberkova, M.; Juhasz, A.; Novosadova, V.; Sedlacek, R. 2019: C-Myb regulates tumorigenic potential of embryonal rhabdomyosarcoma cells. Scientific Reports 9(1): 6342
Sun, R.; Guo, X.; Yang, D.; Tang, Y.; Lu, J.; Sun, H. 2021: C-Myc G-quadruplex is sensitively and specifically recognized by a fluorescent probe. Talanta 226: 122125
Sayyadi, M.; Safaroghli-Azar, A.; Pourbagheri-Sigaroodi, A.; Abolghasemi, H.; Anoushirvani, A.A.; Bashash, D. 2020: C-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis. Archives of Medical Research 51(7): 636-644
Morrish, F.; Isern, N.; Sadilek, M.; Jeffrey, M.; Hockenbery, D.M. 2009: C-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene 28(27): 2485-2491
Deng, Y.; Li, J.; Zhou, M.; Liang, Z.; Zhao, L. 2021: C-Myc affects hedgehog pathway via KCNQ1OT1/RAC1: a new mechanism for regulating HSC proliferation and epithelial-mesenchymal transition. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 53(11): 1458-1467
Sheen, J-H.; Woo, J-K.; Dickson, R.B. 2003: C-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells. British Journal of Cancer 89(8): 1479-1485
Klefstrom, J.; Kovanen, P.E.; Somersalo, K.; Hueber, A.O.; Littlewood, T.; Evan, G.I.; Greenberg, A.H.; Saksela, E.; Timonen, T.; Alitalo, K. 1999: C-Myc and E1A induced cellular sensitivity to activated NK cells involves cytotoxic granules as death effectors. Oncogene 18(13): 2181-2188
Nair, R.; Roden, D.L.; Teo, W.S.; McFarland, A.; Junankar, S.; Ye, S.; Nguyen, A.; Yang, J.; Nikolic, I.; Hui, M.; Morey, A.; Shah, J.; Pfefferle, A.D.; Usary, J.; Selinger, C.; Baker, L.A.; Armstrong, N.; Cowley, M.J.; Naylor, M.J.; Ormandy, C.J.; Lakhani, S.R.; Herschkowitz, J.I.; Perou, C.M.; Kaplan, W.; O'Toole, S.A.; Swarbrick, A. 2014: C-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer. Oncogene 33(30): 3992-4002
Ceballos, E.; Delgado, M.D.; Gutierrez, P.; Richard, C.; Müller, D.; Eilers, M.; Ehinger, M.; Gullberg, U.; León, J. 2000: C-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells. Oncogene 19(18): 2194-2204
Arabi, A.; Wu, S.; Ridderstråle, K.; Bierhoff, H.; Shiue, C.; Fatyol, K.; Fahlén, S.; Hydbring, P.; Söderberg, O.; Grummt, I.; Larsson, L-Gunnar.; Wright, A.P.H. 2005: C-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nature Cell Biology 7(3): 303-310
Grandori, C.; Gomez-Roman, N.; Felton-Edkins, Z.A.; Ngouenet, C.; Galloway, D.A.; Eisenman, R.N.; White, R.J. 2005: C-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nature Cell Biology 7(3): 311-318
Jiang, M-Rong.; Li, Y-Chao.; Yang, Y.; Wu, J-Rui. 2003: C-Myc degradation induced by DNA damage results in apoptosis of CHO cells. Oncogene 22(21): 3252-3259
Wang, H.; Mannava, S.; Grachtchouk, V.; Zhuang, D.; Soengas, M.S.; Gudkov, A.V.; Prochownik, E.V.; Nikiforov, M.A. 2008: C-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene 27(13): 1905-1915
Feng, Y.Chen.; Liu, X.Ying.; Teng, L.; Ji, Q.; Wu, Y.; Li, J.Ming.; Gao, W.; Zhang, Y.Yuan.; La, T.; Tabatabaee, H.; Yan, X.Guang.; Jamaluddin, M.Fairuz.B.; Zhang, D.; Guo, S.Tang.; Scott, R.J.; Liu, T.; Thorne, R.F.; Zhang, X.Dong.; Jin, L. 2020: C-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis. Nature Communications 11(1): 4980
Li, S.; Zhang, S.; Chen, J. 2019: C-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma. Cancer Gene Therapy 26(11-12): 400-410
Shiue, C-N.; Berkson, R.G.; Wright, A.P.H. 2009: C-Myc induces changes in higher order rDNA structure on stimulation of quiescent cells. Oncogene 28(16): 1833-1842
Iaccarino, I.; Hancock, D.; Evan, G.; Downward, J. 2003: C-Myc induces cytochrome c release in Rat1 fibroblasts by increasing outer mitochondrial membrane permeability in a Bid-dependent manner. Cell Death and Differentiation 10(5): 599-608
Luo, W.; Chen, J.; Li, L.; Ren, X.; Cheng, T.; Lu, S.; Lawal, R.Akinyanju.; Nie, Q.; Zhang, X.; Hanotte, O. 2019: C-Myc inhibits myoblast differentiation and promotes myoblast proliferation and muscle fibre hypertrophy by regulating the expression of its target genes, mi RNAs and lincRNAs. Cell Death and Differentiation 26(3): 426-442
Kuschak, T.I.; Kuschak, B.C.; Taylor, C.L.; Wright, J.A.; Wiener, F.; Mai, S. 2002: C-Myc initiates illegitimate replication of the ribonucleotide reductase R2 gene. Oncogene 21(6): 909-920
Wang, X.; Zhao, X.; Gao, P.; Wu, M. 2013: C-Myc modulates microRNA processing via the transcriptional regulation of Drosha. Scientific Reports 3: 1942
Napoli, C.; Lerman, L.O.; de Nigris, F.; Sica, V. 2002: C-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases?. Neoplasia 4(3): 185-190
Arango, D.; Mariadason, J.M.; Wilson, A.J.; Yang, W.; Corner, G.A.; Nicholas, C.; Aranes, M.J.; Augenlicht, L.H. 2003: C-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis. British Journal of Cancer 89(9): 1757-1765
Dong, J.; Naito, M.; Tsuruo, T. 1997: C-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells. Oncogene 15(6): 639-647
Nieminen, A.I.; Partanen, J.I.; Hau, A.; Klefstrom, J. 2007: C-Myc primed mitochondria determine cellular sensitivity to TRAIL-induced apoptosis. EMBO Journal 26(4): 1055-1067
Xu, D.; Wang, B.; Chen, P-Pan.; Wang, Y-Zhe.; Miao, N-Jun.; Yin, F.; Cheng, Q.; Zhou, Z-Li.; Xie, H-Yan.; Zhou, L.; Liu, J.; Wang, X-Xia.; Xue, H.; Zhang, W.; Lu, L-Min. 2019: C-Myc promotes tubular cell apoptosis in ischemia-reperfusion-induced renal injury by negatively regulating c-FLIP and enhancing FasL/Fas-mediated apoptosis pathway. Acta Pharmacologica Sinica 40(8): 1058-1066
Kanazawa, S.; Soucek, L.; Evan, G.; Okamoto, T.; Peterlin, B.Matija. 2003: C-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis. Oncogene 22(36): 5707-5711
Trumpp, A.; Refaeli, Y.; Oskarsson, T.; Gasser, S.; Murphy, M.; Martin, G.R.; Bishop, J.M. 2001: C-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414(6865): 768-773
Cai, C.; Hu, X.; Dai, P.; Zhang, T.; Jiang, M.; Wang, L.; Hua, W.; Fan, Y.; Han, X-Xin.; Gao, Z. 2021: C-Myc regulates neural stem cell quiescence and activation by coordinating the cell cycle and mitochondrial remodeling. Signal Transduction and Targeted Therapy 6(1): 306
Barsyte-Lovejoy, D.; Mao, D.Y.L.; Penn, L.Z. 2004: C-Myc represses the proximal promoters of GADD45a and GADD153 by a post-RNA polymerase II recruitment mechanism. Oncogene 23(19): 3481-3486
Borzi, C.; Calzolari, L.; Ferretti, A.M.; Caleca, L.; Pastorino, U.; Sozzi, G.; Fortunato, O. 2019: C-Myc shuttled by tumour-derived extracellular vesicles promotes lung bronchial cell proliferation through miR-19b and miR-92a. Cell Death and Disease 10(10): 759
Wu, D-W.; Hsu, N-Y.; Wang, Y-C.; Lee, M-C.; Cheng, Y-W.; Chen, C-Y.; Lee, H. 2015: C-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT. Oncogene 34(16): 2072-2082
Gao, P.; Tchernyshyov, I.; Chang, T-Cheng.; Lee, Y-Sil.; Kita, K.; Ochi, T.; Zeller, K.I.; De Marzo, A.M.; Van Eyk, J.E.; Mendell, J.T.; Dang, C.V. 2009: C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458(7239): 762-765
Liu, Y.; Zhou, S.; Shi, J.; Zhang, X.; Shentu, L.; Chen, Z.; Zhou, L. 2019: C-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment. Oncogenesis 8(10): 58
de Alborán, I.Moreno.; Baena, E.; Martinez-A, C. 2004: C-Myc-deficient B lymphocytes are resistant to spontaneous and induced cell death. Cell Death and Differentiation 11(1): 61-68
Moon, H.; Park, H.; Ro, S.W. 2021: C-Myc-driven Hepatocarcinogenesis. Anticancer Research 41(10): 4937-4946
Chou, C.; Pinto, A.K.; Curtis, J.D.; Persaud, S.P.; Cella, M.; Lin, C-Chung.; Edelson, B.T.; Allen, P.M.; Colonna, M.; Pearce, E.L.; Diamond, M.S.; Egawa, T. 2014: C-Myc-induced transcription factor AP4 is required for host protection mediated by CD8+ T cells. Nature Immunology 15(9): 884-893
Xue, G.; Yan, H-L.; Zhang, Y.; Hao, L-Q.; Zhu, X-T.; Mei, Q.; Sun, S-H. 2015: C-Myc-mediated repression of miR-15-16 in hypoxia is induced by increased HIF-2α and promotes tumor angiogenesis and metastasis by upregulating FGF2. Oncogene 34(11): 1393-1406
O'Donnell, K.A.; Wentzel, E.A.; Zeller, K.I.; Dang, C.V.; Mendell, J.T. 2005: C-Myc-regulated micro RNAs modulate E2F1 expression. Nature 435(7043): 839-843
Madhyastha, H.; Madhyastha, R.; Thakur, A.; Kentaro, S.; Dev, A.; Singh, S.; Chandrashekharappa R, B.; Kumar, H.; Acevedo, O.; Nakajima, Y.; Daima, H.K.; Aradhya, A.; Nagaraj P, N.; Maruyama, M. 2020: C-Phycocyanin primed silver nano conjugates: Studies on red blood cell stress resilience mechanism. Colloids and Surfaces. B Biointerfaces 194: 111211
Zaini, A.; Fulford, T.S.; Grumont, R.J.; Runting, J.; Rodrigues, G.; Ng, J.; Gerondakis, S.; Zaph, C.; Scheer, S. 2021: C-Rel Is Required for IL-33-Dependent Activation of ILC2s. Frontiers in Immunology 12: 667922
Li, T.; Li, X.; Zamani, A.; Wang, W.; Lee, C-Nien.; Li, M.; Luo, G.; Eiler, E.; Sun, H.; Ghosh, S.; Jin, J.; Murali, R.; Ruan, Q.; Shi, W.; Chen, Y.H. 2020: C-Rel Is a Myeloid Checkpoint for Cancer Immunotherapy. Nature Cancer 1(5): 507-517
Faumont, N.; Taoui, O.; Collares, D.; Jais, J.-P.; Leroy, K.; Prévaud, L.éa.; Jardin, F.; Molina, T.J.; Copie-Bergman, C.; Petit, B.; Gourin, M.-P.; Bordessoule, D.; Troutaud, D.; Baud, V.ér.; Feuillard, J. 2021: C-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: a LYSA Study. Frontiers in Oncology 11: 638897
Hunter, J.E.; Leslie, J.; Perkins, N.D. 2016: C-Rel and its many roles in cancer: an old story with new twists. British Journal of Cancer 114(1): 1-6
Lorenz, V.N.; Schön, M.P.; Seitz, C.S. 2014: C-Rel downregulation affects cell cycle progression of human keratinocytes. Journal of Investigative Dermatology 134(2): 415-422
Geismann, C.; Grohmann, F.; Sebens, S.; Wirths, G.; Dreher, A.; Häsler, R.; Rosenstiel, P.; Hauser, C.; Egberts, J-H.; Trauzold, A.; Schneider, G.; Sipos, B.; Zeissig, S.; Schreiber, S.; Schäfer, H.; Arlt, A. 2014: C-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells. Cell Death and Disease 5: E1455
Han, S.; Wang, J.; Gao, S.; Sheng, L.; Li, Y. 2021: C-Ski improves beagle atrial structural remodeling by suppressing TGF-β1-SMAD signaling and p38 MAPK pathway. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 37(10): 910-916
Suzuki, H.; Yagi, K.; Kondo, M.; Kato, M.; Miyazono, K.; Miyazawa, K. 2004: C-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements. Oncogene 23(29): 5068-5076
Min, W.; He, C.; Zhang, S.; Zhao, Y. 2021: C-Src Increases the Sensitivity to TKIs in the EGFR-Mutant Lung Adenocarcinoma. Frontiers in Oncology 11: 602900
Suprynowicz, F.A.; Baege, A.; Sunitha, I.; Schlegel, R. 2002: C-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation. Oncogene 21(11): 1695-1706
Logue, J.S.; Cartagena-Rivera, A.X.; Chadwick, R.S. 2018: C-Src activity is differentially required by cancer cell motility modes. Oncogene 37(16): 2104-2121
Peruzzi, B.; Cappariello, A.; Del Fattore, A.; Rucci, N.; De Benedetti, F.; Teti, A. 2012: C-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling. Nature Communications 3: 630
Balzer, E.M.; Whipple, R.A.; Thompson, K.; Boggs, A.E.; Slovic, J.; Cho, E.H.; Matrone, M.A.; Yoneda, T.; Mueller, S.C.; Martin, S.S. 2010: C-Src differentially regulates the functions of microtentacles and invadopodia. Oncogene 29(48): 6402-6408
Mayoral-Varo, V.íc.; Calcabrini, A.; Sánchez-Bailón, M.ía.P.; Martínez-Costa, Ós.H.; González-Páramos, C.; Ciordia, S.; Hardisson, D.; Aragón, J.J.; Fernández-Moreno, M.Án.; Martín-Pérez, J. 2020: C-Src functionality controls self-renewal and glucose metabolism in MCF7 breast cancer stem cells. Plos one 15(7): E0235850
Alvandi, Z.; Opas, M. 2020: C-Src kinase inhibits osteogenic differentiation via enhancing STAT1 stability. Plos one 15(11): E0241646
Ishizawar, R.C.; Miyake, T.; Parsons, S.J. 2007: C-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene 26(24): 3503-3510
Zhang, J.; Wang, S.; Jiang, B.; Huang, L.; Ji, Z.; Li, X.; Zhou, H.; Han, A.; Chen, A.; Wu, Y.; Ma, H.; Zhao, W.; Zhao, Q.; Xie, C.; Sun, X.; Zhou, Y.; Huang, H.; Suleman, M.; Lin, F.; Zhou, L.; Tian, F.; Jin, M.; Cai, Y.; Zhang, N.; Li, Q. 2017: C-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis. Nature Communications 8: 13732
Yang, J.; Zhang, X.; Liu, L.; Yang, X.; Qian, Q.; Du, B. 2021: C-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway. Life Sciences 264: 118711
Kostenko, S.; Heu, C.C.; Yaron, J.R.; Singh, G.; de Oliveira, C.; Muller, W.J.; Singh, V.P. 2018: C-Src regulates cargo transit via the Golgi in pancreatic acinar cells. Scientific Reports 8(1): 11903
Kim, H.; Laing, M.; Muller, W. 2005: C-Src-null mice exhibit defects in normal mammary gland development and ERalpha signaling. Oncogene 24(36): 5629-5636
Fu, J.; He, C.; Xia, B.; Li, Y.; Feng, Q.; Yin, Q.; Shi, X.; Feng, X.; Wang, H.; Yao, H. 2016: C-axis preferential orientation of hydroxyapatite accounts for the high wear resistance of the teeth of black carp (Mylopharyngodon piceus). Scientific Reports 6: 23509
Ren, A.; Patel, D.J. 2014: C-di-AMP binds the ydaO riboswitch in two pseudo-symmetry-related pockets. Nature Chemical Biology 10(9): 780-786
Kundra, S.; Lam, L.N.; Kajfasz, J.K.; Casella, L.G.; Andersen, M.J.; Abranches, J.; Flores-Mireles, A.L.; Lemos, J.é A. 2021: C-di-AMP Is Essential for the Virulence of Enterococcus faecalis. Infection and Immunity 89(11): E0036521
Joshi, A.; Mahmoud, S.A.; Kim, S.-K.; Ogdahl, J.L.; Lee, V.T.; Chien, P.; Yildiz, F.H. 2020: C-di-GMP inhibits LonA-dependent proteolysis of TfoY in Vibrio cholerae. Plos Genetics 16(6): E1008897
Bush, M.J.; Tschowri, N.; Schlimpert, S.; Flärdh, K.; Buttner, M.J. 2015: C-di-GMP signalling and the regulation of developmental transitions in streptomycetes. Nature Reviews. Microbiology 13(12): 749-760
Nicastro, G.G.; Kaihami, G.H.; Pulschen, Aé.A.; Hernandez-Montelongo, J.; Boechat, A.Laura.; de Oliveira Pereira, T.; Rosa, C.Gomes.Tavares.; Stefanello, E.; Colepicolo, P.; Bordi, C.; Baldini, R.L. 2020: C-di-GMP-related phenotypes are modulated by the interaction between a diguanylate cyclase and a polar hub protein. Scientific Reports 10(1): 3077
Gusterson, B.A.; Machin, L.G.; Gullick, W.J.; Gibbs, N.M.; Powles, T.J.; Elliott, C.; Ashley, S.; Monaghan, P.; Harrison, S. 1988: C-erbB-2 expression in benign and malignant breast disease. British Journal of Cancer 58(4): 453-457
McKay, J.A.; Loane, J.F.; Ross, V.G.; Ameyaw, M-M.; Murray, G.I.; Cassidy, J.; McLeod, H.L. 2002: C-erbB-2 is not a major factor in the development of colorectal cancer. British Journal of Cancer 86(4): 568-573
Perren, T.J. 1991: C-erbB-2 oncogene as a prognostic marker in breast cancer. British Journal of Cancer 63(3): 328-332
Charpin, C.; Garcia, S.; Bouvier, C.; Martini, F.; Lavaut, M.N.; Allasia, C.; Bonnier, P.; Andrac, L. 1997: C-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival. British Journal of Cancer 75(11): 1667-1673
Lovekin, C.; Ellis, I.O.; Locker, A.; Robertson, J.F.; Bell, J.; Nicholson, R.; Gullick, W.J.; Elston, C.W.; Blamey, R.W. 1991: C-erbB-2 oncoprotein expression in primary and advanced breast cancer. British Journal of Cancer 63(3): 439-443
Gullick, W.J.; Love, S.B.; Wright, C.; Barnes, D.M.; Gusterson, B.; Harris, A.L.; Altman, D.G. 1991: C-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. British Journal of Cancer 63(3): 434-438
Mezzelani, A.; Alasio, L.; Bartoli, C.; Bonora, M.G.; Pierotti, M.A.; Rilke, F.; Pilotti, S. 1999: C-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates. British Journal of Cancer 80(3-4): 519-525
Knowlden, J.M.; Gee, J.M.; Seery, L.T.; Farrow, L.; Gullick, W.J.; Ellis, I.O.; Blamey, R.W.; Robertson, J.F.; Nicholson, R.I. 1998: C-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer. Oncogene 17(15): 1949-1957
Han, Y.; Ma, F.Y.; Tesch, G.H.; Manthey, C.L.; Nikolic-Paterson, D.J. 2011: C-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat. Laboratory Investigation; a Journal of Technical Methods and Pathology 91(7): 978-991
Zhang, J.; Zhang, D.; McQuade, J.Slane.; Behbehani, M.; Tsien, J.Z.; Xu, M. 2002: C-fos regulates neuronal excitability and survival. Nature Genetics 30(4): 416-420
Hilberg, F.; Aguzzi, A.; Howells, N.; Wagner, E.F. 1993: C-jun is essential for normal mouse development and hepatogenesis. Nature 365(6442): 179-181
Pan, C-Xian.; Yang, X.J.; Lopez-Beltran, A.; MacLennan, G.T.; Eble, J.N.; Koch, M.O.; Jones, T.D.; Lin, H.; Nigro, K.; Papavero, V.; Tretiakova, M.; Cheng, L. 2005: C-kit Expression in small cell carcinoma of the urinary bladder: prognostic and therapeutic implications. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 18(3): 320-323
Aquila, I.; Cianflone, E.; Scalise, M.; Marino, F.; Mancuso, T.; Filardo, A.; Smith, A.J.; Cappetta, D.; De Angelis, A.; Urbanek, K.; Isidori, A.M.; Torella, M.; Agosti, V.; Viglietto, G.; Nadal-Ginard, B.; Ellison-Hughes, G.M.; Torella, D. 2019: C-kit Haploinsufficiency impairs adult cardiac stem cell growth, myogenicity and myocardial regeneration. Cell Death and Disease 10(6): 436
Wardelmann, E.; Neidt, I.; Bierhoff, E.; Speidel, N.; Manegold, C.; Fischer, H-Peter.; Pfeifer, U.; Pietsch, T. 2002: C-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 15(2): 125-136
Liu, Q.; Huang, X.; Zhang, H.; Tian, X.; He, L.; Yang, R.; Yan, Y.; Wang, Q-Dong.; Gillich, A.; Zhou, B. 2015: C-kit(+) cells adopt vascular endothelial but not epithelial cell fates during lung maintenance and repair. Nature Medicine 21(8): 866-868
Rahbarghazi, R.; Keyhanmanesh, R.; Rezaie, J.; Mirershadi, F.; Heiran, H.; Saghaei Bagheri, H.; Saberianpour, S.; Rezabakhsh, A.; Delkhosh, A.; Bagheri, Y.; Rajabi, H.; Ahmadi, M. 2021: C-kit+ cells offer hopes in ameliorating asthmatic pathologies via regulation of miRNA-133 and miRNA-126. Iranian Journal of Basic Medical Sciences 24(3): 369-376
Liu, W.; Wu, M.; Huang, Z.; Lian, J.; Chen, J.; Wang, T.; Leung, A.Y.H.; Liao, Y.; Zhang, Z.; Liu, Q.; Yen, K.; Lin, S.; Zon, L.I.; Wen, Z.; Zhang, Y.; Zhang, W. 2017: C-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish. Leukemia 31(1): 222-233
Tsuneoka, M.; Nakano, F.; Ohgusu, H.; Mekada, E. 1997: C-myc activates RCC1 gene expression through E-box elements. Oncogene 14(19): 2301-2311
Sutherland, K.D.; Vaillant, Fçois.; Alexander, W.S.; Wintermantel, T.M.; Forrest, N.C.; Holroyd, S.L.; McManus, E.J.; Schutz, G.; Watson, C.J.; Chodosh, L.A.; Lindeman, G.J.; Visvader, J.E. 2006: C-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3. EMBO Journal 25(24): 5805-5815
Kuttler, F.; Amé, P.; Clark, H.; Haughey, C.; Mougin, C.; Cahn, J.Y.; Dang, C.V.; Raffeld, M.; Fest, T. 2001: C-myc box II mutations in Burkitt's lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli. Oncogene 20(42): 6084-6094
Blanchard, J.M.; Piechaczyk, M.; Dani, C.; Chambard, J.C.; Franchi, A.; Pouyssegur, J.; Jeanteur, P. 1985: C-myc gene is transcribed at high rate in G0-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors. Nature 317(6036): 443-445
Hernández, L.; Hernández, S.; Beà, S.; Pinyol, M.; Ferrer, A.; Bosch, F.; Nadal, A.; Fernández, P.L.; Palacín, A.; Montserrat, E.; Campo, E. 1999: C-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas. Leukemia 13(12): 2087-2093
Locker, A.P.; Dowle, C.S.; Ellis, I.O.; Elston, C.W.; Blamey, R.W.; Sikora, K.; Evan, G.; Robins, R.A. 1989: C-myc oncogene product expression and prognosis in operable breast cancer. British Journal of Cancer 60(5): 669-672
Hann, S.R.; Thompson, C.B.; Eisenman, R.N. 1985: C-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 314(6009): 366-369
Gavioli, R.; Frisan, T.; Vertuani, S.; Bornkamm, G.W.; Masucci, M.G. 2001: C-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. Nature Cell Biology 3(3): 283-288
Ji, W.; Zhang, W.; Wang, X.; Shi, Y.; Yang, F.; Xie, H.; Zhou, W.; Wang, S.; Guan, X. 2020: C-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis. Cell Death and Disease 11(9): 760
Wang, P.; Fromowitz, F.; Koslow, M.; Hagag, N.; Johnson, B.; Viola, M. 1991: C-src structure in human cancers with elevated pp60c-src activity. British Journal of Cancer 64(3): 531-533
Jiang, J.; Chen, G.; Wu, J.; Luan, X.; Zhou, H.; Liu, X.; Zhu, Z.; Song, X.; Wang, S.; Qian, X.; Du, J.; Huang, X.; Zhang, M.; Xu, W.; Cao, L. 2020: C.1263+1G>A Is a Latent Hotspot for CYP27A1 Mutations in Chinese Patients with Cerebrotendinous Xanthomatosis. Frontiers in Genetics 11: 682
Lu, X.-G.; Yu, U.; Han, C.-X.; Mai, J.-H.; Liao, J.-X.; Hou, Y.-Q. 2021: C.3G>A mutation in the CRYAB gene that causes fatal infantile hypertonic myofibrillar myopathy in the Chinese population. Journal of Integrative Neuroscience 20(1): 143-151
Su, D.; Zhang, W.; Yang, Y.; Zhang, H.; Liu, Y-Qiang.; Bai, G.; Ma, Y-Xin.; Peng, Y.; Zhang, S-Zhong. 2010: C.822+126T>G/C: a novel triallelic polymorphism of the TSSK6 gene associated with spermatogenic impairment in a Chinese population. Asian Journal of Andrology 12(2): 234-239
Latorre, P.; Burgos, C.; Hidalgo, J.; Varona, L.; Carrodeguas, Jé.Alberto.; López-Buesa, P. 2016: C.A2456C-substitution in Pck1 changes the enzyme kinetic and functional properties modifying fat distribution in pigs. Scientific Reports 6: 19617
Saalfrank, C.; Fantuzzi, F.; Kupfer, T.; Ritschel, B.; Hammond, K.; Krummenacher, I.; Bertermann, R.üd.; Wirthensohn, R.; Finze, M.; Schmid, P.; Engel, V.; Engels, B.; Braunschweig, H. 2020: CAAC-Stabilized 9,10-diboraanthracenes-Acenes with Open-Shell Singlet Biradical Ground States. Angewandte Chemie 59(43): 19338-19343
Calzolari, F.; Berninger, B. 2021: CAAVe phaenomena: Beware of appearances!. Cell 184(21): 5303-5305
Rubin, E.Wierman.; Rassman, A. 2021: CAIR: Implementation of peer response support for frontline health care workers facing the COVID-19 pandemic. Social Work in Health Care 2021: 1-10
Lavogina, D.; Laasfeld, T.õn.; Tahk, M.-J.; Kukk, O.; Allikalt, A.; Kopanchuk, S.; Rinken, A. 2021: CAMP Biosensor Assay Using BacMam Expression System: Studying the Downstream Signaling of LH/hCG Receptor Activation. Methods in Molecular Biology 2268: 179-192
Zaccolo, M. 2021: CAMP Buffering via Liquid-Liquid Phase Separation. Function 2(1): Zqaa 048
Medina-Chávez, D.-A.; Sánchez-Ajofrín, I.; Peris-Frau, P.; Maside, C.; Montoro, V.; Fernández-Santos, R.ío.; Garde, J.é J.án.; Soler, A.J. 2021: CAMP Modulators before in Vitro Maturation Decrease DNA Damage and Boost Developmental Potential of Sheep Oocytes. Animals: An Open Access Journal from Mdpi 11(9)
Rodríguez-Valverde, D.; León-Montes, N.; Soria-Bustos, J.; Martínez-Cruz, J.; González-Ugalde, R.; Rivera-Gutiérrez, S.; González-Y-Merchand, J.A.; Rosales-Reyes, R.; García-Morales, L.áz.; Hirakawa, H.; Fox, J.G.; Girón, J.A.; De la Cruz, M.A.; Ares, M.A. 2021: CAMP Receptor Protein Positively Regulates the Expression of Genes Involved in the Biosynthesis of Klebsiella oxytoca Tilivalline Cytotoxin. Frontiers in Microbiology 12: 743594
Jackson, P.K. 2020: CAMP Signaling in Nanodomains. Cell 182(6): 1379-1381
Chen, Y.; Fan, X.; Zhao, X.; Shen, Y.; Xu, X.; Wei, L.; Wang, W.; Wei, D. 2021: CAMP activates calcium signalling via phospholipase C to regulate cellulase production in the filamentous fungus Trichoderma reesei. Biotechnology for Biofuels 14(1): 62
Williams, C. 2004: CAMP detection methods in HTS: selecting the best from the rest. Nature Reviews. Drug Discovery 3(2): 125-135
Narang, A. 2009: CAMP does not have an important role in carbon catabolite repression of the Escherichia coli lac operon. Nature Reviews. Microbiology 7(3): 250
Feng, W.Guo.; Wang, Y.Bing.; Zhang, J.Song.; Wang, X.Yu.; Li, C.Lin.; Chang, Z.Liang. 2002: CAMP elevators inhibit LPS-induced IL-12 p40 expression by interfering with phosphorylation of p38 MAPK in murine peritoneal macrophages. Cell Research 12(5-6): 331-337
Hecquet, C.; Lefevre, Gëlle.; Valtink, M.; Engelmann, K.; Mascarelli, F. 2002: CAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner. Oncogene 21(39): 6101-6112
Gárate, F.; Dokas, S.; Lanfranco, M.F.; Canavan, C.; Wang, I.; Correia, J.J.; Maillard, R.A. 2021: CAMP is an allosteric modulator of DNA-binding specificity in the cAMP receptor protein from Mycobacterium tuberculosis. Journal of Biological Chemistry 296: 100480
Polumuri, S.; Perkins, D.J.; Vogel, S.N. 2021: CAMP levels regulate macrophage alternative activation marker expression. Innate Immunity 27(2): 133-142
Zhu, N.; Cui, J.; Qiao, C.; Li, Y.; Ma, Y.; Zhang, J.; Shen, B. 2008: CAMP modulates macrophage development by suppressing M-CSF-induced MAPKs activation. Cellular and Molecular Immunology 5(2): 153-157
Nicol, X.; Voyatzis, S.; Muzerelle, A.; Narboux-Nême, N.; Südhof, T.C.; Miles, R.; Gaspar, P. 2007: CAMP oscillations and retinal activity are permissive for ephrin signaling during the establishment of the retinotopic map. Nature Neuroscience 10(3): 340-347
Tsai, Y-Lin.; Chien, H-Fei.; Huang, K-Tong.; Lin, W-Yuan.; Liaw, S-Jen. 2017: CAMP receptor protein regulates mouse colonization, motility, fimbria-mediated adhesion, and stress tolerance in uropathogenic Proteus mirabilis. Scientific Reports 7(1): 7282
Liu, D.; Wang, Y.; Pan, Z.; Huang, Z.; Chen, F. 2020: CAMP regulates 11β-hydroxysteroid dehydrogenase-2 and Sp1 expression in MLO-Y4/MC3T3-E1 cells. Experimental and Therapeutic Medicine 20(3): 2166-2172
Leslie, S.N.; Nairn, A.C. 2019: CAMP regulation of protein phosphatases PP1 and PP2A in brain. Biochimica et Biophysica Acta. Molecular Cell Research 1866(1): 64-73
Ikegami, K.; Nakajima, M.; Minami, Y.; Nagano, M.; Masubuchi, S.; Shigeyoshi, Y. 2020: CAMP response element induces Per1 in vivo. Biochemical and Biophysical Research Communications 531(4): 515-521
Fujita, M.; Richards, E.M.; Niciu, M.J.; Ionescu, D.F.; Zoghbi, S.S.; Hong, J.; Telu, S.; Hines, C.S.; Pike, V.W.; Zarate, C.A.; Innis, R.B. 2017: CAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor. Molecular Psychiatry 22(5): 754-759
Park, J-Yeon.; Juhnn, Y-Sung. 2017: CAMP signaling increases histone deacetylase 8 expression via the Epac2-Rap1A-Akt pathway in H1299 lung cancer cells. Experimental and Molecular Medicine 49(2): E297
Perez, J.; Tardito, D.; Racagni, G.; Smeraldi, E.; Zanardi, R. 2002: CAMP signaling pathway in depressed patients with psychotic features. Molecular Psychiatry 7(2): 208-212
Ciullo, I.; Diez-Roux, G.; Di Domenico, M.; Migliaccio, A.; Avvedimento, E.V. 2001: CAMP signaling selectively influences Ras effectors pathways. Oncogene 20(10): 1186-1192
Chen, W.; McRoberts, J.A.; Ennes, H.S.; Marvizon, J.C. 2021: CAMP signaling through protein kinase a and Epac2 induces substance P release in the rat spinal cord. Neuropharmacology 189: 108533
Perrin, A.J.; Patel, A.; Flueck, C.; Blackman, M.J.; Baker, D.A. 2020: CAMP signalling and its role in host cell invasion by malaria parasites. Current Opinion in Microbiology 58: 69-74
Luan, X.; Le, Y.; Jagadeeshan, S.; Murray, B.; Carmalt, J.L.; Duke, T.; Beazley, S.; Fujiyama, M.; Swekla, K.; Gray, B.; Burmester, M.; Campanucci, V.A.; Shipley, A.; Machen, T.E.; Tam, J.S.; Ianowski, J.P. 2021: CAMP triggers Na+ absorption by distal airway surface epithelium in cystic fibrosis swine. Cell Reports 37(1): 109795
Louail, A.; Sierksma, M.C.; Chaffiol, A.; Baudet, S.; Assali, A.; Couvet, S.; Nedjam, M.; Roche, F.; Zagar, Y.; Duebel, J.; Nicol, X. 2020: CAMP-Dependent Co-stabilization of Axonal Arbors from Adjacent Developing Neurons. Cell Reports 33(1): 108220
Lasonder, E.; More, K.; Singh, S.; Haidar, M.; Bertinetti, D.; Kennedy, E.J.; Herberg, F.W.; Holder, A.A.; Langsley, G.; Chitnis, C.E. 2021: CAMP-Dependent Signaling Pathways as Potential Targets for Inhibition of Plasmodium falciparum Blood Stages. Frontiers in Microbiology 12: 684005
Tsutsui, K.; Florio, M.C.; Yang, A.; Wirth, A.N.; Yang, D.; Kim, M.S.; Ziman, B.D.; Bychkov, R.; Monfredi, O.J.; Maltsev, V.A.; Lakatta, E.G. 2021: CAMP-Dependent Signaling Restores AP Firing in Dormant SA Node Cells via Enhancement of Surface Membrane Currents and Calcium Coupling. Frontiers in Physiology 12: 596832
Ehinger, Y.; Morisot, N.; Phamluong, K.; Sakhai, S.A.; Soneja, D.; Adrover, M.F.; Alvarez, V.A.; Ron, D. 2021: CAMP-Fyn signaling in the dorsomedial striatum direct pathway drives excessive alcohol use. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 46(2): 334-342
Ozaki, N.; Shibasaki, T.; Kashima, Y.; Miki, T.; Takahashi, K.; Ueno, H.; Sunaga, Y.; Yano, H.; Matsuura, Y.; Iwanaga, T.; Takai, Y.; Seino, S. 2000: CAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nature Cell Biology 2(11): 805-811
Zhang, M.; Gao, Z.-C.; Chi, Z.; Liu, G.-L.; Hu, Z.; Chi, Z.-M. 2021: CAMP-PKA and HOG1 signaling pathways regulate liamocin production by different ways via the transcriptional activator Msn2 in Aureobasidium melanogenum. Enzyme and Microbial Technology 143: 109705
Portela, P.; Rossi, S. 2020: CAMP-PKA signal transduction specificity in Saccharomyces cerevisiae. Current Genetics 66(6): 1093-1099
Ma, Y.; Chen, J.; Yu, D.; Wei, B.; Jin, H.; Zeng, J.; Liu, X. 2021: CAMP-PKA signaling is involved in regulation of spinal HCN channels function in diabetic neuropathic pain. Neuroscience Letters 750: 135763
Zhuang, P.; Huang, Y.; Lu, Z.; Yang, Z.; Xu, L.; Sun, F.; Zhang, Y.; Duan, J. 2016: CAMP-PKA-CaMKII signaling pathway is involved in aggravated cardiotoxicity during Fuzi and Beimu Combination Treatment of Experimental Pulmonary Hypertension. Scientific Reports 6: 34903
Roh, E.; Yun, C-Yong.; Young Yun, J.; Park, D.; Doo Kim, N.; Yeon Hwang, B.; Jung, S-Hun.; Park, S.Ki.; Kim, Y-Bae.; Han, S-Bae.; Kim, Y. 2013: CAMP-binding site of PKA as a molecular target of bisabolangelone against melanocyte-specific hyperpigmented disorder. Journal of Investigative Dermatology 133(4): 1072-1079
Inda, C.; Bonfiglio, J.José.; Dos Santos Claro, P.A.; Senin, S.A.; Armando, N.G.; Deussing, J.M.; Silberstein, S. 2017: CAMP-dependent cell differentiation triggered by activated CRHR1 in hippocampal neuronal cells. Scientific Reports 7(1): 1944
Ji, S.; Sun, J.; Bian, C.; Huang, X.; Chang, Z.; Yang, M.; Lu, R.-H.; Ji, H. 2020: CAMP-dependent protein kinase a in grass carp Ctenopharyngodon idella: Molecular characterization, gene structure, tissue distribution and mRNA expression in endoplasmic reticulum stress-induced adipocyte lipolysis. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology 250: 110479
Silveira, W.A.; Gonçalves, D.A.; Machado, J.; Lautherbach, N.; Lustrino, D.; Paula-Gomes, S.; Pereira, M.G.; Miyabara, E.H.; Sandri, M.; Kettelhut, I.C.; Navegantes, L.C. 2020: CAMP-dependent protein kinase inhibits FoxO activity and regulates skeletal muscle plasticity in mice. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 34(9): 12946-12962
Ishizaki, T.; Asada, M.; Hakimi, H.; Chaiyawong, N.; Kegawa, Y.; Yahata, K.; Kaneko, O. 2021: CAMP-dependent protein kinase regulates secretion of apical membrane antigen 1 (AMA1) in Plasmodium yoelii. Parasitology International 85: 102435
Fenske, S.; Hennis, K.; Rötzer, Ré.D.; Brox, V.F.; Becirovic, E.; Scharr, A.; Gruner, C.; Ziegler, T.; Mehlfeld, V.; Brennan, J.; Efimov, I.R.; Pauža, A.G.; Moser, M.; Wotjak, C.T.; Kupatt, C.; Gönner, R.; Zhang, R.; Zhang, H.; Zong, X.; Biel, M.; Wahl-Schott, C. 2020: CAMP-dependent regulation of HCN4 controls the tonic entrainment process in sinoatrial node pacemaker cells. Nature Communications 11(1): 5555
Castejón-Griñán, Mía.; Herraiz, C.; Olivares, C.; Jiménez-Cervantes, C.; García-Borrón, J.Carlos. 2018: CAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage. Oncogene 37(27): 3631-3646
Suhasini, M.; Reddy, C.D.; Reddy, E.P.; DiDonato, J.A.; Pilz, R.B. 1997: CAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation. Oncogene 15(15): 1859-1870
Song, H.J.; Ming, G.L.; Poo, M.M. 1997: CAMP-induced switching in turning direction of nerve growth cones. Nature 388(6639): 275-279
Christensen, K.R.; Nairn, A.C. 2021: CAMP-regulated phosphoproteins DARPP-32, ARPP16/19, and RCS modulate striatal signal transduction through protein kinases and phosphatases. Advances in Pharmacology 90: 39-65
Howard, M.; Jilling, T.; DuVall, M.; Frizzell, R.A. 1996: CAMP-regulated trafficking of epitope-tagged CFTR. Kidney International 49(6): 1642-1648
Wu, D.; Zhau, H.E.; Huang, W-C.; Iqbal, S.; Habib, F.K.; Sartor, O.; Cvitanovic, L.; Marshall, F.F.; Xu, Z.; Chung, L.W.K. 2007: CAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis. Oncogene 26(35): 5070-5077
Kim, K.-Y.; Ju, W.-K. 2021: CAMP/PKA pathway and mitochondrial protection in oxidative stress-induced optic nerve head astrocytes. Neural Regeneration Research 16(1): 108-109
Kim, M.; Kim, M.; Lee, S.; Kuninaka, S.; Saya, H.; Lee, H.; Lee, S.; Lim, D-Sik. 2013: CAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. EMBO Journal 32(11): 1543-1555
Zhao, S.-Q.; Gao, Y.; Zhang, Y.; Yang, X.-P.; Yang, Z. 2021: CAMP/PKA/CREB signaling pathway-mediated effects of melatonin receptor genes on clock gene expression in Bactrian camel ovarian granulosa cells. Domestic Animal Endocrinology 76: 106609
Gödecke, A. 2008: CAMP: fuel for extracellular adenosine formation?. British Journal of Pharmacology 153(6): 1087-1089
Osório, J. 2013: CBAT and rBAT crosstalk to regulate temperature and energy balance. Nature Reviews. Endocrinology 9(5): 253
Bleicken, S.; Hofhaus, G.; Ugarte-Uribe, B.; Schröder, R.; García-Sáez, A.J. 2016: CBid, Bax and Bcl-xL exhibit opposite membrane remodeling activities. Cell Death and Disease 7: E2121
Rhodius-Meester, H.F.M.; Paajanen, T.; Koikkalainen, J.; Mahdiani, S.; Bruun, M.; Baroni, M.; Lemstra, A.W.; Scheltens, P.; Herukka, S.-K.; Pikkarainen, M.; Hall, A.; Hänninen, T.; Ngandu, T.; Kivipelto, M.; van Gils, M.; Hasselbalch, S.G.; Mecocci, P.; Remes, A.; Soininen, H.; van der Flier, W.M.; Lötjönen, J. 2020: CCOG: a web-based cognitive test tool for detecting neurodegenerative disorders. Alzheimer's and Dementia 12(1): E12083
Jing, Y.; Cao, M.; Zhang, B.; Long, X.; Wang, X. 2021: CDC1 Dependent Accumulation of Memory T Cells Is Required for Chronic Autoimmune Inflammation in Murine Testis. Frontiers in Immunology 12: 651860
Ramos, M.I.; Garcia, S.; Helder, B.; Aarrass, S.; Reedquist, K.A.; Jacobsen, S.E.; Tak, P.P.; Lebre, M.C. 2020: CDC1 are required for the initiation of collagen-induced arthritis. Journal of Translational Autoimmunity 3: 100066
Dempsey, L.A. 2019: CDC1 cross-priming. Nature Immunology 20(1): 1
Ferris, S.T.; Durai, V.; Wu, R.; Theisen, D.J.; Ward, J.P.; Bern, M.D.; Davidson, J.T.; Bagadia, P.; Liu, T.; Briseño, C.G.; Li, L.; Gillanders, W.E.; Wu, G.F.; Yokoyama, W.M.; Murphy, T.L.; Schreiber, R.D.; Murphy, K.M. 2020: CDC1 prime and are licensed by CD4 + T cells to induce anti-tumour immunity. Nature 584(7822): 624-629
Visan, I. 2019: CDC2 subsets. Nature Immunology 20(12): 1558
Iimura, K.; Hattan, J.-I.; Misawa, N.; Shindo, K. 2020: CDNA Cloning and Functional Analyses of Ashitaba (Angelica keiskei) Sesquiterpene Synthase Genes. Journal of Oleo Science 69(7): 711-718
Jayathilake, C.; Terai, T.; Nemoto, N. 2019: CDNA Display Mediated Immuno-PCR (cD-IPCR): A Novel PCR-based Antigen Detection Method. Bio-Protocol 9(24):E3457
Jayathilake, C.; Nemoto, N. 2021: CDNA Display-Mediated Immuno-PCR (cD-IPCR): An Ultrasensitive Immunoassay for Biomolecular Detection. Methods in Molecular Biology 2261: 307-321
Greenfield, E.A. 2021: CDNA Immunization of Mice, Rats, and Hamsters. Cold Spring Harbor Protocols 2021(5)
Duno, M.; Sveen, M-Louise.; Schwartz, M.; Vissing, J. 2008: CDNA analyses of CAPN3 enhance mutation detection and reveal a low prevalence of LGMD2A patients in Denmark. European Journal of Human Genetics: Ejhg 16(8): 935-940
Sondhi, S.; Castellano, J.M.; Chong, V.Z.; Rogoza, R.M.; Skoblenick, K.J.; Dyck, B.A.; Gabriele, J.; Thomas, N.; Ki, K.; Pristupa, Z.B.; Singh, A.N.; MacCrimmon, D.; Voruganti, P.; Foster, J.; Mishra, R.K. 2006: CDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects. Pharmacogenomics Journal 6(2): 131-140
Tong, B.D.; Auer, D.E.; Jaye, M.; Kaplow, J.M.; Ricca, G.; McConathy, E.; Drohan, W.; Deuel, T.F. 1987: CDNA clones reveal differences between human glial and endothelial cell platelet-derived growth factor A-chains. Nature 328(6131): 619-621
Hanissian, S.H.; Akbar, U.; Teng, B.; Janjetovic, Z.; Hoffmann, A.; Hitzler, J.K.; Iscove, N.; Hamre, K.; Du, X.; Tong, Y.; Mukatira, S.; Robertson, J.H.; Morris, S.W. 2004: CDNA cloning and characterization of a novel gene encoding the MLF1-interacting protein MLF1IP. Oncogene 23(20): 3700-3707
Luo, Y.; Zeng, L.-J.; Liu, X.-Q.; Li, L.; Zeng, Q.-Y. 2021: CDNA cloning of a novel lectin that induce cell apoptosis from Artocarpus hypargyreus. Chinese Journal of Natural Medicines 19(2): 81-89
Masu, Y.; Nakayama, K.; Tamaki, H.; Harada, Y.; Kuno, M.; Nakanishi, S. 1987: CDNA cloning of bovine substance-K receptor through oocyte expression system. Nature 329(6142): 836-838
Inumaru, S.; Takamatsu, H. 1995: CDNA cloning of porcine granulocyte-macrophage colony-stimulating factor. Immunology and Cell Biology 73(5): 474-476
Kokuho, T.; Uchimura, A.; Inumaru, S. 1997: CDNA cloning of porcine interleukin-2 receptor-alpha gene. Immunology and Cell Biology 75(5): 515-518
Li, X.; Li, Y.; Song, W.; Xie, D.; Zhu, F.; Yang, M.; Li, Y. 2021: CDNA cloning, expression and bioinformatical analysis of Tssk genes in tree shrews. Computational Biology and Chemistry 92: 107474
Takashima, T.; Henna, H.; Kozome, D.; Kitajima, S.; Uechi, K.; Taira, T. 2021: CDNA cloning, expression, and antifungal activity of chitinase from Ficus microcarpa latex: difference in antifungal action of chitinase with and without chitin-binding domain. Planta 253(6): 120
Rhee, C.H.; Hess, K.; Jabbur, J.; Ruiz, M.; Yang, Y.; Chen, S.; Chenchik, A.; Fuller, G.N.; Zhang, W. 1999: CDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines. Oncogene 18(17): 2711-2717
Mackay, A.; Jones, C.; Dexter, T.; Silva, R.L.A.; Bulmer, K.; Jones, A.; Simpson, P.; Harris, R.A.; Jat, P.S.; Neville, A.Munro.; Reis, L.F.L.; Lakhani, S.R.; O'Hare, M.J. 2003: CDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene 22(17): 2680-2688
Kluger, H.M.; Kluger, Y.; Gilmore-Hebert, M.; DiVito, K.; Chang, J.T.; Rodov, S.; Mironenko, O.; Kacinski, B.M.; Perkins, A.S.; Sapi, E. 2004: CDNA microarray analysis of invasive and tumorigenic phenotypes in a breast cancer model. Laboratory Investigation; a Journal of Technical Methods and Pathology 84(3): 320-331
Betsholtz, C.; Johnsson, A.; Heldin, C.H.; Westermark, B.; Lind, P.; Urdea, M.S.; Eddy, R.; Shows, T.B.; Philpott, K.; Mellor, A.L. 1986: CDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature 320(6064): 695-699
Dalton, R. 1999: CDNA sequence databank will safeguard research access. Nature 401(6752): 418
McLean, J.W.; Tomlinson, J.E.; Kuang, W.J.; Eaton, D.L.; Chen, E.Y.; Fless, G.M.; Scanu, A.M.; Lawn, R.M. 1987: CDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330(6144): 132-137
Persico, M.G.; Toniolo, D.; Nobile, C.; D'Urso, M.; Luzzatto, L. 1981: CDNA sequences of human glucose 6-phosphate dehydrogenase cloned in pBR322. Nature 294(5843): 778-780
Toi, M.; Harris, A.L.; Bicknell, R. 1993: CDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo. British Journal of Cancer 68(6): 1088-1096
Tanner, D.C.; Campbell, A.; O'Banion, K.M.; Noble, M.; Mayer-Pröschel, M. 2015: CFLIP is critical for oligodendrocyte protection from inflammation. Cell Death and Differentiation 22(9): 1489-1501
Budd, R.C.; Yeh, W-Chen.; Tschopp, Jürg. 2006: CFLIP regulation of lymphocyte activation and development. Nature Reviews. Immunology 6(3): 196-204
Li, C.; Xin, Z.; He, L.; Ning, J.; Lin, K.; Pan, J.; Rao, J.; Wang, G.; Zhu, H. 2021: CFUT8 promotes liver cancer progression by miR-548c/FUT8 axis. Signal Transduction and Targeted Therapy 6(1): 30
Lu, C.; Shen, Q.; DuPré, E.; Kim, H.; Hilsenbeck, S.; Brown, P.H. 2005: CFos is critical for MCF-7 breast cancer cell growth. Oncogene 24(43): 6516-6524
Wang, H.; Liu, J.; Gharib, S.; Chai, C.M.; Schwarz, E.M.; Pokala, N.; Sternberg, P.W. 2017: CGAL, a temperature-robust GAL4-UAS system for Caenorhabditis elegans. Nature Methods 14(2): 145-148
Liu, Y.; Li, H-Bing.; Flavell, R.A. 2018: CGAS activation in phased droplets. Cell Research 28(10): 967-968
Kerur, N.; Fukuda, S.; Banerjee, D.; Kim, Y.; Fu, D.; Apicella, I.; Varshney, A.; Yasuma, R.; Fowler, B.J.; Baghdasaryan, E.; Marion, K.M.; Huang, X.; Yasuma, T.; Hirano, Y.; Serbulea, V.; Ambati, M.; Ambati, V.L.; Kajiwara, Y.; Ambati, K.; Hirahara, S.; Bastos-Carvalho, A.; Ogura, Y.; Terasaki, H.; Oshika, T.; Kim, K.Bo.; Hinton, D.R.; Leitinger, N.; Cambier, J.C.; Buxbaum, J.D.; Kenney, M.Cristina.; Jazwinski, S.Michal.; Nagai, H.; Hara, I.; West, A.Phillip.; Fitzgerald, K.A.; Sadda, S.R.; Gelfand, B.D.; Ambati, J. 2018: CGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nature Medicine 24(1): 50-61
Zhou, W.; Mohr, L.; Maciejowski, J.; Kranzusch, P.J. 2021: CGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensing. Molecular Cell 81(4): 739-755.E7
Ablasser, A.; Goldeck, M.; Cavlar, T.; Deimling, T.; Witte, G.; Röhl, I.; Hopfner, K-Peter.; Ludwig, J.; Hornung, V. 2013: CGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature 498(7454): 380-384
Wu, M.; Shi, J.; He, S.; Wang, D.; Zhang, N.; Wang, Z.; Yang, F.; He, J.; Hu, D.; Yang, X.; Yuan, C. 2021: CGAS promotes sepsis in radiotherapy of cancer by up-regulating caspase-11 signaling. Biochemical and Biophysical Research Communications 551: 86-92
Andreeva, L.; Hiller, Börn.; Kostrewa, D.; Lässig, C.; de Oliveira Mann, C.C.; Jan Drexler, D.; Maiser, A.; Gaidt, M.; Leonhardt, H.; Hornung, V.; Hopfner, K-Peter. 2017: CGAS senses long and HMGB/TFAM-bound U-turn DNA by forming protein-DNA ladders. Nature 549(7672): 394-398
Mackenzie, K.J.; Carroll, P.; Martin, C-Anne.; Murina, O.; Fluteau, A.; Simpson, D.J.; Olova, N.; Sutcliffe, H.; Rainger, J.K.; Leitch, A.; Osborn, R.T.; Wheeler, A.P.; Nowotny, M.; Gilbert, N.; Chandra, T.; Reijns, M.A.M.; Jackson, A.P. 2017: CGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548(7668): 461-465
Li, F.; Wang, N.; Zheng, Y.; Luo, Y.; Zhang, Y. 2021: CGAS- Stimulator of Interferon Genes Signaling in Central Nervous System Disorders. Aging and Disease 12(7): 1658-1674
Motwani, M.; McGowan, J.; Antonovitch, J.; Gao, K.M.; Jiang, Z.; Sharma, S.; Baltus, G.A.; Nickerson, K.M.; Marshak-Rothstein, A.; Fitzgerald, K.A. 2021: CGAS-STING Pathway Does not Promote Autoimmunity in Murine Models of SLE. Frontiers in Immunology 12: 605930
Chen, B.; Rao, X.; Wang, X.; Luo, Z.; Wang, J.; Sheng, S.; Liu, Y.; Zhang, N.; Jin, S.; Chen, H.; Sun, C.; Xu, T.; Du, Y. 2021: CGAS-STING Signaling Pathway and Liver Disease: from Basic Research to Clinical Practice. Frontiers in Pharmacology 12: 719644
Patel, S.; Tucker, H.R.; Gogoi, H.; Mansouri, S.; Jin, L. 2021: CGAS-STING and MyD88 Pathways Synergize in Ly6Chi Monocyte to Promote Streptococcus pneumoniae-Induced Late-Stage Lung IFNγ Production. Frontiers in Immunology 12: 699702
Suter, M.Adrian.; Tan, N.Y.; Thiam, C.Hwee.; Khatoo, M.; MacAry, P.A.; Angeli, V.; Gasser, S.; Zhang, Y.L. 2021: CGAS-STING cytosolic DNA sensing pathway is suppressed by JAK2-STAT3 in tumor cells. Scientific Reports 11(1): 7243
Yu, P.; Miao, Z.; Li, Y.; Bansal, R.; Peppelenbosch, M.P.; Pan, Q. 2021: CGAS-STING effectively restricts murine norovirus infection but antagonizes the antiviral action of N-terminus of RIG-I in mouse macrophages. Gut Microbes 13(1): 1959839
Raaby Gammelgaard, K.; Sandfeld-Paulsen, B.; Godsk, S.H.øv.; Demuth, C.; Meldgaard, P.; Sorensen, B.S.; Jakobsen, M.R. 2021: CGAS-STING pathway expression as a prognostic tool in NSCLC. Translational Lung Cancer Research 10(1): 340-354
Wang, Y.; Luo, J.; Alu, A.; Han, X.; Wei, Y.; Wei, X. 2020: CGAS-STING pathway in cancer biotherapy. Molecular Cancer 19(1): 136
Hoong, B.Y.D.; Gan, Y.H.; Liu, H.; Chen, E.S. 2020: CGAS-STING pathway in oncogenesis and cancer therapeutics. Oncotarget 11(30): 2930-2955
Du, H.; Xu, T.; Cui, M. 2021: CGAS-STING signaling in cancer immunity and immunotherapy. Biomedicine and PharmacoTherapy 133: 110972
Jiang, M.; Chen, P.; Wang, L.; Li, W.; Chen, B.; Liu, Y.; Wang, H.; Zhao, S.; Ye, L.; He, Y.; Zhou, C. 2020: CGAS-STING, an important pathway in cancer immunotherapy. Journal of Hematology and Oncology 13(1): 81
Cai, H.; Imler, J.-L. 2021: CGAS-STING: insight on the evolution of a primordial antiviral signaling cassette. Faculty Reviews 10: 54
Fan, Y.; Zhang, L.; Zhou, F. 2021: CGAS-like receptors: new RNA sensors in Drosophila. Signal Transduction and Targeted Therapy 6(1): 370
Uggenti, C.; Lepelley, A.; Depp, M.; Badrock, A.P.; Rodero, M.P.; El-Daher, M-Thérèse.; Rice, G.I.; Dhir, S.; Wheeler, A.P.; Dhir, A.; Albawardi, W.; Frémond, M-Louise.; Seabra, L.; Doig, J.; Blair, N.; Martin-Niclos, M.José.; Della Mina, E.; Rubio-Roldán, A.; García-Pérez, J.L.; Sproul, D.; Rehwinkel, J.; Hertzog, J.; Boland-Auge, A.; Olaso, R.; Deleuze, J-François.; Baruteau, J.; Brochard, K.; Buckley, J.; Cavallera, V.; Cereda, C.; De Waele, L.M.H.; Dobbie, A.; Doummar, D.; Elmslie, F.; Koch-Hogrebe, M.; Kumar, R.; Lamb, K.; Livingston, J.H.; Majumdar 2020: CGAS-mediated induction of type I interferon due to inborn errors of histone pre-mRNA processing. Nature Genetics 52(12): 1364-1372
Chen, H.; Li, F.; Lai, W.; Fang, Y.; Jiang, M.; Duan, D.; Yang, X. 2021: CGAS/STING signaling pathways induces the secretion of type Ⅰ interferon in porcine alveolar macrophages infected with porcine circovirus type 2. Sheng Wu Gong Cheng Xue Bao 37(9): 3201-3210
Dang, T.A.; Schunkert, H.; Kessler, T. 2020: CGMP Signaling in Cardiovascular Diseases: Linking Genotype and Phenotype. Journal of Cardiovascular Pharmacology 75(6): 516-525
Wang, W.; Qin, L-Wei.; Wu, T-Hong.; Ge, C-Li.; Wu, Y-Qian.; Zhang, Q.; Song, Y-Xue.; Chen, Y-Hua.; Ge, M-Hai.; Wu, J-Jing.; Liu, H.; Xu, Y.; Su, C-Ming.; Li, L-Lan.; Tang, J.; Li, Z-Yu.; Wu, Z-Xing. 2016: CGMP Signalling Mediates Water Sensation (Hydrosensation) and Hydrotaxis in Caenorhabditis elegans. Scientific Reports 6: 19779
Caudano, F.; Montalto, G.; Passalacqua, M.; Pronzato, M.A.; Fedele, E.; Ricciarelli, R. 2020: CGMP favors the interaction between APP and BACE1 by inhibiting Rab5 GTPase activity. Scientific Reports 10(1): 1358
Galione, A.; White, A.; Willmott, N.; Turner, M.; Potter, B.V.; Watson, S.P. 1993: CGMP mobilizes intracellular Ca2+ in sea urchin eggs by stimulating cyclic ADP-ribose synthesis. Nature 365(6445): 456-459
Wiley, L.A.; Burnight, E.R.; DeLuca, A.P.; Anfinson, K.R.; Cranston, C.M.; Kaalberg, E.E.; Penticoff, J.A.; Affatigato, L.M.; Mullins, R.F.; Stone, E.M.; Tucker, B.A. 2016: CGMP production of patient-specific iPSCs and photoreceptor precursor cells to treat retinal degenerative blindness. Scientific Reports 6: 30742
VerPlank, J.J.S.; Tyrkalska, S.D.; Fleming, A.; Rubinsztein, D.C.; Goldberg, A.L. 2020: CGMP via PKG activates 26S proteasomes and enhances degradation of proteins, including ones that cause neurodegenerative diseases. Proceedings of the National Academy of Sciences of the United States of America 117(25): 14220-14230
Zhou, J.; Rasmussen, M.; Ekström, P. 2021: CGMP-PKG dependent transcriptome in normal and degenerating retinas: Novel insights into the retinitis pigmentosa pathology. Experimental Eye Research 212: 108752
Jaumann, M.; Dettling, J.; Gubelt, M.; Zimmermann, U.; Gerling, A.; Paquet-Durand, Fçois.; Feil, S.; Wolpert, S.; Franz, C.; Varakina, K.; Xiong, H.; Brandt, N.; Kuhn, S.; Geisler, H-Soon.; Rohbock, K.; Ruth, P.; Schlossmann, J.; Hütter, J.; Sandner, P.; Feil, R.; Engel, J.; Knipper, M.; Rüttiger, L. 2012: CGMP-Prkg1 signaling and Pde5 inhibition shelter cochlear hair cells and hearing function. Nature Medicine 18(2): 252-259
Matesic, D.; Liebman, P.A. 1987: CGMP-dependent cation channel of retinal rod outer segments. Nature 326(6113): 600-603
Paupardin-Tritsch, D.; Hammond, C.; Gerschenfeld, H.M.; Nairn, A.C.; Greengard, P. 1986: CGMP-dependent protein kinase enhances Ca2+ current and potentiates the serotonin-induced Ca2+ current increase in snail neurones. Nature 323(6091): 812-814
Lingam, S.; Liu, Z.; Yang, B.; Wong, W.; Parikh, B.H.; Ong, J.Y.; Goh, D.; Wong, D.S.L.; Tan, Q.S.W.; Tan, G.S.W.; Holder, G.E.; Regha, K.; Barathi, V.A.; Hunziker, W.; Lingam, G.; Zeng, X.; Su, X. 2021: CGMP-grade human iPSC-derived retinal photoreceptor precursor cells rescue cone photoreceptor damage in non-human primates. Stem Cell Research and Therapy 12(1): 464
Haramis, G.; Zhou, Z.; Pyriochou, A.; Koutsilieris, M.; Roussos, C.; Papapetropoulos, A. 2008: CGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines. British Journal of Pharmacology 155(6): 804-813
McComb, S.; Cheung, H.H.; Korneluk, R.G.; Wang, S.; Krishnan, L.; Sad, S. 2012: CIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation. Cell Death and Differentiation 19(11): 1791-1801
Marivin, A.; Berthelet, J.; Cartier, J.; Paul, C.; Gemble, S.; Morizot, A.; Boireau, W.; Saleh, M.; Bertoglio, J.; Solary, E.; Dubrez, L. 2014: CIAP1 regulates TNF-mediated cdc42 activation and filopodia formation. Oncogene 33(48): 5534-5545
Majorini, M.Teresa.; Manenti, G.; Mano, M.; De Cecco, L.; Conti, A.; Pinciroli, P.; Fontanella, E.; Tagliabue, E.; Chiodoni, C.; Colombo, M.Paolo.; Delia, D.; Lecis, D. 2018: CIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells. Cell Death and Differentiation 25(12): 2147-2164
Jiang, X.-J.; Chen, Z.-W.; Zhao, J.-F.; Liao, C.-X.; Cai, Q.-H.; Lin, J. 2021: CIAP2 via NF-κB signalling affects cell proliferation and invasion in hepatocellular carcinoma. Life Sciences 266: 118867
Min, B.; Jin, J.; Kim, H.; Her, N.-G.; Park, C.; Kim, D.; Yang, J.; Hwang, J.; Kim, E.; Choi, M.; Song, H.Y.; Nam, D.-H.; Yoon, Y. 2020: CIRCR201-dPBD, a Novel Pyrrolobenzodiazepine Dimer-Containing Site-Specific Antibody-Drug Conjugate Targeting c-Met Overexpression Tumors. Acs Omega 5(40): 25798-25809
Khalid, S.; Drasche, A.; Thurner, M.; Hermann, M.; Ashraf, M.Imtiaz.; Fresser, F.; Baier, G.; Kremser, L.; Lindner, H.; Troppmair, J. 2016: CJun N-terminal kinase (JNK) phosphorylation of serine 36 is critical for p66Shc activation. Scientific Reports 6: 20930
Marek, K.W.; Kurtz, L.M.; Spitzer, N.C. 2010: CJun integrates calcium activity and tlx3 expression to regulate neurotransmitter specification. Nature Neuroscience 13(8): 944-950
Smith, L.M.; Wise, S.C.; Hendricks, D.T.; Sabichi, A.L.; Bos, T.; Reddy, P.; Brown, P.H.; Birrer, M.J. 1999: CJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18(44): 6063-6070
Wendling, F.; Maraskovsky, E.; Debili, N.; Florindo, C.; Teepe, M.; Titeux, M.; Methia, N.; Breton-Gorius, J.; Cosman, D.; Vainchenker, W. 1994: CMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 369(6481): 571-574
Sun, L.; Song, L.; Wan, Q.; Wu, G.; Li, X.; Wang, Y.; Wang, J.; Liu, Z.; Zhong, X.; He, X.; Shen, S.; Pan, X.; Li, A.; Wang, Y.; Gao, P.; Tang, H.; Zhang, H. 2015: CMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Research 25(4): 429-444
Li, Z.; Gao, Y.; Zhang, Z.; Xiong, Q.; Deng, L.; Li, X.; Zhou, Q.; Fang, Y.; Gao, P. 2021: CPCN-Regulated SnO 2 Composites Enables Perovskite Solar Cell with Efficiency Beyond 23. Nano-MicroLetters 13(1): 101
Chen, L.; Fu, H.; Luo, Y.; Chen, L.; Cheng, R.; Zhang, N.; Guo, H. 2017: CPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling. Cell Death and Disease 8(4): E2728
Wang, Y.; Hu, W.; Ding, B.; Chen, D.; Cheng, L. 2020: CRGD mediated redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for efficiently intracellular antitumor drug delivery. Colloids and Surfaces. B Biointerfaces 194: 111195
Li, D.; Gao, J.; Yang, C.; Li, B.; Sun, J.; Yu, M.; Wang, Y.; Wang, H.; Lu, Y. 2021: CRGDyK-modified procaine liposome inhibits the proliferation and motility of glioma cells via the ERK/p38MAPK pathway. Experimental and Therapeutic Medicine 22(2): 859
Domka, K.; Goral, A.; Firczuk, M. 2020: CROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies. Frontiers in Immunology 11: 1538
Fognani, C.; Rondi, R.; Romano, A.; Blasi, F. 2000: CRel-TD kinase: a serine/threonine kinase binding in vivo and in vitro c-Rel and phosphorylating its transactivation domain. Oncogene 19(18): 2224-2232
Rossman, U.; Dadosh, T.; Eldar, Y.C.; Oron, D. 2021: CSPARCOM: Multi-detector reconstruction by confocal super-resolution correlation microscopy. Optics Express 29(9): 12772-12786
Faria, M.T.; Rego, R.; Rocha, H.; Sá, F.; Farinha, R.; Oliveira, A.; Barata, P.; Alves, D.íl.; Pereira, J.; Rocha-Gonçalves, F.; Gonçalves, H.ân.; Martins, E. 2020: CTnI, BNP and CRP profiling after seizures in patients with drug-resistant epilepsy. Seizure 80: 100-108
Yao, Y.; Zhao, Z.; Qi, X.; Jia, H.; Zhang, L. 2022: CVEMP and VAT for the diagnosis of vestibular migraine. European Journal of Clinical Investigation 52(1): E13657
Ahmad, S.A.; Abdul Wahat, N.H.; Zakaria, M.N.; Wiener-Vacher, S.R.; Abdullah, N.A. 2020: CVEMPs and oVEMPs normative data in Malaysian preschool and primary school-aged children. International Journal of Pediatric Otorhinolaryngology 135: 110132
Yi, X.; Liao, Y.; Wen, B.; Li, K.; Dou, Y.; Savage, S.R.; Zhang, B. 2021: CaAtlas: An immunopeptidome atlas of human cancer. Iscience 24(10): 103107
Mungmunpuntipantip, R.; Wiwanitkit, V. 2021: CagA+ Helicobacter pylori infection and N-nitrosodimethylamine and cholangiocarcinoma. Helicobacter 26(5): E12834
Mangione, W.; Falls, Z.; Chopra, G.; Samudrala, R. 2020: Cando.py: Open Source Software for Predictive Bioanalytics of Large Scale Drug-Protein-Disease Data. Journal of Chemical Information and Modeling 60(9): 4131-4136
Metzger, H.; Levy, J.G. 1948: Case of acute hemolytic jaundice; Lederer's disease. Paris Medical 38(27): 337-339
Keane, M.M.; Ettenberg, S.A.; Nau, M.M.; Banerjee, P.; Cuello, M.; Penninger, J.; Lipkowitz, S. 1999: Cbl-3: a new mammalian cbl family protein. Oncogene 18(22): 3365-3375
Ettenberg, S.A.; Keane, M.M.; Nau, M.M.; Frankel, M.; Wang, L.M.; Pierce, J.H.; Lipkowitz, S. 1999: Cbl-b inhibits epidermal growth factor receptor signaling. Oncogene 18(10): 1855-1866
Neff, E.P. 2020: Cbsa in vestigial eyes. Lab Animal 49(7): 197
Dandri, M.; Petersen, J. 2020: CccDNA Maintenance in Chronic Hepatitis B - Targeting the Matrix of Viral Replication. Infection and Drug Resistance 13: 3873-3886
Balaur, I.; Roy, L.; Mazein, A.; Karaca, S.G.ök.; Dogrusoz, U.; Barillot, E.; Zinovyev, A. 2020: Cd2sbgnml: bidirectional conversion between CellDesigner and SBGN formats. Bioinformatics 36(19): 4975
Smith, E.M.; Proud, C.G. 2008: Cdc2-cyclin B regulates eEF2 kinase activity in a cell cycle- and amino acid-dependent manner. EMBO Journal 27(7): 1005-1016
Davidson, A.J.; Ernst, P.; Wang, Y.; Dekens, M.P.S.; Kingsley, P.D.; Palis, J.; Korsmeyer, S.J.; Daley, G.Q.; Zon, L.I. 2003: Cdx4 mutants fail to specify blood progenitors and can be rescued by multiple hox genes. Nature 425(6955): 300-306
Luo, X.; Tu, T.; Zhong, Y.; Xu, S.; Chen, X.; Chen, L.; Yang, F. 2021: CeRNA Network Analysis Shows that lncRNA CRNDE Promotes Progression of Glioblastoma Through Sponge mir-9-5p. Frontiers in Genetics 12: 617350
Martirosyan, A.; De Martino, A.; Pagnani, A.; Marinari, E. 2017: CeRNA crosstalk stabilizes protein expression and affects the correlation pattern of interacting proteins. Scientific Reports 7: 43673
Chen, L.; Zou, W.; Zhang, L.; Shi, H.; Li, Z.; Ni, C. 2021: CeRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma. Medical Oncology 38(7): 85
Liu, S.; Song, A.; Zhou, X.; Huo, Z.; Yao, S.; Yang, B.; Liu, Y.; Wang, Y. 2020: CeRNA network development and tumour-infiltrating immune cell analysis of metastatic breast cancer to bone. Journal of Bone Oncology 24: 100304
Yang, Y.-W.; Meng, X.; Meng, Y.-Y.; Tang, H.-K.; Cheng, M.-H.; Zhang, Z.-Q.; Xu, W.-Q.; Long, W. 2021: CeRNA regulatory network of FIH inhibitor as a radioprotector for gastrointestinal toxicity by activating the HIF-1 pathway. Molecular Therapy. Nucleic Acids 25: 173-185
Yang, N.; Liu, K.; Yang, M.; Gao, X. 2021: CeRNAs in Cancer: Mechanism and Functions in a Comprehensive Regulatory Network. Journal of Oncology 2021: 4279039
Metheetrairut, C.; Adams, B.D.; Nallur, S.; Weidhaas, J.B.; Slack, F.J. 2017: Cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation. Oncogene 36(4): 512-524
Johnson, G.T.; Autin, L.; Al-Alusi, M.; Goodsell, D.S.; Sanner, M.F.; Olson, A.J. 2015: CellPACK: a virtual mesoscope to model and visualize structural systems biology. Nature Methods 12(1): 85-91
La Greca, A.D.án.; Pérez, N.; Castañeda, S.; Milone, P.M.; Scarafía, M.ía.A.; Möbbs, A.M.; Waisman, A.; Moro, L.ía.N.; Sevlever, G.E.; Luzzani, C.D.; Miriuka, S.G. 2021: Celldeath: a tool for detection of cell death in transmitted light microscopy images by deep learning-based visual recognition. Plos one 16(6): E0253666
He, Q.; Zhu, X.; Shi, X.; Lin, C.; Jin, Y.; Yan, J.; He, J.; Yu, X. 2020: CfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma. Translational Lung Cancer Research 9(3): 807-810
Paunel-Görgülü, A.; Wacker, M.; El Aita, M.; Hassan, S.; Schlachtenberger, G.; Deppe, A.; Choi, Y-Hoon.; Kuhn, E.; Mehler, T.O.; Wahlers, T. 2017: CfDNA correlates with endothelial damage after cardiac surgery with prolonged cardiopulmonary bypass and amplifies NETosis in an intracellular TLR9-independent manner. Scientific Reports 7(1): 17421
Zhu, J.; Hui, F.; Mao, X.; Zhang, S.; Qi, H.; Du, Y. 2021: CfDNA deconvolution via NIPT of a pregnant woman after bone marrow transplant and donor egg IVF. Human Genomics 15(1): 14
Chatfield-Reed, K.; Roche, V.P.; Pan, Q. 2021: CfDNA detection for HPV+ squamous cell carcinomas. Oral Oncology 115: 104958
Thomas, T. 2020: CfDNA methylation analysis detects RCC. Nature Reviews. Urology 17(10): 543
Sidaway, P. 2020: CfDNA monitoring is feasible in SCLC. Nature Reviews. Clinical Oncology 17(1): 7
Normanno, N.; De Luca, A.; Perrone, F. 2020: CfDNA testing for monitoring response to EGFR tyrosine kinase inhibitors: time for clinical implementation?. Ebiomedicine 57: 102886
Erger, F.; Nörling, D.; Borchert, D.; Leenen, E.; Habbig, S.; Wiesener, M.S.; Bartram, M.P.; Wenzel, A.; Becker, C.; Toliat, M.R.; Nürnberg, P.; Beck, B.B.; Altmüller, J. 2020: CfNOMe - A single assay for comprehensive epigenetic analyses of cell-free DNA. Genome Medicine 12(1): 54
Kolenda, T.; Guglas, K.; Baranowski, D.; Sobocińska, J.; Kopczyńska, M.; Teresiak, A.; Bliźniak, R.; Lamperska, K. 2020: CfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?. Reports of Practical Oncology and Radiotherapy: Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 25(5): 783-792
Wang, Y.-L.; Zhang, Y.-Y. 2020: Cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma. Biomed Research International 2020: 4854390
Young, T.A.; Gheorghe, R.; Duarte, F. 2020: Cgbind: a Python Module and Web App for Automated Metallocage Construction and Host-Guest Characterization. Journal of Chemical Information and Modeling 60(7): 3546-3557
Xu, X.; Li, H.; Qi, X.; Chen, Y.; Qin, Y.; Zheng, J.; Jiang, X. 2020: CheA, cheB, cheR, cheV, and cheY Are Involved in Regulating the Adhesion of Vibrio harveyi. Frontiers in Cellular and Infection Microbiology 10: 591751
Schep, A.N.; Wu, B.; Buenrostro, J.D.; Greenleaf, W.J. 2017: ChromVAR: inferring transcription-factor-associated accessibility from single-cell epigenomic data. Nature Methods 14(10): 975-978
Zhu, B.; Ge, X.; Stone, V.; Kong, X.; El-Rami, F.; Liu, Y.; Kitten, T.; Xu, P. 2017: CiaR impacts biofilm formation by regulating an arginine biosynthesis pathway in Streptococcus sanguinis SK36. Scientific Reports 7(1): 17183
Zhang, J.; Chang, S. 2020: Cine-Silylative Ring-Opening of α-Methyl Azacycles Enabled by the Silylium-Induced C-N Bond Cleavage. Journal of the American Chemical Society 142(29): 12585-12590
Huang, D.; Li, C. 2021: Circ-ACACA promotes proliferation, invasion, migration and glycolysis of cervical cancer cells by targeting the miR-582-5p/ERO1A signaling axis. Oncology Letters 22(5): 795
Wang, Y. 2021: Circ-ANXA7 facilitates lung adenocarcinoma progression via miR-331/LAD1 axis. Cancer Cell International 21(1): 85
Wang, Z.; Zhao, Y.; Sun, R.; Sun, Y.; Liu, D.; Lin, M.; Chen, Z.; Zhou, J.; Lv, L.; Tian, X.; Yao, J. 2020: Circ-CBFB upregulates p66Shc to perturb mitochondrial dynamics in APAP-induced liver injury. Cell Death and Disease 11(11): 953
Feng, D.; Wang, Z.; Zhao, Y.; Li, Y.; Liu, D.; Chen, Z.; Ning, S.; Hu, Y.; Yao, J.; Tian, X. 2020: Circ-PRKCB acts as a ceRNA to regulate p66Shc-mediated oxidative stress in intestinal ischemia/reperfusion. Theranostics 10(23): 10680-10696
Zhu, J.; Wang, Y.; Yang, C.; Feng, Z.; Huang, Y.; Liu, P.; Chen, F.; Deng, Z. 2021: Circ-PSD3 promoted proliferation and invasion of papillary thyroid cancer cells via regulating the miR-7-5p/METTL7B axis. Journal of Receptor and Signal Transduction Research 2021: 1-10
Wu, S.-G.; Zhou, P.; Chen, J.-X.; Lei, J.; Hua, L.; Dong, Y.; Hu, M.; Lian, C.-L.; Yang, L.-C.; Zhou, J. 2021: Circ-PTK2 (hsa_circ_0008305) regulates the pathogenic processes of ovarian cancer via miR-639 and FOXC1 regulatory cascade. Cancer Cell International 21(1): 277
Chen, L.; Huang, H.; Chen, L.; Xu, L.; Chen, J.; Lu, Q. 2021: Circ-PTTG1IP/miR-671-5p/TLR4 axis regulates proliferation, migration, invasion and inflammatory response of fibroblast-like synoviocytes in rheumatoid arthritis. General Physiology and Biophysics 40(3): 207-219
Li, Z.; Zhou, G.; Tao, F.; Cao, Y.; Han, W.; Li, Q. 2020: Circ-ZUFSP regulates trophoblasts migration and invasion through sponging miR-203 to regulate STOX1 expression. Biochemical and Biophysical Research Communications 531(4): 472-479
Chen, Z.; Ling, K.; Zhu, Y.; Deng, L.; Li, Y.; Liang, Z. 2021: Circ0000069 promotes cervical cancer cell proliferation and migration by inhibiting miR-4426. Biochemical and Biophysical Research Communications 551: 114-120
Du, W.; Hu, J.; Hu, R.; Yang, M.; Peng, Y.; Zhang, Z.; Li, Y.; He, X. 2021: Circ0101675 promotes malignant process via sponging miR-1278 and upregulating WNT3A/5A in non-small cell lung cancer. Journal of Cancer 12(14): 4209-4217
Ma, Z.; Han, C.; Xia, W.; Wang, S.; Li, X.; Fang, P.; Yin, R.; Xu, L.; Yang, L. 2020: Circ5615 functions as a ceRNA to promote colorectal cancer progression by upregulating TNKS. Cell Death and Disease 11(5): 356
Wang, H.-G.; Yan, H.; Wang, C.; Li, M.-M.; Lv, X.-Z.; Wu, H.-D.; Fang, Z.-H.; Mo, D.-L.; Zhang, Z.-Y.; Liang, B.; Lai, K.-G.; Bao, J.-Y.; Yang, X.-J.; Zhao, H.-J.; Chen, S.; Fan, Y.-M.; Tong, X.-G. 2020: CircAFF1 Aggravates Vascular Endothelial Cell Dysfunction Mediated by miR-516b/SAV1/YAP1 Axis. Frontiers in Physiology 11: 899
Ma, X.; Wang, C.; Chen, J.; Wei, D.; Yu, F.; Sun, J. 2021: CircAGFG1 sponges miR-28-5p to promote non-small-cell lung cancer progression through modulating HIF-1α level. Open Medicine 16(1): 703-717
Zhang, B.; Huo, S.; Cen, X.; Pan, X.; Huang, X.; Zhao, Z. 2020: CircAKT3 positively regulates osteogenic differentiation of human dental pulp stromal cells via miR-206/CX43 axis. Stem Cell Research and Therapy 11(1): 531
Shi, P.; Ji, H.; Zhang, H.; Yang, J.; Guo, R.; Wang, J. 2020: CircANRIL reduces vascular endothelial injury, oxidative stress and inflammation in rats with coronary atherosclerosis. Experimental and Therapeutic Medicine 20(3): 2245-2251
Xiong, H.-L.; Zhong, X.-H.; Guo, X.-H.; Liao, H.-J.; Yuan, X. 2021: CircASS1 overexpression inhibits the proliferation, invasion and migration of colorectal cancer cells by regulating the miR-1269a/VASH1 axis. Experimental and Therapeutic Medicine 22(4): 1155
Zhao, X.; Tian, Z.; Liu, L. 2021: CircATP2B1 Promotes Aerobic Glycolysis in Gastric Cancer Cells Through Regulation of the miR-326 Gene Cluster. Frontiers in Oncology 11: 628624
Wang, C.-J.; Gao, F.; Huang, Y.-J.; Han, D.-X.; Zheng, Y.; Wang, W.-H.; Jiang, H.; Gao, Y.; Yuan, B.; Zhang, J.-B. 2020: CircAkap17b acts as a miR-7 family molecular sponge to regulate FSH secretion in rat pituitary cells. Journal of Molecular Endocrinology 65(4): 135-148
Ni, Y.; Lu, C.; Wang, W.; Gao, W.; Yu, C. 2021: CircBANP promotes colorectal cancer growth and metastasis via sponging let-7d-5p to modulate HMGA1/Wnt/β-catenin signaling. Molecular Therapy Oncolytics 21: 119-133
Qiu, L.; Zheng, L.; Gan, C.; Deng, W.; Sun, Y.; Wang, T. 2021: CircBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 50(7): 668-680
Chen, Z.; Xu, W.; Zhang, D.; Chu, J.; Shen, S.; Ma, Y.; Wang, Q.; Liu, G.; Yao, T.; Huang, Y.; Ye, H.; Wang, J.; Ma, J.; Fan, S. 2021: CircCAMSAP1 promotes osteosarcoma progression and metastasis by sponging miR-145-5p and regulating FLI1 expression. Molecular Therapy. Nucleic Acids 23: 1120-1135
Ren, H.; Song, Z.; Chao, C.; Mao, W. 2021: CircCCDC66 promotes thyroid cancer cell proliferation, migratory and invasive abilities and glycolysis through the miR-211-5p/PDK4 axis. Oncology Letters 21(5): 416
Zeng, X.-Y.; Yuan, J.; Wang, C.; Zeng, D.; Yong, J.-H.; Jiang, X.-Y.; Lan, H.; Xiao, S.-S. 2020: CircCELSR1 facilitates ovarian cancer proliferation and metastasis by sponging miR-598 to activate BRD4 signals. Molecular Medicine 26(1): 70
Cao, G.; Zhang, C.; Tian, X.; Jing, G.; Zhou, X.; Yan, T. 2021: CircCEP128 Knockdown Suppresses Bladder Cancer Progression via Regulating microRNA-515-5p/SDC1 Axis. Cancer Management and Research 13: 2885-2896
Ma, Y.; Ren, Y.; Wen, H.; Cui, C. 2021: CircCOL1A1 Promotes the Progression of Gastric Cancer Cells through Sponging miR-145 to Enhance RABL3 Expression. Journal of Immunology Research 2021: 6724854
Wu, F.; Sun, G.; Zheng, W.; Tang, W.; Cheng, Y.; Wu, L.; Li, X.; Tao, J.; Ma, S.; Cao, H. 2021: CircCORO1C promotes the proliferation and metastasis of hepatocellular carcinoma by enhancing the expression of PD-L1 through NF-κB pathway. Journal of Clinical Laboratory Analysis 35(12): E24003
Nan, C.; Wang, Y.; Yang, S.; Chen, Y. 2020: CircCRKL suppresses the progression of prostate cancer cells by regulating the miR-141/KLF5 axis. Pathology Research and Practice 216(11): 153182
Peng, L.; Sang, H.; Wei, S.; Li, Y.; Jin, D.; Zhu, X.; Li, X.; Dang, Y.; Zhang, G. 2020: CircCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2. Molecular Cancer 19(1): 156
Wang, Y.; Niu, Q.; Dai, J.; Shi, H.; Zhang, J. 2021: CircCUX1 promotes neuroblastoma progression and glycolysis by regulating the miR-338-3p/PHF20 axis. General Physiology and Biophysics 40(1): 17-29
Lin, J.; Liao, S.; Li, E.; Liu, Z.; Zheng, R.; Wu, X.; Zeng, W. 2020: CircCYFIP2 Acts as a Sponge of miR-1205 and Affects the Expression of its Target Gene E2F1 to Regulate Gastric Cancer Metastasis. Molecular Therapy. Nucleic Acids 21: 121-132
Liang, Y.; Wang, H.; Chen, B.; Mao, Q.; Xia, W.; Zhang, T.; Song, X.; Zhang, Z.; Xu, L.; Dong, G.; Jiang, F. 2021: CircDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression. Molecular Therapy. Nucleic Acids 23: 355-368
Zhu, J.; Luo, Y.; Zhao, Y.; Kong, Y.; Zheng, H.; Li, Y.; Gao, B.; Ai, L.; Huang, H.; Huang, J.; Li, Z.; Chen, C. 2021: CircEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGFβR1/VEGF-D signaling. Molecular Therapy: the Journal of the American Society of Gene Therapy 29(5): 1838-1852
Yan, M.; Niu, L.; Liu, J.; Yao, Y.; Li, H. 2021: CircEVI5 acts as a miR-4793-3p sponge to suppress the proliferation of gastric cancer. Cell Death and Disease 12(8): 774
Xu, J.; Zhang, Y.; Huang, Y.; Dong, X.; Xiang, Z.; Zou, J.; Wu, L.; Lu, W. 2020: CircEYA1 Functions as a Sponge of miR-582-3p to Suppress Cervical Adenocarcinoma Tumorigenesis via Upregulating CXCL14. Molecular Therapy. Nucleic Acids 22: 1176-1190
Wang, Z.; Zhang, Y.; Dai, K.; Liang, Z.; Zhu, M.; Zhang, M.; Pan, J.; Hu, X.; Zhang, X.; Xue, R.; Cao, G.; Gong, C. 2020: CircEgg regulates histone H3K9me3 by sponging bmo-miR-3391-5p and encoding circEgg-P122 protein in the silkworm, Bombyx mori. Insect Biochemistry and Molecular Biology 124: 103430
Zhao, M.; Liu, Y.; Qu, H. 2021: CircExp database: an online transcriptome platform for human circRNA expressions in cancers. Database: the Journal of Biological Databases and Curation 2021
Zhou, T.; Ni, T.; Li, Y.; Zhang, Q.; Yan, J.; Chen, Z-Jiang. 2021: CircFAM120A participates in repeated implantation failure by regulating decidualization via the miR-29/ABHD5 axis. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(9): e21872
Liu, J.; Li, H.; Wei, C.; Ding, J.; Lu, J.; Pan, G.; Mao, A. 2020: CircFAT1(e2) Promotes Papillary Thyroid Cancer Proliferation, Migration, and Invasion via the miRNA-873/ZEB1 Axis. Computational and Mathematical Methods in Medicine 2020: 1459368
Dong, Y.; Qiu, T.; Xuan, Y.; Liu, A.; Sun, X.; Huang, Z.; Su, W.; Du, W.; Yun, T.; Wo, Y.; Navarro, A.; Jiao, W. 2021: CircFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p. Translational Lung Cancer Research 10(3): 1457-1473
Shan, G.; Shao, B.; Liu, Q.; Zeng, Y.; Fu, C.; Chen, A.; Chen, Q. 2020: CircFMN2 Sponges miR-1238 to Promote the Expression of LIM-Homeobox Gene 2 in Prostate Cancer Cells. Molecular Therapy. Nucleic Acids 21: 133-146
Drula, R.; Pirlog, R.; Trif, M.; Slaby, O.; Braicu, C.; Berindan-Neagoe, I. 2021: CircFOXO3: Going around the mechanistic networks in cancer by interfering with mi RNAs regulatory networks. Biochimica et Biophysica Acta. Molecular Basis of Disease 1867(5): 166045
Wu, W.-P.; Zhou, M.-Y.; Liu, D.-L.; Min, X.; Shao, T.; Xu, Z.-Y.; Jing, X.; Cai, M.-Y.; Xu, S.; Liang, X.; Mo, M.; Liu, X.; Xiong, X.-D. 2021: CircGNAQ, a circular RNA enriched in vascular endothelium, inhibits endothelial cell senescence and atherosclerosis progression. Molecular Therapy. Nucleic Acids 26: 374-387
Cai, J.; Chen, Z.; Wang, J.; Wang, J.; Chen, X.; Liang, L.; Huang, M.; Zhang, Z.; Zuo, X. 2019: CircHECTD1 facilitates glutaminolysis to promote gastric cancer progression by targeting miR-1256 and activating β-catenin/c-Myc signaling. Cell Death and Disease 10(8): 576
Fang, S.; Guo, H.; Cheng, Y.; Zhou, Z.; Zhang, W.; Han, B.; Luo, W.; Wang, J.; Xie, W.; Chao, J. 2018: CircHECTD1 promotes the silica-induced pulmonary endothelial-mesenchymal transition via HECTD1. Cell Death and Disease 9(3): 396
Cao, Z.; Xiao, Q.; Dai, X.; Zhou, Z.; Jiang, R.; Cheng, Y.; Yang, X.; Guo, H.; Wang, J.; Xi, Z.; Yao, H.; Chao, J. 2017: CircHIPK2-mediated σ-1R promotes endoplasmic reticulum stress in human pulmonary fibroblasts exposed to silica. Cell Death and Disease 8(12): 3212
Qi, L.; Sun, B.; Yang, B.; Lu, S. 2021: CircHIPK3 (hsa_circ_0000284) Promotes Proliferation, Migration and Invasion of Breast Cancer Cells via miR-326. Oncotargets and Therapy 14: 3671-3685
Hong, W.; Zhang, Y.; Ding, J.; Yang, Q.; Xie, H.; Gao, X. 2020: CircHIPK3 Acts as Competing Endogenous RNA and Promotes Non-Small-Cell Lung Cancer Progression through the miR-107/BDNF Signaling Pathway. Biomed Research International 2020: 6075902
Chen, G.; Shi, Y.; Liu, M.; Sun, J. 2018: CircHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma. Cell Death and Disease 9(2): 175
Zhang, J-Xiang.; Lu, J.; Xie, H.; Wang, D-Peng.; Ni, H-Er.; Zhu, Y.; Ren, L-Hao.; Meng, X-Xiao.; Wang, R-Lan. 2019: CircHIPK3 regulates lung fibroblast-to-myofibroblast transition by functioning as a competing endogenous RNA. Cell Death and Disease 10(3): 182
Xu, Y.-P.; Dong, Z.-N.; Wang, S.-W.; Zheng, Y.-M.; Zhang, C.; Zhou, Y.-Q.; Zhao, Y.-J.; Zhao, Y.; Wang, F.; Peng, R.; Tang, M.-C.; Bai, D.-S.; Huang, X.-Y.; Guo, C.-Y. 2021: CircHMGCS1-016 reshapes immune environment by sponging miR-1236-3p to regulate CD73 and GAL-8 expression in intrahepatic cholangiocarcinoma. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 290
Li, Y.; Jiang, B.; He, Z.; Zhu, H.; He, R.; Fan, S.; Wu, X.; Xie, L.; He, X. 2020: CircIQCH sponges miR-145 to promote breast cancer progression by upregulating DNMT3A expression. Aging 12(15): 15532-15545
Liang, Y.; Song, X.; Li, Y.; Su, P.; Han, D.; Ma, T.; Guo, R.; Chen, B.; Zhao, W.; Sang, Y.; Zhang, N.; Li, X.; Zhang, H.; Liu, Y.; Duan, Y.; Wang, L.; Yang, Q. 2019: CircKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer. Oncogene 38(42): 6850-6866
Sheng, S.; Hu, Y.; Yu, F.; Tong, W.; Wang, S.; Cai, Y.; Zhu, J. 2020: CircKIF4A sponges miR-127 to promote ovarian cancer progression. Aging 12(18): 17921-17929
An, Q.; Liu, T.; Wang, M.-Y.; Yang, Y.-J.; Zhang, Z.-D.; Lin, Z.-J.; Yang, B. 2020: CircKRT7-miR-29a-3p-COL1A1 Axis Promotes Ovarian Cancer Cell Progression. Oncotargets and Therapy 13: 8963-8976
Yu, K.; Liu, M.; Huang, Y.; Yu, Q.; Ma, D.; Dai, G.; Chen, Y. 2021: CircMBOAT2 serves as the sponge of miR-433-3p to promote the progression of bladder cancer. Pathology Research and Practice 227: 153613
Zhou, F.; Wang, B.; Wang, H.; Hu, L.; Zhang, J.; Yu, T.; Xu, X.; Tian, W.; Zhao, C.; Zhu, H.; Liu, N. 2021: CircMELK promotes glioblastoma multiforme cell tumorigenesis through the miR-593/EphB2 axis. Molecular Therapy. Nucleic Acids 25: 25-36
Pei, X.; Chen, S.-W.; Long, X.; Zhu, S.-Q.; Qiu, B.-Q.; Lin, K.; Lu, F.; Xu, J.-J.; Zhang, P.-F.; Wu, Y.-B. 2020: CircMET promotes NSCLC cell proliferation, metastasis, and immune evasion by regulating the miR-145-5p/CXCL3 axis. Aging 12(13): 13038-13058
Li, P.; Song, R.; Yin, F.; Liu, M.; Liu, H.; Ma, S.; Jia, X.; Lu, X.; Zhong, Y.; Yu, L.; Li, X.; Li, X. 2022: CircMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma. Molecular Therapy: the Journal of the American Society of Gene Therapy 30(1): 431-447
Wang, P.; Zhou, C.; Li, D.; Zhang, D.; Wei, L.; Deng, Y. 2021: CircMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-β/Smad and EGFR pathways. Oncology Letters 22(1): 563
Wang, Z.; Chen, Y.; Wang, W.; Wang, H.; Liu, R. 2021: CircMYC promotes cell proliferation, metastasis, and glycolysis in cervical cancer by up-regulating MET and sponging miR-577. American Journal of Translational Research 13(6): 6043-6054
Li, B.; Zhu, L.; Lu, C.; Wang, C.; Wang, H.; Jin, H.; Ma, X.; Cheng, Z.; Yu, C.; Wang, S.; Zuo, Q.; Zhou, Y.; Wang, J.; Yang, C.; Lv, Y.; Jiang, L.; Qin, W. 2021: CircNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nature Communications 12(1): 295
Jia, C.; Yao, Z.; Lin, Z.; Zhao, L.; Cai, X.; Chen, S.; Deng, M.; Zhang, Q. 2021: CircNFATC3 sponges miR-548i acts as a ceRNA to protect NFATC3 itself and suppressed hepatocellular carcinoma progression. Journal of Cellular Physiology 236(2): 1252-1269
Xiao, E.; Zhang, D.; Zhan, W.; Yin, H.; Ma, L.; Wei, J.; Kang, Y.; Mao, Z. 2021: CircNFIX facilitates hepatocellular carcinoma progression by targeting miR-3064-5p/HMGA2 to enhance glutaminolysis. American Journal of Translational Research 13(8): 8697-8710
Xie, F.; Xiao, X.; Tao, D.; Huang, C.; Wang, L.; Liu, F.; Zhang, H.; Niu, H.; Jiang, G. 2020: CircNR3C1 Suppresses Bladder Cancer Progression through Acting as an Endogenous Blocker of BRD4/C-myc Complex. Molecular Therapy. Nucleic Acids 22: 510-519
Chen, L.; Li, W.; Li, Z.; Song, Y.; Zhao, J.; Chen, Z.; Kazobinka, G.; Li, L.; Xing, Y.; Hou, T. 2021: CircNUDT21 promotes bladder cancer progression by modulating the miR-16-1-3p/MDM2/p53 axis. Molecular Therapy. Nucleic Acids 26: 625-636
Li, F.; Long, T.-Y.; Bi, S.-S.; Sheikh, S.A.; Zhang, C.-L. 2020: CircPAN3 exerts a profibrotic role via sponging miR-221 through FoxO3/ATG7-activated autophagy in a rat model of myocardial infarction. Life Sciences 257: 118015
Gao, W.; Guo, H.; Niu, M.; Zheng, X.; Zhang, Y.; Xue, X.; Bo, Y.; Guan, X.; Li, Z.; Guo, Y.; He, L.; Zhang, Y.; Li, L.; Cao, J.; Wu, Y. 2020: CircPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Molecular Cancer 19(1): 166
Fang, Q.; Yang, A.; Dong, A.; Zhao, L. 2020: CircPDSS1 Stimulates the Development of Colorectal Cancer via Activating the Wnt/β-Catenin Signaling. Oncotargets and Therapy 13: 6329-6337
Su, W.; Shen, Y.; Wang, Y.; Wang, F.; Hong, X.; Chen, Y.; Lin, Y.; Yang, H. 2021: CircPHIP promotes oral squamous cell carcinoma progression by sponging miR-142-5p and regulating PHIP and ACTN4 expression. Molecular Therapy. Nucleic Acids 23: 185-199
Liu, H.; Hu, G.; Wang, Z.; Liu, Q.; Zhang, J.; Chen, Y.; Huang, Y.; Xue, W.; Xu, Y.; Zhai, W. 2020: CircPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis. Theranostics 10(23): 10791-10807
Deng, L.; Chen, Q.; Xie, J.; Wei, W.; Hui, H. 2020: CircPUM1 promotes polycystic ovary syndrome progression by sponging to miR-760. Gene 754: 144903
Zheng, X.; Rui, S.; Wang, X.-F.; Zou, X.-H.; Gong, Y.-P.; Li, Z.-H. 2021: CircPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/CXCR4 signaling. Journal of Experimental and Clinical Cancer Research: Cr 40(1): 157
Du, J.; Xu, J.; Chen, J.; Liu, W.; Wang, P.; Ye, K. 2020: CircRAE1 promotes colorectal cancer cell migration and invasion by modulating miR-338-3p/TYRO3 axis. Cancer Cell International 20: 430
Wu, D.; Xia, A.; Fan, T.; Li, G. 2021: CircRASGRF2 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1224 sponge. Molecular Therapy. Nucleic Acids 23: 13-26
Chen, M.; Yang, Y.; Zeng, J.; Deng, Z.; Wu, B. 2020: CircRNA Expression Profile in Dental Pulp Stem Cells during Odontogenic Differentiation. Stem Cells International 2020: 5405931
Xin, T.; Li, S.; Zhang, Y.; Kamali, X.; Liu, H.; Jia, T. 2020: CircRNA Hsa_circ_0020850 Silence Represses the Development of Lung Adenocarcinoma via Regulating miR-195-5p/IRS2 Axis. Cancer Management and Research 12: 10679-10692
Chen, R.; Mao, L.; Shi, R.; Wang, W.; Cheng, J. 2020: CircRNA MYLK Accelerates Cervical Cancer via Up-Regulation of RHEB and Activation of mTOR Signaling. Cancer Management and Research 12: 3611-3621
Wang, Z.; Jiang, Z.; Zhou, J.; Liu, Z. 2020: CircRNA RNF111 regulates the growth, migration and invasion of gastric cancer cells by binding to miR‑27b‑3p. International Journal of Molecular Medicine 46(5): 1873-1885
Fang, X.; Wang, J.; Chen, L.; Zhang, X. 2021: CircRNA circ_POLA2 increases microRNA-31 methylation to promote endometrial cancer cell proliferation. Oncology Letters 22(5): 762
Ni, S.; Jiang, T.; Hao, S.; Luo, P.; Wang, P.; Almatari, Y.; Wang, Y.; Zhang, Z.; Guo, L. 2021: CircRNA expression pattern and ceRNA network in the pathogenesis of aseptic loosening after total hip arthroplasty. International Journal of Medical Sciences 18(3): 768-777
Song, H.-M.; Meng, D.; Wang, J.-P.; Zhang, X.-Y. 2021: CircRNA hsa_circ_0005909 Predicts Poor Prognosis and Promotes the Growth, Metastasis, and Drug Resistance of Non-Small-Cell Lung Cancer via the miRNA-338-3p/SOX4 Pathway. Disease Markers 2021: 8388512
Yao, Y.; Zhou, Y.; Hua, Q. 2021: CircRNA hsa_circ_0018414 inhibits the progression of LUAD by sponging miR-6807-3p and upregulating DKK1. Molecular Therapy. Nucleic Acids 23: 783-796
Liu, G.; Guo, W.; Rao, M.; Qin, J.; Hu, F.; Li, K. 2020: CircRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression. Cell Transplantation 29: 963689720963948
Zheng, T.; Gan, M.L.; Shen, L.Y.; Niu, L.L.; Guo, Z.Y.; Wang, J.Y.; Zhang, S.H.; Zhu, L. 2020: CircRNA on animal skeletal muscle development regulation. Yi Chuan 42(12): 1178-1191
Wang, J.; Zhao, X.; Wang, Y.; Ren, F.; Sun, D.; Yan, Y.; Kong, X.; Bu, J.; Liu, M.; Xu, S. 2020: CircRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death and Disease 11(1): 32
Xu, Q.; Deng, B.; Li, M.; Chen, Y.; Zhuan, L. 2020: CircRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382-5p/PRPF8 axis. Journal of Ovarian Research 13(1): 81
Su, Y.; Yi, Y.; Li, L.; Chen, C. 2021: CircRNA-miRNA-mRNA network in age-related macular degeneration: from construction to identification. Experimental Eye Research 203: 108427
Peng, Q-Shi.; Cheng, Y-Nan.; Zhang, W-Bai.; Fan, H.; Mao, Q-Hua.; Xu, P. 2020: CircRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway. Cell Death and Disease 11(2): 112
Zhang, X.; Yang, H.; Jia, Y.; Xu, Z.; Zhang, L.; Sun, M.; Fu, J. 2021: CircRNA_0005529 facilitates growth and metastasis of gastric cancer via regulating miR-527/Sp1 axis. Bmc Molecular and Cell Biology 22(1): 6
Guo, X-Ya.; Sun, F.; Chen, J-Neng.; Wang, Y-Qin.; Pan, Q.; Fan, J-Gao. 2018: CircRNA_0046366 inhibits hepatocellular steatosis by normalization of PPAR signaling. World Journal of Gastroenterology 24(3): 323-337
Chen, L.; Zhang, S.; Wu, J.; Cui, J.; Zhong, L.; Zeng, L.; Ge, S. 2017: CircRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene 36(32): 4551-4561
Zhou, P.; Xie, W.; Huang, H.-L.; Huang, R.-Q.; Tian, C.; Zhu, H.-B.; Dai, Y.-H.; Li, Z.-Y. 2020: CircRNA_100859 functions as an oncogene in colon cancer by sponging the miR-217-HIF-1α pathway. Aging 12(13): 13338-13353
Jin, Y.; Zhang, Y.; Luo, X. 2021: CircRNA_PTPRA functions as a sponge of miR-582-3p to regulate hepatocellular carcinoma cell proliferation, migration, invasion and apoptosis. Experimental and Therapeutic Medicine 22(5): 1276
Yu, X.; Zhang, Y.; Jiang, C.; Zhan, F.; Shen, Z.; Shen, Z.; Zhang, F. 2021: CircSLC30A7 Inhibits Hepatocellular Carcinoma Cell Proliferation via the miR-767-5p/FBXW7/NOTCH1 Axis. Journal of Oncology 2021: 8800657
Hu, J.; Peng, X.; Du, W.; Huang, Y.; Zhang, C.; Zhang, X. 2021: CircSLC6A6 Sponges miR-497-5p to Promote Endometrial Cancer Progression via the PI4KB/Hedgehog Axis. Journal of Immunology Research 2021: 5512391
Wang, D.; Yan, S.; Wang, L.; Li, Y.; Qiao, B. 2021: CircSLC8A1 Acts as a Tumor Suppressor in Prostate Cancer via Sponging miR-21. Biomed Research International 2021: 6614591
Zhang, H.; Meng, F.; Dong, S. 2020: CircSMARCA5 Promoted Osteosarcoma Cell Proliferation, Adhesion, Migration, and Invasion through a Competing Endogenous RNA Network. Biomed Research International 2020: 2539150
Zhu, K.; Zhu, J.; Geng, J.; Zhang, Y.; Qin, Y.; Wang, F.; Weng, Y. 2021: CircSNX6 (hsa_circ_0031608) enhances drug resistance of non-small cell lung cancer (NSCLC) via miR-137. Biochemical and Biophysical Research Communications 567: 79-85
Tan, S.; Kang, Y.; Li, H.; He, H-Qing.; Zheng, L.; Wu, S-Qing.; Ai, K.; Zhang, L.; Xu, R.; Zhang, X-Zhi.; Zhao, X-Kun.; Zhu, X. 2021: CircST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis. Cell Death and Disease 12(2): 168
Hu, L.; Fang, L.; Zhang, Z.; Yan, Z. 2021: CircTADA2A Retards the Progression of Colorectal Cancer via Regulating miR-1229/BCL2L10 Signal Axis. Cancer Management and Research 13: 6811-6821
Xu, J-Zhen.; Shao, C-Chun.; Wang, X-Jia.; Zhao, X.; Chen, J-Qing.; Ouyang, Y-Xiu.; Feng, J.; Zhang, F.; Huang, W-He.; Ying, Q.; Chen, C-Fa.; Wei, X-Long.; Dong, H-Yan.; Zhang, G-Jun.; Chen, M. 2019: CircTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death and Disease 10(3): 175
Lei, X.; Yang, M.; Xiao, Z.; Zhang, H.; Tan, S. 2021: CircTLK1 facilitates the proliferation and metastasis of renal cell carcinoma by regulating miR-495-3p/CBL axis. Open Life Sciences 16(1): 362-374
Cheng, Z.; Yu, C.; Cui, S.; Wang, H.; Jin, H.; Wang, C.; Li, B.; Qin, M.; Yang, C.; He, J.; Zuo, Q.; Wang, S.; Liu, J.; Ye, W.; Lv, Y.; Zhao, F.; Yao, M.; Jiang, L.; Qin, W. 2019: CircTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nature Communications 10(1): 3200
Yu, J.; Shen, W.; Xu, J.; Gong, B.; Gao, B.; Zhu, J. 2020: CircUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated with Poor Prognosis. Technology in Cancer Research and Treatment 19: 1533033820950827
Chen, H.; Zhang, Y.; Wu, K.; Qiu, X. 2021: CircVAPA promotes the proliferation, migration and invasion of oral cancer cells through the miR-132/HOXA7 axis. Journal of International Medical Research 49(6): 3000605211013207
Zhao, M.; Qu, H. 2020: CircVAR database: genome-wide archive of genetic variants for human circular RNAs. Bmc Genomics 21(1): 750
Zhang, X-Yun.; Tang, H.; Liu, Y.; Du, N.; Tian, S.; Dou, Y-Qing. 2021: CircYap inhibits oral squamous cell carcinoma by arresting cell cycle. Acta Odontologica Scandinavica 2021: 1-8
Chen, H.; Wu, C.; Luo, L.; Wang, Y.; Peng, F. 2021: Circ_0000467 promotes the proliferation, metastasis, and angiogenesis in colorectal cancer cells through regulating KLF12 expression by sponging miR-4766-5p. Open Medicine 16(1): 1415-1427
Ai, Y.; Song, J.; Wei, H.; Tang, Z.; Li, X.; Lv, X.; Luo, H.; Wu, S.; Zou, C. 2021: Circ_0001461 promotes oral squamous cell carcinoma progression through miR-145/TLR4/NF-κB axis. Biochemical and Biophysical Research Communications 566: 108-114
Chen, F.; Zheng, H.; Zhang, W.; Kang, J.; Liu, Q.; Pu, J.; Yang, L. 2021: Circ_0003170 aggravates human hippocampal neuron injuries by regulating the miR-421/CCL2 axis in cells models of epilepsy. General Physiology and Biophysics 40(2): 115-126
Wan, H.; You, T.; Luo, W. 2021: Circ_0003204 Regulates Cell Growth, Oxidative Stress, and Inflammation in ox-LDL-Induced Vascular Endothelial Cells via Regulating miR-942-5p/HDAC9 Axis. Frontiers in Cardiovascular Medicine 8: 646832
Zhou, H.-X.; Wang, L.-Y.; Chen, S.; Wang, D.-D.; Fang, Z. 2021: Circ_0005379 inhibits the progression of oral squamous cell carcinoma by regulating the miR-17-5p/acyl-CoA oxidase 1 axis. Hua Xi Kou Qiang Yi Xue Za Zhi 39(4): 425-433
Zhang, Z.; Shan, Z.; Chen, R.; Peng, X.; Xu, B.; Xiao, L.; Zhang, G. 2021: Circ_0005962 functions as an oncogene to aggravate NSCLC progression. Open Medicine 16(1): 997-1009
Ye, Y.; Zhao, L.; Li, Q.; Xi, C.; Li, Y.; Li, Z. 2020: Circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells. Thoracic cancer 11(8): 2196-2208
Ren, K.; Li, B.; Jiang, L.; Liu, Z.; Wu, F.; Zhang, Y.; Liu, J.; Duan, W. 2021: Circ_0023461 Silencing Protects Cardiomyocytes from Hypoxia-Induced Dysfunction through Targeting miR-370-3p/PDE4D Signaling. Oxidative Medicine and Cellular Longevity 2021: 8379962
Shao, Y.; Yang, Z.; Miao, W.; Yu, X.; Wu, Y.; Pu, Y. 2021: Circ_0030018 promotes glioma proliferation and metastasis. Translational Neuroscience 12(1): 260-272
Wang, Q.; Cang, Z.; Shen, L.; Peng, W.; Xi, L.; Jiang, X.; Ge, X.; Xu, B.; Huang, S. 2021: Circ_0037128/miR-17-3p/AKT3 axis promotes the development of diabetic nephropathy. Gene 765: 145076
Jin, X.; Wang, L.; Yang, M. 2021: Circ_0038467 promotes PM2.5-induced bronchial epithelial cell dysfunction. Open Medicine 16(1): 854-863
Zhou, C.; Li, R.; Mi, W. 2020: Circ_0067934: a Potential Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Annals of Clinical and Laboratory Science 50(6): 734-738
Qu, X.; Zhu, L.; Song, L.; Liu, S. 2020: Circ_0084927 promotes cervical carcinogenesis by sponging miR-1179 that suppresses CDK2, a cell cycle-related gene. Cancer Cell International 20: 333
Bai, L.; Gao, Z.; Jiang, A.; Ren, S.; Wang, B. 2021: Circ_0101802 functions as a sponge of miR-1236-3p to facilitate the proliferation, migration and invasion of colorectal cancer via regulating MACC1. Journal of Pharmacological Sciences 147(1): 104-113
Li, Y.; Zang, H.; Zhang, X.; Huang, G. 2020: Circ_0136666 Facilitates the Progression of Colorectal Cancer via miR-383/CREB1 Axis. Cancer Management and Research 12: 6795-6806
Zhu, L.-S.; Wang, Y.-L.; Li, R.; Xu, X.-T.; Li, K.-Y.; Zuo, C.-R. 2020: Circ_BICD2 acts as a ceRNA to promote tumor progression and Warburg effect in oral squamous cell carcinoma by sponging miR-107 to enhance HK2. American Journal of Translational Research 12(7): 3489-3500
Yin, J.; Huang, H-Yan.; Long, Y.; Ma, Y.; Kamalibaike, M.; Dawuti, R.; Li, L. 2021: Circ_C20orf11 enhances DDP resistance by inhibiting miR-527/YWHAZ through the promotion of extracellular vesicle-mediated macrophage M2 polarization in ovarian cancer. Cancer Biology and Therapy 2021: 1-15
Wu, S.; Yang, S.; Qu, H. 2021: Circ_CHFR regulates ox-LDL-mediated cell proliferation, apoptosis, and EndoMT by miR-15a-5p/EGFR axis in human brain microvessel endothelial cells. Open Life Sciences 16(1): 1053-1063
Wang, M.; Yang, Y.; Yang, J.; Yang, J.; Han, S. 2020: Circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m6A-YTHDF3-Zeb1. Life Sciences 257: 118082
Guan, B.; Li, Q.; Zhang, H.-Z.; Yang, H.-S. 2020: Circ_NOTCH3 Functions as a Protooncogene Competing with miR-205-5p, Modulating KLF12 Expression and Promoting the Development and Progression of Basal-Like Breast Carcinoma. Frontiers in Oncology 10: 602694
Zhou, S.; Guo, Z.; Zhou, C.; Zhang, Y.; Wang, S. 2021: Circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway. Cancer Cell International 21(1): 250
Zhang, W.; Wu, G.; Sun, P.; Zhu, Y.; Zhang, H. 2021: Circ_SMAD2 regulate colorectal cancer cells proliferation through targeting miR-1258/RPN2 signaling pathway. Journal of Cancer 12(6): 1678-1686
Wang, Q.; Zhang, X.; Chen, D. 2021: Circ_VMA21 protects WI-38 cells against LPS-induced apoptotic and inflammatory injury by acting on the miR-409-3p/KLF4 axis. General Physiology and Biophysics 40(4): 275-287
Tsipis, A.C. 2020: Cis- and trans-Ligand Effects on the Inverse trans-Influence in [UVI(O)(L)Cl4]0/- (L = Unidentate Ligand) Complexes. Inorganic Chemistry 59(13): 8946-8959
Cao, Q.; Lu, X.; Azad, B.B.; Pomper, M.; Smith, M.; He, J.; Pi, L.; Ren, B.; Ying, Z.; Sichani, B.S.; Morris, M.; Dilsizian, V. 2020: Cis-4-[18F]fluoro-L-proline Molecular Imaging Experimental Liver Fibrosis. Frontiers in Molecular Biosciences 7: 90
Ben Jamaa, A.; Latrache, M.; Riguet, E.; Grellepois, F. 2020: Cis-Dihydroxylated α-Trifluoromethylated N,O-Acetal from l-Tartaric Acid: Synthesis of Tetrasubstituted Stereocenter via Diastereoselective Pictet-Spengler Cyclization of N-Acyliminium Ions. Journal of Organic Chemistry 85(15): 9585-9598
Ahlburg, N.L.; Jones, P.G.; Werz, D.B. 2020: Cis-Selective, Enantiospecific Addition of Donor-Acceptor Cyclopropanes to Activated Alkenes: An Iodination/Michael-Cyclization Cascade. Organic Letters 22(16): 6404-6408
Carlotto, S.; Casella, G.; Sambi, M.; Casarin, M. 2021: Cis-[(η5-C5H5)Fe(η1-CO)(μ-CO)]2, the poor relative between cis and trans tautomers. a theoretical study of the gas-phase Fe L3-edge and C and O K-edge XAS of trans-/cis-[(η5-C5H5)Fe(η1-CO)(μ-CO)]2. Physical Chemistry Chemical Physics: Pccp 23(43): 24661-24668
Merritt, I.C.D.; Jacquemin, D.; Vacher, M. 2021: Cis → trans photoisomerisation of azobenzene: a fresh theoretical look. Physical Chemistry Chemical Physics: Pccp 23(35): 19155-19165
O'Brien, P.; Poyner, E.A.; Alraddadi, T.S.; Hursthouse, M.B.; Foxman, B.M. 2021: Cis-Bis(L-DOPA-κ2N,O)copper(II) monohydrate: synthesis, crystal structure, and approaches to the analysis of pseudosymmetry. Acta Crystallographica. Section C Structural Chemistry 77(Part 7): 383-390
Izzi, L.; Turbide, C.; Houde, C.; Kunath, T.; Beauchemin, N. 1999: Cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 18(40): 5563-5572
Leyfer, D.; Bond, A.; Tworog, E.; Perron, D.; Maska, S.; Brito, A.; Kamens, J.; Weng, Z.; Voss, J. 2004: Cis-Element clustering correlates with dose-dependent pro- and antisignaling effects of IL18. Genes and Immunity 5(5): 354-362
Michaelson, J.; Ferreira, A.; Nussenzweig, V. 1981: Cis-Interacting genes in the S region of the murine major histocompatibility complex. Nature 289(5795): 306-308
Kaneko, K.; Walker, S.L.; Lai-Cheong, J.; Matsui, M.S.; Norval, M.; Young, A.R. 2011: Cis-Urocanic acid enhances prostaglandin E2 release and apoptotic cell death via reactive oxygen species in human keratinocytes. Journal of Investigative Dermatology 131(6): 1262-1271
Kaneko, K.; Travers, J.B.; Matsui, M.S.; Young, A.R.; Norval, M.; Walker, S.L. 2009: Cis-Urocanic acid stimulates primary human keratinocytes independently of serotonin or platelet-activating factor receptors. Journal of Investigative Dermatology 129(11): 2567-2573
Macdonald, P.M.; Struhl, G. 1988: Cis-acting sequences responsible for anterior localization of bicoid mRNA in Drosophila embryos. Nature 336(6199): 595-598
Pasic, T.R.; Dobie, R.A. 1991: Cis-platinum ototoxicity in children. Laryngoscope 101(9): 985-991
Johnson, E.S.; Gonda, D.K.; Varshavsky, A. 1990: Cis-trans recognition and subunit-specific degradation of short-lived proteins. Nature 346(6281): 287-291
Bravo González-Blas, C.; Minnoye, L.; Papasokrati, D.; Aibar, S.; Hulselmans, G.; Christiaens, V.; Davie, K.; Wouters, J.; Aerts, S. 2019: CisTopic: cis-regulatory topic modeling on single-cell ATAC-seq data. Nature Methods 16(5): 397-400
Wu, T.; Hu, E.; Xu, S.; Chen, M.; Guo, P.; Dai, Z.; Feng, T.; Zhou, L.; Tang, W.; Zhan, L.; Fu, X.; Liu, S.; Bo, X.; Yu, G. 2021: ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2(3): 100141
Modell, A.E.; Siriwardena, S.U.; Shoba, V.M.; Li, X.; Choudhary, A. 2021: Chemical and optical control of CRISPR-associated nucleases. Current Opinion in Chemical Biology 60: 113-121
Fu, R.; Gillen, A.E.; Sheridan, R.M.; Tian, C.; Daya, M.; Hao, Y.; Hesselberth, J.R.; Riemondy, K.A. 2020: Clustifyr: an R package for automated single-cell RNA sequencing cluster classification. F1000research 9: 223
Aquino-Nunez, W.; Mielko, Z.E.; Dunn, T.; Santorella, E.M.; Hosea, C.; Leitner, L.; McCalla, D.; Simms, C.; Verola, W.M.; Vijaykumar, S.; Hudson, M.L. 2020: Cnd-1/NeuroD1 Functions with the Homeobox Gene ceh-5/Vax2 and Hox Gene ceh-13/labial to Specify Aspects of RME and DD Neuron Fate in Caenorhabditis elegans. G3 10(9): 3071-3085
Oberti, M.; Vaisman, I.I. 2020: CnnAlpha: Protein disordered regions prediction by reduced amino acid alphabets and convolutional neural networks. Proteins 88(11): 1472-1481
Coin, L.J.M.; Asher, J.E.; Walters, R.G.; Moustafa, J.S.El-Sayed.; de Smith, A.J.; Sladek, R.; Balding, D.J.; Froguel, P.; Blakemore, A.I.F. 2010: CnvHap: an integrative population and haplotype-based multiplatform model of SNPs and CNVs. Nature Methods 7(7): 541-546
Crawford, R.D.; Snitkin, E.S. 2021: Cognac: rapid generation of concatenated gene alignments for phylogenetic inference from large, bacterial whole genome sequencing datasets. Bmc Bioinformatics 22(1): 70
Rodríguez de Castro, A.; Goyeau, B. 2021: A pore network modelling approach to investigate the interplay between local and Darcy viscosities during the flow of shear-thinning fluids in porous media. Journal of Colloid and Interface Science 590: 446-457
Drapkina, O.M.; Samorodskaya, I.V.; Semenov, V.Y.; Zairatyants, O.V. 2020: Comparative analysis of variability of mortality rates from various causes in the subjects of Russian Federation. Arkhiv Patologii 82(3): 31-37
Boucher, R.; Bernier, J. 1947: Conic fungus with tumor fungus; presumption of a case. L'Union Medicale du Canada 76(4): 422-428
Arena, A.R.; Gomez, J.B.; Brisco Capurro, A.I. 1948: Consumption of the city of Buenos Aires. Medicina 8(4): 271-281
Landgraf, K.E.; Williams, S.R.; Steiger, D.; Gebhart, D.; Lok, S.; Martin, D.W.; Roybal, K.T.; Kim, K.Chan. 2020: ConvertibleCARs: A chimeric antigen receptor system for flexible control of activity and antigen targeting. Communications Biology 3(1): 296
Wu, L.; Shimada, N.; Kano, A.; Maruyama, A. 2008: Copolymer accelerates DNA hybridization by two orders. Soft Matter 4(4): 744-747
Zeng, P.; Lin, Z. 2021: CoupleCoC+: An information-theoretic co-clustering-based transfer learning framework for the integrative analysis of single-cell genomic data. Plos Computational Biology 17(6): E1009064
Niburski, K. 2020: Courvoisier's law. JAMA 324(13): 1355
Revell, L.J. 2021: Covid19.Explorer: a web application and R package to explore United States COVID-19 data. Peerj 9: E11489